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SUMMARY 
The development of biosensors represents a rapidly growing area at the 
interface of chemistry, biochemistry, physics and of nanotechnology. A biosensor 
is an analytical device that relies on a biological recognition element, such as an 
enzyme, an antibody, a DNA fragment, which communicates with a signal 
transducer, thus providing a measurable response related to the concentration of 
an analyte.  
The common aim in biosensor development is to produce either discrete or 
continuous digital electronic signals that are proportional to a single analyte 
concentration.  
The development of most biosensors involves the identification of naturally 
occurring macromolecules that provide the desired analyte specificity (typically an 
enzyme or antibody): this macromolecule represents the recognition element of 
the sensor. Once identified, a suitable signal transduction and detection 
methodology needs to be developed to transform the biological event, occurring 
between the recognition element and the specific analyte, in a measurable signal. 
Currently, electrochemical biosensors, which exploit an electron transfer (ET) 
event at a solid electrode for the signal transduction, are the larger and most 
promising biosensor category in terms of ease of construction, costs, versatility, 
tunability and miniaturization (up to the nanoscale) for in vivo applications. 
A key factor for the development of these devices is the strategy for ensuring a 
fast electrical communication between the biological recognition element and the 
electrode. The first- and second-generation biosensors use natural (enzyme 
products) and artificial (dye molecules) “mediators”, which are freely diffusing 
molecules that shuttle electrons between the recognition element and the 
electrode. These systems suffered several drawbacks, especially regarding 
selectivity, interfering reactions and stability of the system. 
A real breakthrough toward the development of electrochemical systems with 
superior selectivity, stability and durability is represented by the third generation 
biosensors. These devices exploit the unmediated direct electron transfer 
occurring at interfaces made up of an electrode immobilized redox-active specie, 
with a current transduction of the biological interaction, resulting in an 
amperometric detection of the analyte. An attractive feature of systems based on 
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direct electron transfer is the possibility of modulating the properties of the 
analytical device using protein modification with genetic or chemical engineering 
techniques. 
Efficient direct electron transfer (DET) reactions have been reported for a 
restricted number of redox enzymes. The majority of these redox enzymes contain 
metal sites and particularly heme. The heme electrochemical properties, such as 
the formal redox potential for the Fe2+/Fe3+ couple, can be varied over a wide 
range of potentials by changing the protein environment. By itself, heme exhibits 
several catalytic properties, which drastically change when incorporated into a 
protein environment. This creates wonderful opportunities for heme-proteins, in 
terms of their electrochemical applications, especially in the field of biosensors. 
Nevertheless, several studies based on heme-proteins adsorbed or immobilized 
on various electrodes showed that high-molecular weight enzymes are not 
amenable to direct electrical communication with the electrode. The 
heterogeneous ET with the redox-active centre is unfavoured, due to unavailability 
of efficient ET routes, also due to partial or full protein unfolding/denaturation on 
the electrodesurface. 
Our strategy to overcome the above limitations is the exploitation of artificial 
low-molecular weight proteins, designed on rational bases, to possess the 
required activity. In our laboratory, a new class of heme-peptide conjugate, named 
Mimochromes, have been developed, with the aim of understanding the effects of 
the peptide chain composition and conformation in  modulating the heme redox 
potential. The main features of these molecules are the covalent structure and the 
well defined helical conformation of the peptide chains linked to the 
deuteroporphyrin ring. 
The presented work exploits the use of two different class of Mimochromes, 
the penta-coordinated Fe(III)-Mimochrome VI and the esa-coordinated Fe(III)-
Mimochrome IV Lys3, in biosensor technology. These two artificial molecules were 
used as bio-recognition elements/signal transducers for biosensing. The aim of 
this thesis was to develop and optimise catalytic and affinity-based biosensors for 
the rapid screening of target analytes in complex matrices. 
In a first step, the two synthetic heme-protein models were characterized by 
square wave and cyclic voltammetry, freely diffusing and bound to a gold electrode 
surface, to analyse their electrochemical behaviour. 
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An affinity electrochemical immunosensor was developed taking advantage of 
the ability of Fe(III)-Mimochrome IV Lys3 to act as a redox tag for the detection of 
the binding event between electrochemically inactive species. The system realized 
comprises a gold electrode on which the electron transfer protein,  Fe(III)-
Mimochrome IV Lys3, was covalently anchored through the formation of a self-
assembled monolayer (SAM) of 11-mercaptoundecanoic acid. This protein is 
functionalized with a suitable recognition element: in particular, an epitope 
(corresponding to the aminoacids 98-106) of the human influenza virus 
hemagglutinin (HA), recognized by an anti-HA monoclonal antibody, was used. 
The assembled biosensor was characterized with voltammetric techniques and 
then tested for analyte recognition. The results clearly demonstrated that the 
binding of the specific analyte to the recognition element affects the redox 
properties of the metal ion encapsulated into Fe(III)-Mimochrome IV Lys3. This 
makes the developed device a future candidate for use in antibody detection, and 
may have interesting applications in the diagnostic field. 
A bio-catalytic electrochemical biosensor was developed by adsorbing, via 
hydrophobic interactions, Fe(III)-Mimochrome VI on a SAM of 1-decanthiol. 
Mimochrome VI was developed to engineer into the Mimochrome scaffold a 
catalytic site, by creating a cavity able to accommodate small molecules and/or 
substrates. It is an attractive system to be exploited as novel catalyst or as a 
constituent of hybrid synthetic interfaces in electrochemical sensing devices. 
Cyclic voltammetry experiments were performed to study the thermodynamics 
and kinetics of the electron transfer process for the Fe(III)/Fe(II) couple of the 
immobilized molecule, and the ability of this construct to electrocatalitically turn 
over molecular oxygen. This study opens the way to the development of 
electrocatalytic hybrid Mimochrome-modified electrode surfaces for biosensing in 
the clinical and pharmaceutical areas. 
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Chapter 1: Biosensors, general principles 
 
 
1.1 Biosensors: history and definition 
The field of biosensors represents a rapidly expanding research area devoted 
to the development of devices to determine the concentration analytes in complex 
samples. The most important step for biosensors development was made by Clark 
and Lyons in 1962, who created the first enzyme biosensor, as a result of the work 
with oxygen electrodes by Clark (Clark, 1956). They suggested the possibility of 
using enzyme-containing membranes to transform glucose into a product that 
could be detected with an oxygen electrode, for a rapid, simple and accurate 
detection of glucose.  In their work, it was described for the first time how to make 
an electrochemical sensor after the attachment of an enzyme onto a transducer. In 
particular, glucose oxidase was attached on the oxygen electrode and by 
measuring the decrease of oxygen concentration it was possible to determine the 
concentration of glucose in the sample. Based on Clark‟s pioneering work (Clark 
and Lyons, 1962), the first biosensor was commercialized in 1975 by the Yellow 
Springs Instrument Company (Ohio). It was a glucose analyzer based on the 
amperometric detection of hydrogen peroxide. The original model of glucose 
analyzer has been superseded by more advanced devices, but the basic 
construction of the biosensor has changed little over the years: glucose oxidase is 
immobilized between two membrane layers. The outer polycarbonate membrane 
retains the enzyme, allows glucose to pass, but prevents larger molecules from 
entering, thus reducing interference. The glucose enters the enzyme layer, where 
it is oxidized, producing hydrogen peroxide. This passes through the cellulose 
acetate membrane to a platinum electrode where it is measured amperometrically. 
The second membrane acts as a further size exclusion barrier preventing other 
potentially interfering (electroactive) compounds from reaching the electrode 
surface. 
Since then, scientists from different and complementary disciplines (chemistry, 
biochemistry, physics, molecular biology and material science) have contributed to 
this multidisciplinary field, developing more reliable and robust biosensing devices 
3 
 
(Figure 1.1) for applications in diagnostic, veterinary, agriculture, food quality, 
environmental analysis, and bioterrorism prevention. 
 
 
IUPAC defines chemical and biological sensors as in the following: A chemical 
sensor is a device that transforms chemical information, ranging from the 
concentration of a specific sample component to total composition analysis, into 
an analytically useful signal. Chemical sensors usually contain two basic 
components connected in series: a chemical (molecular) recognition system 
(receptor) and a physicochemical transducer. Biosensors are chemical sensors in 
which the recognition system utilizes a biochemical mechanism (Thévenot et al., 
2001). 
The biological recognition system translates information, usually an analyte 
concentration,  from the biochemical domaininto a chemical or physical output 
signal with a defined sensitivity (Figure 1.2). The main purpose of the recognition 
system is to provide the sensor with a high degree of selectivity for the analyte to 
be measured (Thévenot et al., 2001). Biosensing takes advantage of the bio-
recognition elements such as whole-cells, cell organelles, tissues, enzymes, 
antibodies, nucleic acids, proteins and peptides. The fast developments in 
molecular biology and biomolecular engineering continuously expand the list of 
possible biological and synthetic bio-recognition elements with great speed. 
 The biological recognition event needs to be transformed into a measurable 
signal in conjunction with a physicochemical transduction mechanism. The 
behavior of both elements, the high specificity of the bio-molecules and the 
Figure 1.1: Historical timeline displaying the evolutionary milestones in biosensors 
development. 
4 
 
sensitivity of the transducer mechanism (electrochemical, optical, electrical, 
piezoelectric, thermal and magnetic) (Collings and Caruso, 1997), make possible 
to recognize and quantify specific 
molecules in a complex solution. 
The advances in transduction are 
closely linked to the accelerated 
technological breakthroughs related 
to electronics, informatics, data 
mining, and computer technologies. 
Signal transduction and data 
analysis research, oriented to 
lowering the cost and portability of 
biosensor analysis, are areas of high 
activity in electrical and electronic 
engineering, and analytical chemistry 
bringing to the construction of more 
reliable and easy to use biosensors. 
The coupling between the bio-
recognition molecule and the 
transducer is often a critical step in 
biosensor development and can be 
performed by membrane 
entrapment, physical adsorption, 
matrix entrapment, or covalent 
binding among others. It is important 
to maintain the bio-recognition capacity during such procedures, while at the same 
time guarantee the robustness and reproducibility of the sensor. 
 
1.2 Biosensors: classification 
Biosensors can be classified according to the biological specificity conferring 
mechanism (recognition element), or to the type of signal transduction or, 
alternatively, to a combination of the two. They can also be described on the basis 
of the measurement mode. 
 
Figure 1.2: Schematic diagram 
showing the main components of a 
biosensor. The bioreceptor binds the 
analyte. This event is transformed 
by the transducer, which converts it 
to an electrical signal. The output 
from the transducer is amplified, 
processed and displayed . 
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1.2.1 Biosensors classification according to the bio-recognition element 
Biosensors can be classified according to the type of biological recognition. 
The interaction of the biological element with a specific analyte can be either 
“productive” or “non-productive”. 
 “Productive interaction” is specific to biological catalysis. The biological 
recognition elements are made up of enzymes or enzymatic cascades. 
 “Non-productive” recognition is represented by biological affinity interaction, 
such as antigen-antibody binding, ligand receptor interactions,  or DNA-DNA 
hybridization (Figure 1.3).  
Several molecules or whole cells can be used as bio-recognition elements, 
and the most relevant are discussed below. A particular relevance has been given 
to enzymatic and immunoaffinity biosensors, since these sensors have been 
studied during the present project. 
a. DNA biosensors: They are commonly employed to detect specific 
sequences of DNA. These biosensors usually employ short synthetic 
oligodeoxynucleotides for detecting target DNAs with the same length 
(Palecek, 2002). They can reach high levels of selectivity and affinity based 
on the hybridization between a DNA target and its complementary probe, 
which is present either in solution or on a solid support. The system can be 
used for repeated analysis since the nucleic acid ligands can be 
Figure 1.3: Schematic representation showing the most popular recognition 
elements. 
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denaturated to reverse binding and then regenerated (Ivnitski et al., 1999). 
The hybridization event can be detected via electroactive or redox 
indicators, such as metal coordination complexes or intercalating organic 
compounds (Peng et al., 2002; Wong et al., 2003; Meric et al., 2002 ). 
Besides the electrochemical detection, Surface Plasmon Resonance (SPR) 
has gained significant popularity in DNA sensing, since measurements can 
be obtained directly, in few minutes, by measuring the changes in the 
refractive index of the medium, caused by the binding of the analyte to the 
sensor surface (Luong et al., 2008). The main disadvantage of this type of 
biosensor is that DNA has to be extracted from cells or tissue: as a 
consequence, the sample solution obtained may contain only a small 
number of molecules; therefore, multiple copies of the sample DNA need to 
be created for proper analysis. This is achieved by the help of polymerase 
chain reaction (PCR), providing an additional step in the analysis. 
 
b. Aptasensors: Aptamers are oligonucleotides (DNA or RNA) that can 
bind with high affinity and specificity to a wide range of target molecules, 
such as drugs, proteins, or other organic and inorganic molecules (Tombelli 
et al., 2007). Aptamers show a very high affinity towards their targets, with 
dissociation constants in the micromolar to low picomolar range, 
comparable to those of some monoclonal antibodies, and sometimes even 
better (Centi et al, 2009). The high affinity of aptamers towards their target 
is given by their capability of folding upon binding their target molecule. 
Aptamers can incorporate small molecules into their nucleic acid structure, 
otherwise they can be integrated into the structure of larger molecule, such 
as proteins (Tombelli et al., 2007; O'Sullivan, 2002; Luzi et al, 2003). For 
the detection of the binding event, electrochemistry offers  a large range of 
techniques, which can be chosen depending on the specific application. 
Aptamers have also been widely used as bio-recognition elements in optical 
bioassays, with fluorescence and calorimetry as most popular techniques, 
and in mass-sensitive biosensors, including evanescent wave-based 
sensors (e.g., SPR, acoustic wave-based sensors (e.g., quartz crystal 
microbalance (QCM)) and surface acoustic wave (SAW) devices. 
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c. Synthetic peptides biosensors: New interesting scenarios in the 
development of affinity biosensors have appeared with the increased 
understanding of the structure and functions of peptide sequences, in 
particular as ligand binding molecules. Compared to natural receptors such 
as antibodies, synthetic receptors, and in particular, synthetic peptides offer 
many advantages. Peptides are relatively small, stable, and easily obtained 
through solid phase synthesis (Van den Heuvel et al., 1993). Therefore, 
peptides and peptide analogues may represent efficient probes in biosensor 
technology for the detection of specific analytes. 
 
d. Enzymatic biosensors: Catalytic biosensors involve a catalytic 
event in which a substrate is converted into a product. Catalysis occurs at 
the transducer interface and depletion of the substrate or formation of the 
product is monitored by a transducer. The most commonly used biological 
components in catalytic biosensors are enzymes. Enzymes offer several 
advantages compared to conventional chemical catalysts. These 
advantages include not only their specificity and selectivity for a particular 
reaction, but also their discrimination between similar parts of molecules 
(regiospecificity) and between different isomers (stereospecificity). 
Enzymes catalyse reactions with a range of reactants (substrates), which 
may consist of a small number of closely related classes of compounds, a 
single class of compounds, or even one single compound. In several 
application, the enzyme stability may represent a problem and the ability to 
maintain enzyme activity for a long period of time still remains a formidable 
task to be achieved (Tothill, 2001; D'Orazio, 2003). 
 
e. Immunosensors: Biosensors which monitor antigen–antibody 
interactions are referred to as immunosensors (North, 1985). Either an 
antigen or antibody is immobilized on a solid-state surface and participates 
in a biospecific interaction with the other component, allowing detection and 
quantification of an analyte of interest. The specific interaction is followed 
by a measuring device (transducer) capable of sensing a change in a 
physical property resulting from the antigen–antibody interaction. The 
sensitivity and specificity of an immunosensor are governed by the 
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specificity and affinity of the antigen–antibody interaction and the noise and 
selectivity of the transducer. Ideally, an immunosensor would be a reusable 
device, since the reversibility of the antigen–antibody interaction may allow 
to regenerate the immobilized component. However, in practice, adequate 
analytical sensitivity can only be achieved by using antibodies with high 
affinity (>1010 M−1) are used (Hock, 1997). Therefore, a high-affinity 
constant and a labile immobilized antibody, sensitive to the harsh conditions 
often required, make regeneration of the surface difficult to realize, limiting 
practical application of immunosensors to single-use devices (Morgan et al, 
1996). 
 
1.2.2 Biosensors according to the transduction method 
A variety of transducer methods have been applied in the development of 
biosensor technology. The most common are reported in Table 1.1 and 
summarized below: 
 Optical biosensors are particularly attractive for the applications of 
direct detection systems (Gerard et al., 2002). They are based on the 
measurement of the light adsorbed or emitted as a result of a biological 
and/or chemical reaction. Several optical properties, such as light 
absorption, fluorescence, bio/chemiluminescence, reflectance, Raman 
scattering, and refractive index have been exploited as transduction 
mechanisms for biosensor development (Collings and Caruso, 1997). 
However, surface plasmon resonance (SPR) has recently been used as the 
basis for the optical signal transduction in biosensor development (Luong et 
al., 2008). Even though these biosensors are very sensitive, one of their 
limitation is that they cannot be used in turbid media. 
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 Piezoelectric biosensors are considered very useful devices 
suitable for monitoring bioaffinity interactions in real time without any 
labeling. The surface of the device, e.g. a quartz crystal, is coupled with a 
bio-recognition element. When the analyte molecule binds to the specific 
probe, the mass of the crystal changes. The resulting change in the mass 
subsequently changes the resonant frequency of the transducer. This 
frequency change is then measured (Fung and Wong, 2002; Yuan et al., 
2002). An example of piezoelectric biosensors are QCM, in which  the mass 
of the crystal increases and the oscillation resonance frequency decreases 
proportionally upon the binding event. Piezoelectric biosensors offer a real-
time output, simplicity of use, wider working pH range, and cost 
effectiveness. A disadvantage of PZ sensors is the relatively long 
incubation time, the numerous washing and drying steps, and the problem 
of regeneration on the crystal surface. This last problem may not be 
important if small crystals can be manufactured at low cost so that 
disposable transducers are economically feasible. Possible limitations of 
this technology include also the lack of specificity, sensitivity and 
interferences from the liquid media where the analysis takes place (Ivnitski 
et al., 1999). 
Table 1.1: Biosensor transduction systems. 
 
 
Types of transducers 
 
 
Measured properties 
 
Electrochemical 
Potentiometric 
Amperometric 
Voltametric 
Electrical 
Surface conductivity 
Electrolyte conductivity 
Optical 
Fluorescence 
Adsorption 
Reflection 
Mass sensitive 
Resonance frequency of 
piezocrystals 
Thermal 
Heat of reaction 
Heat of adsorption 
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 Calorimetric biosensors detect substrates on the bases of the heat 
evolved from the biochemical reactions of the analyte with a suitable 
biological active substance, such as an enzyme. The most commonly used 
approach is to attach the substances directly to a thermistor that detects the 
heat evolved from the biochemical reaction. The majority of the heat 
evolved in the enzymatic reactions is lost to the surrounding media without 
being detected. Therefore, the lost heat lowers the sensitivity of the thermal 
biosensor (Ramanathan and Danielsson, 2001). 
 
 Electrochemical biosensors emerge as the most commonly used 
biosensors, since they are more amenable to miniaturization, have well-
suited instrumental sensitivity and can even operate in turbid media. 
Electrochemical biosensors are mainly used for the detection of hybridized 
DNA, DNA-binding drugs, glucose concentration, etc. The underlying 
principle for this class of biosensors is that numerous chemical reactions 
produce or consume ions or electrons. Therefore, changes in the electrical 
properties of the analyte can be sensed out and used as measuring 
parameter.  
Electrochemical biosensors can be classified according to the different 
mechanism of the electronic transport. The so-called first generation 
biosensors are based on the detection of a substrate or a product of  a 
biocatalytic reaction. They work on the direct detection, by an electrode, of 
the electroactive species that are enzymatically produced or consumed 
(Dicks et al.,1989). In the most common first generation biosensors that 
need of a co-substrate in the reaction environment, the enzyme was 
physically entrapped near the electrode surface. When the electrode was 
immersed in the sample solution, the enzymatic reaction occurred and the 
product freely diffused to the electrode surface, generating a signal 
proportional to its concentration. These systems suffered of several  
drawbacks, such as the possible interference from electrochemically 
oxidable compounds in the assay samples and low detection limits due to 
the slow diffusion of the product to the electrode surface. 
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The second generation biosensors make use of an artificial electron 
carrier, or mediator, which shuttles the electron involved in the redox 
process from the active center of the enzyme to the electrode or vice versa 
(Turner  et al.,1989; Pishko  et al.,1991; Bartlett et al.,1991; Bourdillon and 
Majda, 1990). Both mediators and enzymatic substrates must be in the 
analytical solution. Examples of mediators are low molecular weight redox 
couple as ferrocene (Yokohama et al., 1989), ferrocene derivatives (Pishko  
and Katakis, 1990), bipyridil complexes (Betso et al., 1972). Ideally, it is 
preferable to have a material which communicates directly with a redox 
enzyme, in order to remove the complexity due to the presence of 
mediators in the analytical solution. In that case, no cosubstrates (oxygen 
or mediator) are required and the electrons involved in the process are 
measured directly at the electrode (DET, direct electron transfer). Enzyme 
electrodes based on this principle are called third generation biosensors 
(Turner et al.,1989).  
The field of third generation biosensors grew a few years ago, when it 
was found that direct electrochemistry with redox proteins is possible 
without using a co-substrate (Armstrong and Cox, 1987). The foremost 
work in this field used mercury electrodes, onto which enzyme adsorption 
was strong. However, it was observed molecule denaturation. Hence, in 
order to make the metal electrode compatible with redox enzymes and the 
biological receptor, surface modification of the bare electrode has been 
required (Hagen,1989). Nevertheless it has been demonstrated that small 
redox protein, such as cytochrome c, can shuttle electrons directly to bare 
glassy carbon electrodes (Heller, 1990). For large redox enzyme, such as 
glucose oxidase, this is difficult to accomplish as they have thick insulating 
protein shells and their catalytic centers are buried deep inside and 
protected from the surroundings (Detaxis Du Poet and Miyamoto, 1990). 
Therefore in these cases they must be immobilized on a compatible 
modified electrode surface in a way that makes the electron transfer from 
the catalytic center to the electrode feasible without the occurrence of 
denaturation (Armstrong, 1988; Boutelle, 1986). 
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Depending upon the electrochemical property to be measured, 
electrochemical biosensors can be further classified into conductimetric, 
potentiometric and amperometric biosensors. 
 
a. Conductimetric biosensors use noble metal electrodes to 
measure the changes in conductance/impedance of a solution 
caused by the biological component. The large applicability of 
conductimetric detection is due to the observation that almost all 
enzymatic reactions involve either consumption or a production of 
charged species, and therefore lead to change in the ionic 
composition of the enzymatic film. The electric field is generated 
using a sinusoidal voltage (AC), which helps in minimizing 
undesirable effects, such as Faradic processes, double layer 
charging and concentration polarization (Senillou et al., 1999). The 
primary advantage of this technique is the use of inexpensive, 
reproducible and disposable sensors. However, in order to obtain a 
reliable measurement, the ionic species produced must significantly 
change the total ionic strength of the solution. Therefore, this 
requirement increases the detection limit to unacceptable levels, and 
results in potential interferences depending of  the ionic strength of 
the sample. 
 
b. Potentiometric biosensors measure the potential difference 
between a working electrode and a reference electrode under 
conditions of zero current flow (Koncki et al., 2000). The potential 
generated is directly proportional to the logarithm of the 
concentration of an ion in an ideal solution. The basis of this type of 
biosensor is the Nernst equation, which relates the electrode 
potential (E) to the concentration of the oxidized and reduced 
species. For the reaction: aA + ne- ⇔ bB, the Nernst equation can be 
described as the following, 
 
                (1.1) 
13 
 
 
where E° is the standard redox potential, R is the gas constant, T 
is the absolute temperature, F is the Faraday constant, n is the 
number of exchanged electrons in the reaction, CA and CB  are the 
concentration of oxidized and reduced species, respectively. The 
main advantage of such devices is the wide concentration range for 
which ions can be detected, generally between 10-6 to 10-1 mol/l. 
Their continuous measurement capability is also an interesting 
possibility for environmental applications. The apparatus is 
unexpensive, portable, and it is well suited for in situ measurements. 
The main disadvantage is that the limit of detection for some 
environmental samples can be high (10-5 mol/l or 1 ppm) and the 
selectivity can be poor. 
 
c. Amperometric biosensors measure the currents resulting 
from the electrochemical oxidation or reduction of an electroactive 
species under a constant potential applied to working electrodes. 
Amperometric enzyme biosensors form the majority of commercial 
biosensor devices today available; these biosensors operate at a 
fixed potential with respect to a reference electrode, while the 
measured signal is the current generated by the oxidation or 
reduction of an electroactive species at the surface of a working 
electrode. 
The most important of these is the glucose biosensor, which has 
been successfully commercialized for blood glucose monitoring in 
diabetics (Matthews et al., 1987). This signal-transduction 
mechanism is frequently used for enzymatic and catalytic 
biosensors. The main advantage of this class of transducer is their 
low cost; therefore, disposable electrodes often use this technique. 
The high degree of reproducibility that is possible for these (one time 
use) electrodes, eliminates the cumbersome requirement for 
repeated calibration. The type of instrument used for these 
measurements is also very easy to obtain and can be inexpensive 
and compact, thus allowing in situ measurements. Limitations of this 
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signal transduction mechanism include interferences to the response 
caused by the presence of several electroactive compounds that can 
generate false current values. 
 
1.3 Coupling between the bio-recognition molecule and the transducer 
Since the detection of target molecules and the transduction usually occur at a 
liquid-solid interface, one key factor in biosensor construction is the development 
of immobilization technologies for stabilizing biomolecules and tethering them to a 
solid surface. The usual aim is to produce a thin film of immobilized biologically 
active material on or near the transducer surface which responds only to the 
presence of one or a group of materials or substances to be detected. There are a 
number of requirements that the immobilization technique must satisfy:  
 the biological component must retain substantial biological activity 
when attached to the sensor surface;  
 the biological film must remain tightly associated with the sensor 
surface while retaining its structure and function; 
 the immobilized biological film needs to have long-term stability and 
durability;  
 the biological material needs to have a high degree of specificity to a 
particular biological component.  
These conditions must be satisfied for an efficient sensing device.  
Further,  the immobilization procedure should guarantee that the biological 
films are assembled by reproducible procedures, and that once formed, these 
films are adaptable to different environments. In particular, the immobilized films 
need to be resistant to a wide range of physiological pHs; they must maintain their 
stability and activity upon changes in the temperature, ionic strength and chemical 
composition of the solution (Collings  and Caruso, 1997). The ability to co-
immobilize more than one biologically active component is also desirable in some 
cases.  
Sensitivity is especially important for an efficient biosensor. Biosensor 
sensitivity depends on both the sensitivity of the detection system and the density 
of distribution and/or orientation of the biological material near the sensor surface. 
Therefore, an important aspect of biosensor development, especially for the 
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affinity based biosensors, is the ability of the immobilization technique used to 
afford the desired distribution and/or orientation of the biological molecules, once 
immobilized on the solid surface. Although a high surface density of functional 
biological molecules is required for a sensitive device, overloading of the surface 
should be avoided, particularly for affinity-based systems where the biological 
component is interacting with another biomolecule. While activity generally 
increases initially with surface loading, high surface loading often leads to 
biomolecule aggregation with an associated reduction in activity. In these systems, 
overloading could block or inactivate the active site of the immobilized biomaterial 
(Collings  and Caruso, 1997). 
The need of an uniform layering of the biologically active material on the 
sensor surface, while preserving its structure, has long been recognized as a 
prerequisite for the production of an optimal biosensor surface. Ideally, the 
enzyme or protein molecules would be attached to the sensor surface through the 
same locus, leaving the active site(s) of the biological molecules exposed. It has 
been suggested that the sensor surface should only react with a single site on the 
protein, a site which is distant from the active site (Zull et al., 1994). 
Numerous biosensors are fraught with problems associated with non-specific 
binding. Usually, the presence of a specific analyte is to be detected in a ‟serum‟ 
or in a solution containing many molecular species, and there is interference from 
other species in the solution. It is common practice to introduce blocking agents 
(e.g. bovine serum albumin for immunosensing applications) into the system in 
order to curtail non-specific binding. The non-specific binding must be minimized, 
in order to obtain unambiguous information on specific biomolecule interactions. It 
has also been proposed that surfaces with minimal non-specific adsorption of 
biomolecules should in general be used to attach the biological component 
through single sites (Zull et al., 1994). 
Another important consideration in biomolecule immobilization is that the 
biological component would not desorb during the use of the biosensor, 
particularly when the methods of entrapment utilize polymer trapping or membrane 
barriers to contain the biomolecules. 
The available immobilization techniques can be grouped into two categories: 
direct and indirect binding, that can be further divided into non-covalent and 
covalent interactions. 
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1.3.1 Direct binding 
Non-covalent interactions. The immobilization by direct, physical adsorption 
(Figure 1.4 a) is the less complex method, since it involves reversible surface 
interactions between 
bioreceptor and support 
material. The forces 
involved in the interaction 
are mostly electrostatic, as 
ionic and hydrogen bonds, 
although sometimes 
hydrophobic interactions 
become significant. These 
forces are weak, but 
sufficiently large in number 
to enable reasonable 
binding. This method does 
not require activation or 
chemical modification of 
proteins, and in this way 
little damage is done to 
biomolecules. On the other 
hand, when biomolecules 
are directly in contact with 
solid surfaces through 
adsorption, they can undergo a denaturation process, losing their bio-specific 
activity (Collings  and Caruso, 1997). Another problem of this method is that 
irregular distributions of randomly oriented protein are commonly observed on the 
electrode surface. For this reason, biosensors employing adsorbed biomolecules 
are mostly insensitive and display a large degree of non-specificity.  
 
Covalent site-specific attachment (Fig 1.4 f). Biomolecules, such as enzymes 
and proteins, have several functional groups useful for covalent immobilization 
onto surfaces, such as amino-acid side chains (e.g. amino groups of lysine, 
Figure 1.4: Graphical representation of some 
methods used to achieve protein immobilization. (a) 
Physical adsorption; (b) inclusion in 
polyelectrolytes/conducting polymers; (c) inclusion in 
self-assembled monolayers (SAMs); (d) non-oriented 
attachment to SAM; (e) oriented attachment to SAM; 
(f) direct site-specific attachment to gold. 
(Figure taken from Gilardi and Fantuzzi, 2001.) 
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carboxyl groups of aspartate and glutamate, sulfhydryl groups of cysteine), 
phenolic, thiol and imidazole groups. Covalent coupling between the enzyme or 
protein and the solid support must occur through functional groups on the 
biomolecule, which are not required for its biological activity. Suitable functional 
groups which are available for covalent attachment are also present on some 
transducer materials (hydroxyl groups on silica). Most surfaces, however, need to 
be modified in order to introduce a functionality, which may be coupled with the 
enzyme or protein. Solid supports include glass, titanium dioxide, polysaccharides 
and polymers (nylon, polymethylmethacrylate), where a bifunctional reagent is 
reacted with the support giving an activated surface to which enzymes or proteins 
can then be covalently coupled. Metal surfaces, such as gold and silver, can be 
modified by reaction with a hydroxyalkanethiol to generate hydroxyl, carboxyl or 
amino groups, which may react with enzymes or proteins (Collings  and Caruso, 
1997). Usually, this method leads to the formation of a randomly oriented layer, 
either on the surface of an electrode or into the cavities formed by the porosity of 
the matrix.  
 
1.3.2 Indirect binding 
The attachment of biomolecules to sensor surfaces can be achieved through 
indirect binding: the biomolecules are immobilized on the solid surfaces through 
the formation of self-assembly monolayers (SAM).  
Self-assembly is an attractive choice for the immobilisation of probe molecules 
at surfaces.  A self assembled monolayer is a well organized monolayer formed by 
the attachment of head group of molecules (in case of alkanethiols -SH group) 
with the surface of a support (Nuzzo et al., 1983). Self-organization is achieved 
when the alkyl chains align themselves by van der Waals forces and form a 
compact monolayer (Figure 1.5).  
SAMs spontaneously form upon exposure of the substrate to a solution 
containing the molecules. SAMs have become the focus of intensive investigation 
as they provide a facile means of defining the chemical composition and structure 
of a surface (Finklea, 2000). Self-assembled monolayers of thiols, sulphides, 
cyanides and alkylphosphonates are known to form on different substrates, but 
most of the work on self-assembled monolayers has focused on SAMs of 
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alkanethiols. It is possible to find a wide range of terminal functional groups in the 
adsorbing thiolated molecule without disturbing the self-assembly process or 
destabilising the SAM. The high affinity of the sulphur head group for a metal 
substrate and the high strength of the interaction between the two is one of the 
reasons for the use of SAMs based on alkanethiols in biosensors, as the method 
is simple and allows for a number of useful attachment chemistries to be realised 
(Ulman, 1996; Schreiber, 2004; Love et al., 2005). SAMs offer substantial 
advantages in biosensor development. The ability to pre-design the monolayer on 
a molecular rational introducing specific interactions between the monolayer and 
the protein to immobilize should enable tailoring surfaces and acquire them with 
specific properties and functions. The possibility of achieving an ordered molecular 
structure oriented specifically and consistently, makes it possible to optimize 
complexation and protein orientation. Furthermore, the high organization exhibited 
by the monolayer assures a cooperative and homogeneous behavior of the entire 
electrode surface. Finally, the molecular dimension of the layer avoids slow 
diffusion of  unwanted electroactive species toward the surface reducing undesired 
accumulation of species close to the electrode surface (Mandler and Turyan, 
1995). 
 
 
 
 
Figure 1.5: Schematic representation of self-assembled monolayer of alkanethiols 
on metal substrate (Figure taken from Love et al., 2005). 
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SAMs can be used with three different approaches: 
Inclusion in SAM (Fig. 1.4 c) can be achieved, for example, using alkane-thiol 
or other thiol-terminated chains immobilized on the surface of a noble metal. The 
left part of Fig. 1.4 c shows a monolayer of thio-lipids forming a membrane-like 
structure in which the proteins are immersed in different orientations. The right-
hand part of Fig. 1.4 c shows a SAM of alkanethiol chains of different length 
allowing the formation of depressions on the surface that can accommodate the 
protein molecules.  
 
The other two approaches involve interaction of the molecules to be 
immobilized with the exposed terminal functional groups (ω-groups) (Mandler and 
Turyan, 1995). Functional groups such as -NH2, -OH and -COOH have been 
widely used. Through the proper selection of the terminal functional group, specific 
surface/solution interactions (chemical covalent, electrostatic, or hydrophobic) can 
be exploited to immobilize molecules at the interface.  
Non-covalent interactions with SAM. The most common non covalent 
approach to immobilizing molecules to a SAM coated surface is via electrostatic 
binding (Gooding and Hibbert, 1999). This simple and gentle method provides the 
potential for control over the orientation of the immobilized protein molecules 
depending on the charge distribution of the protein. It can provide even oriented 
(Fig. 1.4 e) and non-oriented attachment to the SAM (Fig. 1.4 d), depending on the 
protein structure and aminoacidic composition. Therefore this method has been 
used to investigate direct electron transfer between enzymes (Li et al., 1997) or 
redox proteins (Tarlow and Bowden, 1991) more frequently than for the 
development of sensors directly. The major drawback of electrostatic binding is 
that the strength of the bond is dependent on the solution conditions. Changes in 
ionic strength and pH can cause the protein to be lost from the surface of the SAM 
(Hodak et al., 1997). 
Covalent attachment to SAMs has the greatest potential for the development 
of commercial sensors due to the stability of the resultant bond (Gooding and 
Hibbert, 1999). A popular, and highly versatile, method for covalently attaching 
proteins to SAMs is by using carbodiimide coupling which couples amines to 
carboxylic acids. If proteins to immobilize have several reactive groups, this 
interaction is not site-specific, it results in a  non-oriented attachment to SAM (Fig. 
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1.4 d). Oriented attachment to SAM (Fig. 1.4 e) can be achieved with the same 
strategy, but here, the reactive function of the SAM can interact specifically, with a 
unique site on the protein surface. This unique site, if not naturally present in the 
protein sequence, can be made either by chemical modification of an existing 
surface residue or by a genetic engineering approach. 
 
 Gold is the most widely used substrate for alkanethiols based SAMs. The first 
reports of SAMs formed on gold substrates were highly focused on the preparation 
of atomically flat, well-defined, gold surfaces. Using these surfaces some very 
important characteristics alkanethiols SAMs have been extracted. Gold is a noble 
metal that can be handled in air without the formation of an oxide surface layer, 
and can survive harsh chemical treatments such as those used to remove organic 
contaminants during cleaning. Gold electrodes may be composed of bulk gold, 
either polycrystalline or single crystal, or thin films deposited on various 
substrates. 
Finally, an alternative method for the non-covalent immobilization of biological 
molecules is encapsulation in polyelectrolytes or conducting polymers (Fig 1.4 b). 
In this case, the proteins are trapped either in a polyelectrolyte or in a conducting 
polymer that is directly adsorbed or linked to the surface. This results in a non-
oriented multilayer film. 
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Chapter 2: Heme-proteins and biosensors development 
 
2.1 Heme-proteins, structures and functions 
Hemes are prosthetic groups widely used in nature. Heme-containing proteins 
include molecules with distinct activities, ranging from electron transfer, catalysis, 
oxygen transport and storage, ligand binding, signal transduction, and control of 
gene expression. This functional diversity is strictly related to the versatility of the 
heme group and to the protein scaffolds, that create different heme environments. 
Because of these reasons, heme-proteins have been the focus of a great deal of 
work over the last century. In addition to their distinct functions, heme-proteins 
feature a fascinating range of different folding architectures. The phylogenetic 
widespread occurrence of hemes originates from the use of porphyrins in 
photosynthesis and cellular respiration for energy transduction reactions, 
supporting the proton motive force (PMF) (Paoli et al., 2002). Oxygen transport 
and storage by hemoglobin and myoglobin account for the ubiquitous presence of 
heme throughout vertebrates and invertebrates. 
 How different proteins are able to fine-tune the environment of the heme 
cofactor, thus producing such different chemistries, is becoming increasingly clear 
through the study of natural and artificial model systems. 
High-resolution X-ray crystallographic data as well NMR analysis available for 
an increasing number of heme-proteins, have deeply contributed to understanding 
their reactivity and structural and electronic properties at the molecular level 
(Bertini and Luchinat, 1999; Perutz et al., 1998; Peterson and Graham, 1998; 
                      (a)                                                      (b)                                                  (c) 
 
Figure 2.1: Three natural heme-proteins: Myoglobin (a), Cytochrome c (b) (Figure 
taken from Bortolotti et al., 2006) and Horseradish Preoxidase (c). 
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Loew and Harris, 2000; Li and Poulos, 1994; Wong, 1998; Smith and Veitch, 1998; 
Banci, 1997; Sono et al., 1996; Barke, and Ferguson,  1999; Poulos et al., 1999; 
Michel et al., 1998; Lederer, 1994). It is now well ascertained that the protein 
matrix, which surrounds the heme active site, controls the intrinsic reactivity of the 
prosthetic group, selecting one reaction as the only or predominant one. 
However the inherent complexity of natural heme proteins continues to obscure 
the full description of the factors governing the heme properties. 
Therefore, a large number of artificial model systems are being developed in an 
attempt to (i) provide further insights for structure-activity relationships, (ii) 
understand the minimal requirements for function, (iii) reproduce the properties of 
the parent natural proteins in smaller molecules, and (iv) most importantly 
construct new, tailor-made molecules useful for biomedical, pharmaceutical, 
biological, and environmental applications. 
 
2.1.2 Heme structure: properties of the porphyrin macrocycle 
The basic structure of natural heme protein is a tetrapyrrole macrocycle called 
porphyrin. The porphyrin (shown in figure 2.2) consists of four pyrrole-like five-
membered units, A, B, C and D, which are linked by four methine bridges, 5, 10, 
15, 20 (meso positions). The porphyrin macrocycle is an aromatic system 
containing 22 π electrons, but only 18 of them are involved in a delocalization  
pathway. Porphyrin obeys Huckel's rule of aromaticity (4n + 2 π electrons, n = 4) 
and is shown by X ray crystallography to be planar. The aromatic character of 
porphyrins can also be seen by NMR spectroscopy. Due to the anisotropic effect 
from the porphyrin ring current, the NMR signals for the deshielded meso protons 
appear at low field (8 to 10 ppm), whereas the signals for the shielded protons (on 
the inner nitrogen atoms) appear at very high field (-2 to -4 ppm). 
Figure 2.2:  Basic structure of the porphyrin macrocycle: numbering, functionalization 
sites and planarity. 
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The identity of porphyrin in natural heme proteins is distinguished by its 
peripheral β-pyrrolic substituents, as shown in Figure 2.3. The most common 
heme tetrapyrrole macrocycle is heme b or iron(II) protoporphyrin IX, whose 
structure was synthetically demonstrated by Hans Fischer (Fischer and Zeile, 
1929). The term “heme” specifically refers to the ferrous complex of protoporphyrin 
IX, with the ferric-hydroxy and ferric-chloride complexes to as hematin and hemin, 
respectively. 
 
Heme b, also called protoheme, has methyl groups at positions 1, 3, 5, and 8, 
vinyl groups at positions 2 and 4, and propionates at positions 6 and 7 on the 
macrocycle. All the porphyrins are synthesized in vivo as the free base forms 
before incorporation of the iron(II) by the enzyme ferrocheletase (Sellers et al., 
2001; Wu et al., 2001). Additionally, heme b serves as the structure from which 
hemes a and c are biosynthetically derived (O‟Brian and Thony-Meyer, 2002; Mogi 
et al., 1994; Brown et al., 2002). Aside from b-type cytochromes, heme b is also 
found in globins, cytochromes P-450, and heme-sensor proteins. Protein scaffolds 
bind hemes via the combination of the axial coordination positions available on 
Figure 2.3: : Chemical structures of commonly occurring natural hemes a, b, c, and 
d. (Figure taken from Reedy and Gibney, 2004). 
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iron, hydrophobic interactions with the heme macrocycle, and polar interactions 
with the propionic acids (Hargrove and Olson, 1996; Hargrove et al., 1996; 
Breslow and Koehler, 1965; Breslow et al., 1967). 
Heme c is structurally similar to heme b except that thioether bonds to cysteine 
residues replace one or both the vinyl groups and covalently link the heme 
macrocycle directly to the protein scaffold (Moore and Pettigrew, 1990). The 
covalent attachment of heme to the protein is effected by the enzyme heme lyase 
(Drygas et al, 1989), but in vitro chemical synthesis has also been used to form 
the thioether bonds in b-type cytochrome and c-type cytochrome scaffolds (Sano 
and Tanaka, 1964; Barker et al., 1996; Tomlinson and Ferguson, 2000; Arnesano 
et al., 2000). Cytochromes c typically contain a CXXCH sequence motif from 
which the two cysteines link to the porphyrin macrocycle and the histidine binds to 
the encapsulated iron. The presence of the covalently linked heme designates it a 
c-type heme that includes all cytochromes c as well as cytochrome f (Martinez et 
al., 1996). Heme a is biosynthesized from heme b by conversion of the vinyl group 
at position 2 into a hydroxyethylfarnesyl side chain, yielding heme o, followed by 
subsequent oxidation of the methyl at position 8 to a formyl group (Mogi et al., 
1994). These modifications render heme  both more hydrophobic and more 
electron-withdrawing, as an equatorial ligand to iron, than heme b. Heme a is 
found only in terminal oxidases such as mammalian cytochrome c oxidase. Other 
less common heme architectures include heme d (Vainshtein et al., 1986), heme 
(Williams et al., 1997), heme P-460 (Igarashi et al., 1997), siroheme (Crane et al., 
1995), and chlorocruoroheme (Lemberg and Falk, 1951). 
 
2.1.3 Coordination properties 
It is now well ascertained that the protein matrix, which surrounds the heme 
active site, controls the intrinsic reactivity of the prosthetic group, selecting one 
reaction as the only or predominant one. The protein composition and structural 
organization of the peptide chain dictate the properties of the primary (metal 
coordination geometry, number, type, and donor properties of the axial ligands) 
and secondary (local dielectric constant, hydrophobicity, and hydrogen bonding 
interactions near the active site coordination sphere) coordination shells. Further, 
the protein directs long-range interactions (Tainer et al., 1992). These factors all 
contribute to the functional specificity of the heme.  
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It has been well recognized that the primary coordination sphere plays 
important roles in modulating the structure and function of heme proteins, such as 
redox potentials, electronic structure, spin states, electron-transfer rates, and 
catalytic properties (Moore and Pettigrew, 1990; Scott and Mauk, 1996; Turano 
and Lu, 2001; Goodin, 1996; Gross, 1996, Banci et al., 1996; Weiss et al., 1996). 
Several amino acids are known to serve as axial or proximal ligands to heme    
proteins (Moore and Pettigrew,1990; Scott and Mauk, 1996; Turano and Lu, 
2001). In cytochromes (cyt), histidine, methionine, lysine, and cysteine are 
common axial ligands that coordinate the heme. Bis-His and His-Met coordination, 
found in cyt b5 and cyt c, respectively, are by far the most common ligation states 
of the cytochromes (Figure 2.4). Other ligation states, such as bis-Met and His-
Lys, have also been found. Interesting ligation from the terminal α-amino group of 
a peptide bond has been observed in cyt f (Figure 2.4) (Martinez et al., 1994).  
Figure 2.4: : Cytochromes with different axial ligand coordination. 
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Heme-based sensors and enzymes are mostly five coordinate with an open site 
for binding small molecules such as O2 and CO. In these proteins, histidine is by 
far the most common axial ligand, with cysteine and tyrosine found in a few 
classes of heme enzymes such as cyt P450, chloroperoxidase (CPO), and 
catalase (Figure 2.5). Recently, a new axial ligand, the N-terminal nitrogen of 
proline, was discovered in the CO sensing heme protein called CooA (Figure 2.5) 
(Lanzilotta et al., 2000).  
While the axial ligands to heme iron establish the basic coordination chemistry, 
the interaction of amino acids beyond the primary coordination sphere is critical of 
modulating the chemical properties of the heme, allowing it to perform a variety of 
biochemical functions. The local protein environment surrounding the heme more 
finely regulates the heme-protein properties, such as the iron redox potential 
(Tezcan et al., 1998; Mauk and Moore, 1997; Gunner et al., 1997; Naray-Szabo‟, 
1997; Wuttke and Gray, 1993; Gray and Winkler, 1996). For instance, a large 
number of positively charged residues around the heme in hemoglobin and 
myoglobin may favour a low oxidation state for the iron, making it ready to bind 
dioxygen. On the contrary, the progressive change in the polarity of the 
surrounding peptide environment, from a negative charge distribution in 
cytochromes b to a positive one in cytochromes c, determines a gradual increase 
Figure 2.5: : Heme proteins with one open coordination site. 
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in the Fe(III)/Fe(II) redox potential. The resulting stabilization of the matching Fe(II) 
and Fe(III) states enables cytochromes to mediate the electron transfer. 
 
2.2 Direct electron transfer 
Electron transfer reactions of biomolecules are central to the most fundamental 
processes of life. Respiration, for example, is the stepwise oxidation of an organic 
substrate through a series of redox reactions involving a chain of electron 
acceptors, between which electrons are shuttled by electron carriers such as 
cytochromes, iron-sulphur proteins and flavin nucleotide coenzymes. These 
molecules also play a similar role in the photo-induced electron transfer chain of 
the photosynthesis. Consequently, the study of metalloproteins electrochemistry 
should provide invaluable insights into the dynamic behaviour of the molecules 
involved in meeting the energy requirements of all living organisms. In particular, 
direct electrochemistry of metalloproteins and metalloenzymes is a subject of 
immense interest in recent years, because of its potential application in the study 
of the redox and electron transfer properties of the biomolecules (Armstrong et al., 
1986; Armstrong, 1990).  
Efficient direct electron transfer reactions have been reported for a restricted 
number of redox enzymes. The majority of these redox enzymes contain metal 
sites and particularly heme. The first reports on a reversible DET between redox 
proteins and electrodes were published 30 years ago, and showed that 
cytochrome c (Cyt c) is reversibly oxidized and reduced at tin doped indium oxide 
(Yeh and Kuwana, 1977) and gold in the presence of 4,4-bipyridyl (Eddowes and 
Hill, 1977). At the same time the DET between bare electrodes and enzymes was 
reported for laccase, peroxidase, and P450-enzymes (CYP-enzymes) 
(Varfolomeev and Berezin, 1978; Yaropolov et al., 1979; Tarasevich, 1979; 
Scheller et al., 1977).  
The redox potential of the heme moiety varies from high negative value, -450 
mV (Davis, 1978) in simple aqueous and non-aqueous solutions, to a very high 
positive value when embedded inside the protein cavity, e.g. + 260 mV (vs SHE) in 
cytochrome c (Guo and Hill, 1991). Moreover, its electrochemical characteristics, 
e.g., formal potential (E0') for its redox conversion from Fe3+ to Fe2+, can be varied 
over a wide range of potentials by the protein environment, e.g., from + 260 mV for 
cytochrome c to −270 mV for HRP (Harbury, 1957). By itself, heme exhibits 
28 
 
various catalytic properties, which drastically change when incorporated into a 
protein environment. This creates wonderful opportunities for the heme-proteins 
and heme-enzymes in terms of their bioelectrochemical applications, e.g., in 
biosensors based on direct electron transfer between redox proteins and 
electrodes (third generation biosensors).  
Cytochromes c and P450 have been studied as components of bio-catalytic 
surfaces (Gray et al., 1994; Scott and Mauk, 1995). These proteins have a good 
stability in a wide range of temperature and pH, and they are able to exchange 
electrons quite rapidly with solid electrodes (Battistuzzi et al., 1997; Battistuzzi et 
al., 1999), therefore they have been employed as components of electrocatalytic 
complexes protein-electrode, active in the reduction of dioxygen and hydrogen 
peroxide. 
 
Cytochromes P450 constitute a super family of heme enzymes found from 
bacteria to humans (Nelson et al., 1996). Cytochrome P450 monooxygenases are 
versatile biocatalysts that introduce oxygen into a variety of substrates, many of 
them are molecules of pharmaceutical interest. The ability of all P450s to activate 
the Fe–O–O moiety (universal for all P450s) is determined by the mode by which 
the heme (here, heme b) is bound to apoprotein. The central atom of the heme 
macrocycle, i.e., the heme iron, is bound to the protein through the anionic, 
thiolate sulfur of a cysteine residue. This type of bond gives the heme moiety the 
ability to mediate the transfer of electron density to the dioxygen bound as the 
trans (sixth) ligand of the heme iron (Anzenbacher et al., 1989). Hence, this bond 
also explains why the heme b (the same as in the well-known hemoproteins, 
hemoglobin and myoglobin) possesses here this unique property characteristic of 
all P450s, that is the ability to activate the dioxygen for chemical reactions 
(Anzenbacher and Anzenbacherová, 2001).  
Since their discovery and the elucidation of their structure, cytochromes P450 
have attracted the interest of scientist for many years, particularly due to their 
catalytic abilities. Since the late 1970s, attempts were concentrated on the 
construction and development of electrochemical sensors. Although sensors 
based on mediated electron transfer have also been constructed, the direct 
electron transfer approach has attracted most of the interest (Bistolas et al., 2005).  
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The electrochemistry of CYPs was investigated using a variety of metal 
electrodes such as Au, Pt and Tin oxide, as well as non-metal electrodes such as 
glassy carbon (GC), pyrolytic graphite (PG), edge-plane graphite (EPG), and 
carbon cloth (CC). Although direct electron transfer was observed on bare 
electrodes, modifying the electrode with an appropriate medium, such as a 
polymer or a polyelectrolyte, has been very popular in recent years. This was often 
performed in order to attain native structure and appropriate orientation, with the 
consequence of increasing electron transfer between the enzyme and the 
electrode, (Bistolas et al., 2005). Cytochrome P450, efficiently linked to solid 
electrodes, can provide the opportunity of studying numerous xenobiotics from a 
biosensoristic point of view (Gilardi and Fantuzzi, 2001). Gilardi and co-workers 
took advantage of protein engineering to build assemblies with improved 
electrochemical properties (Gilardi et al., 2002). They  used the molecular Lego 
approach with the bacterial P450 BM3 from Bacillus megaterium (BMP). The 
heme domain of P450 BM3 was used as a module in the construction of an 
electrochemically active assembly, fused with a redox modules, flavodoxin from 
Desulfovibrio vulgaris (FLD) generating the BMP–FLD fusion protein and creating 
an artificial redox chain (Fantuzzi et al., 2006). In this work it was found that the 
catalytic activity of BMP was improved by almost 6 times when it was fused to the 
non-physiological redox partner FLD. Thus, the authors demonstrated that the 
molecular Lego approach was successful for improving electrochemical and 
catalytic properties of P450 BMP, suggesting that the same approach could be 
used for the production of new devices for nanobiotechnoloical applications. 
 
Cytochromes c is the most extensively studied molecules at various electrode 
surfaces, due to their diffusion (they are present virtually in all living systems), 
stability, and ease of purification (Banci et al., 1999; Gray and Ellis, 1994; Moore 
and Pettigrew, 1990; Pettigrew and Moore, 1987; Scott and Mauk, 1996). These 
species are monomeric heme-proteins, in which the heme group(s) is covalently 
linked to the polypeptide chain through two thioether bonds involving two cysteines 
and two axial ligands to the iron (His, Met). Cyt c are grouped into four subclasses 
on the basis of their structural properties (Moore and Pettigrew, 1990). The most 
widely studied species belong to class I, found in both eukaryotes and 
prokaryotes, which feature a low spin six-coordinate heme iron possessing a His- 
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Met axial coordination, and to class III, which are multiheme proteins with bis-
histidinyl coordination of bacterial origin (Moore and Pettigrew, 1990; Pettigrew 
and Moore, 1987; Scott and Mauk, 1996). In electrochemical studies, particular 
emphasis was placed on the redox behaviour of the molecules, the rate 
dependence of the electron transfer process on pH, and the type of electrode, 
employing bare metal or modified electrode surface (Hanrahan et al., 1996). 
Electron transfer from cytochrome c to metal electrodes such as platinum, gold, 
nickel, mercury and p-type silicon has shown to be slow due to adsorption induced 
denaturation  (Tarasevich, 1985; Bowden et al., 1985; Daido and, Akaike, 1993). 
However, direct and quasi-reversible electrochemistry was observed with the 
surface modified electrodes of metals, such as platinum (Gui and Kuwana, 1987), 
gold (Bortolotti et al., 2006; Monari et al., 2008), and glassy carbon (Wang et al., 
2002). For example, Sola and co-workers studied the redox behavior of the Yeast 
Iso-1-cytochrome c (YCC), native and mutated, covalently immobilized on 
unmodified gold electrodes at varying temperature and pH values (Bortolotti et al., 
2006). They found that pH induced conformational transition both in the native 
protein and in its mutants ( C102T/N62C). The observed conformers presented 
differences of 300 mV in the measured E°‟, due to the detachment of both the axial 
ligands from the heme iron at low pH. In this acidic condition, the Iso-1-cytochrome 
c was able to catalyze dioxygen reduction. Moreover, the electron transfer rate 
was slow and strongly influenced by the protein orientation on the electrode 
surface.  The same group achieved the electrochemical characterization of the 
Met80Ala YCC variant (Casalini et al., 2008), in which the axial heme iron Met 
ligand was replaced by a non-coordinating Ala residue. This penta-coordinated 
mutant, covalently bound to a gold electrode surface, was able to 
electrocatalitically reduce dioxygen between pH 5 and 11. This opens the way to 
the exploitation of Met80Ala YCC variant for O2 biosensing. 
 
Despite the tremendous progress made in the development of heme-proteins 
based biosensors, a major problem in these electrochemical systems lies in the 
electrical communication between the redox protein and the electrode.  
Direct electron transfer can be difficult to achieve, and the electron transfer 
rates between the majority of redox proteins and electrode surfaces are often 
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prohibitively slow (Zhang and Li, 2004). This may be due to several reasons, as 
reported in the following: 
 Unfavourable orientation of protein molecules on electrode surface may 
hinder electron exchange between the electrode and the electroactive 
centre of the proteins, which is usually deeply buried inside the 
polypeptide chains, especially in larger proteins.  
 The "bad" orientation may increase the distance between the redox 
centre and the electrode surface, thus limiting the direct 
electrochemistry of the molecules (Zhang and Li, 2004).  
 The monolayer concentration/coverage of the redox protein on the 
electrode surface decreases as the protein size increased, thus 
resulting in low electrochemical signals.  
 Natural proteins can also denaturate on the electrode surface, blocking 
the electron exchange (Heller, 1990; Armstrong, 1990). 
 
A strategy to overcome the above limitations is the use of artificial proteins, 
designed on rational bases to possess the required activity, structural robustness 
(to prevent denaturation on the electrode surface), and small size (to simplify the 
electron transfer path to the electrode and increase surface coverage). 
For application in biosensor technology, we have employed a particular class of 
heme-protein models, named Mimochromes. 
 
2.3 Synthetic heme-protein systems: the Mimochromes family 
Our laboratory has approached the challenge of constructing heme-protein 
models using a miniaturization process (Nastri et al., 1998). A miniaturized heme-
protein is a peptide-based model which contains a minimum set of constituents 
necessary for  
• an accurate reconstruction of a well-defined structure and  
• a fine tuned reproduction of a defined function.  
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This strategy leads to the development of a class of miniaturized heme-proteins, 
named mimochromes (Nastri et al., 1997; D‟Auria et al., 1997; Lombardi et al., 
1998; Nastri et al., 1998; D‟Andrea et al., 1999). The schematic structures of 
mimochromes are reported in Figure 2.6. 
Mimochromes are peptide-porphyrin conjugates, with pseudo-C2 symmetry. 
They are made up of deuteroporphyrin, covalently linked to two peptides (nine or 
fourteen residues), via an amide bond between the porphyrin propionyl groups and 
the side chains of two Lys residues (Nastri et al., 1997; D‟Auria et al., 1997; 
Lombardi et al., 1998; Nastri et al., 1998). The peptide fragments, which face the 
porphyrin plane, are in α-helical conformation, a common feature of several natural 
heme-proteins. The α-helix is a well-defined rigid scaffold, which can 
accommodate several amino acid substitutions without severe structural 
perturbations; therefore, numerous model compounds, based on helical peptides, 
have been developed (Moffet and Hecht, 2001; Lombardi et al., 2001). The 
peptide sandwiched mesoheme (Benson et al., 1995; Arnold et al, 1997; Wang et 
al., 1997), the disulfide linked α-helices-mono-heme adducts (Sakamoto et al., 
1998; Sakamoto et al., 1999; Rosenblatt et al., 2002), the MOP derivatives (Rau 
and Haehnel, 1998; Rau et al., 1998; Rau et al., 2000), and the heme-maquettes 
(Robertson et al., 1994; Shifman et al., 1998; Shifman et al., 2000; Gibney and 
Dutton; 1999) are examples of either covalent or non-covalent artificial heme-
peptide conjugates. 
Figure 2.6: : Schematic representation of  Mimochromes. 
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The prototype Mimochrome I was designed on the β-chain of human 
deoxyhemoglobin as template structure. The X-ray structure of deoxyhemoglobin 
(Perutz et al., 1982) showed that the proximal His89 residue is located in the 
central position of the Leu88-Leu96 protein fragment. This protein fragment adopts 
an helical conformation. It represents a 
rigid framework both for properly 
positioning His89 in the correct 
coordination site, and for completely 
covering one face of the heme. The helix 
axis is about parallel to the porphyrin 
plane; hydrophobic residues surround the 
axial coordinating residue and face the 
heme directly. 
All the information derived from the 
analysis of the natural systems served as 
starting points for engineering the 
mimochrome models. As a first step in this 
direction, we used the Leu88-Leu96 
fragment as a scaffold for building a nine 
residue polypeptide sequence able to fold into an α-helical conformation (Nastri et 
al., 1997; Figure 2.7). The natural sequence was appropriately changed by 
considering the factors that affect helix stability. 
Therefore, Ser89 and Cys93 were replaced with alanine, which is known to have 
a high preference for the α-helical conformation. The resulting sequence contained 
five helix inducing residues, Leu1,4,9 and Ala2,6. Moreover, Glu90 and Asp94 were 
substituted with Gln and Asn respectively, in order to obtain an uncharged 
compound. N- and C-terminal ends were acetylated and amidated, respectively, to 
avoid unfavorable end-charge to helix-dipole interactions. The peptide chain was 
then covalently linked to the porphyrin propionic group through the ε-amino 
function of Lys8. Molecular modeling showed that changing the side chain 
conformation of Lys95 as found on the β chain of deoxyemoglobin and the 
conformation of the closest propionyl carboxyl group, the lysine ε-amino group 
may approach the carboxyl group at bonding distance. Finally, an identical peptide 
NH
1
2
3
4
20
5
19
N
6
7
8
NH 14
13
12
11
N
15
10
16
17
18
ON O
9
N
Leu
Lys
Asn
Ala
His
Gln   
Ala
Leu
NH2
Ac
Leu
Lys
Asn
Ala
His
Gln   
Ala
Leu
NH2
Ac
Leu   Leu   
 
Figure 2.7: Formula of 
Mimochrome I: (3, 7, 12,17-
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chain was placed on the other side of the heme by applying a C2 symmetry 
operation (Figure 2.8) . 
The two covalent bridges between the peptide moiety and the porphyrin, 
together with the coordination of the two His residues, would make the peptide 
chains able to cover both heme faces. These factors would also serve as a strong 
local constraint to firmly keep the prosthetic group inside the hydrophobic cavity 
created by the two peptide chains. Finally, deuteroporphyrin was preferred to the 
most common protoporphyrin IX to avoid degradation of the sensitive vinyl 
substituents during the synthesis. 
The fully characterization of Mimochrome I iron and cobalt complexes confirmed 
the design, even though some unexpected features were observed. The iron 
complex showed quite low solubility in water (in the µm range), in a wide range of 
experimental conditions (D‟Auria et al., 1997; Nastri et al., 1997; Nastri et al., 
1998;) Its detailed characterization was henceforth strongly limited. On the 
opposite, the cobalt complex was soluble in water (up to mM concentration), but 
two equally abundant isomers were obtained (Figure 2.9). 
Figure 2.8: Helix-heme-helix sandwich obtained by 
applying a C2 symmetry operation. 
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Because of the flexibility of the linker between the peptide and the 
deuteroporphyrin ring, each peptide chain can be positioned either above or below 
the porphyrin plane, giving rise to Λ and Δ diastereomers (Lombardi et al., 1998; 
Figure 2.10). This finding was confirmed by the solution structural characterization 
(D‟Auria et al., 1997). In fact, the NMR structures of the two diamagnetic Co(III) 
isomers (Figure 2.10), which represent the first example of structure determination 
of a designed heme-protein models, allowed a definitive identification of the two 
isomers as the Λ and Δ diastereomers and a straightforward correlation between 
their structure and spectral properties. As expected, the peptide chains adopt an 
almost regular α-helical conformation; the helices lie parallel to the porphyrin 
plane, and they are antiparallel to each other in the Λ isomer and about orthogonal 
in the Δ isomer (Figure 2.10). The analysis of the three-dimensional structure of 
the two cobalt isomers was important in understanding the properties of the Fe(II) 
and Fe(III) complexes, which could not be studied by NMR spectroscopy because 
of their poor solubility. The remarkably different solubility between the iron and 
cobalt complexes was tentatively attributed to the simultaneous presence of the 
two diastereomers, for the iron complex, in fast interconverting equilibrium. During 
this process both peptide chains might be displaced from the porphyrin plane. The 
porphyrin ring is thus exposed to the solvent, and aggregation by stacking of the 
porphyrin ring may occur. Confirmation for this hypothesis came from the CD 
spectral properties in the Soret region, which are an average of those 
corresponding to the two separate diastereomers. 
Figure 2.9: Schematic representation of the two possible orientations of the peptide 
chains around the metal center, which give rise to the two Λ and Δ diastereomers. 
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The unpredicted but experimentally observed Λ and Δ isomers of Co(III)-
mimochrome I clarify the concept of diastereomerism that may occur when 
polypeptides coordinate to metal ions. The use of local pseudo-C2 symmetry is 
particularly advantageous to construct symmetric molecules with minimized size, 
because it simplifies the design, reduces the size of the molecules to be 
synthesized, and may simplify their structural characterization (Lombardi et al., 
2000a; b). However, great attention should be paid in the design to overcome the 
problem of diastereomer formation. 
The information derived from Mimochrome I was fruitfully applied for improving 
the structure by design. Two strategies were used to reduce the peptide flexibility:  
• by elongating the peptide chain at the C-termini, with a four residue 
fragment, modeled in an extended conformation; 
• by amino acid substitutions that may provide intra-molecular, inter-chain 
interactions. 
The first strategy was successfully applied, as reported for mimochrome II, 
where the stabilization of the Λ isomer was achieved (Lombardi et al., 1998). The 
second strategy led to the design of mimochrome IV, where the lambda isomer 
was observed as unique species. 
 
 
 
Figure 2.10: Average molecular structures of Co(III) mimochrome I Δ and Λ 
isomers, as obtained from NMR experimental data and RMD calculations. 
37 
 
2.3.1 Fe(III)-Mimochrome IV and its analogs 
Mimochrome IV was designed by using the NMR structures of Co(III)-
Mimochrome I Δ and Λ isomers as templates (D'Auria et al., 1997). Mimochrome I 
contains two leucine residues at both the N- and C-termini. These residues were 
selected in the initial design of Mimochrome I, because of their high propensity to 
be accommodated in α-helical 
conformation (DeGrado et al., 
1999). Further, it was expected that 
hydrophobic interactions, between 
the leucine side chains and the 
porphyrin, would drive the helices to 
lay on the porphyrin. Nevertheless 
as mentioned previously , the 
sandwich was stable for the Co(III) 
derivative, and not for the Fe(III) 
(Nastri et al., 1997; D'Auria et al., 
1997). In order to provide an extra 
contribution to the stability of the 
sandwich, beside the metal coordination force, the sequence of Mimochrome I 
was modified by introducing intra-molecular, inter-helical interactions. 
The Cα atoms of Leu
1 of one helix and of Leu9 of the other helix are about 12 Å 
apart in both isomers. At this distance, the carboxylate side chain of a Glu residue 
at position 1 of one peptide chain could ion pair with the guanidine group of an Arg 
residue at position 9 of the other peptide chain. Thus, Glu1 and Arg9, which replace 
Leu1 and Leu9, was inserted to stabilize one of the two possible diastereomers.  
Further, the solvent exposed Ala2 and Ala6 in Mimochrome I, were replaced by Ser 
residues in Mimochrome IV, in order to further increase the water solubility of the 
new molecule. 
The insertion of Glu and Arg residues at position 1 and 9 of the sequence, 
respectively, was successful in stabilizing the sandwich structure and in favoring 
the formation of Λ isomer (Figure 2.11) over the other, both in the Fe(III) and 
Co(III) complexes. These results were confirmed by NMR data and RMD 
calculations (Lombardi et al., 2003). The UV-vis pH titration showed the iron bis-
His coordination is strong enough to bring the His pKa value around 3.8. The bis-
Figure 2.11: Co(III)-Mimochrome IV average 
structure as obtained from NMR data and 
RMD calculations. 
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His coordination is even stronger in Co(III) complex, and it  occurs at very acidic 
conditions (pH < 2). 
This finding is related to the high preference of cobalt for nitrogen donor ligands, 
and to the exchange inertness of low-spin Co(III) complexes. These low pKa 
values of the axially coordinating His (with values very close to what observed in 
several myoglobins, hemoglobins and cytochromes in the oxidized and reduced 
forms) strongly support the designed sandwich structure (Palaniappan and Bocian, 
1994; Coletta et al., 1997). 
CD spectra in the far UV region confirmed the peptide chain to be 
predominantly in an α-helical conformation in both the apo and metalated species. 
The definitive answer of the structural identity of the diastereomer stabilized in 
Mimochrome IV was obtained by NMR structural characterization of the cobalt 
complex. The NMR analysis fully confirms the UV-Vis and CD data, both regarding 
the helical conformation of the peptide chains, and the Λ configuration of the 
hexacoordinated CoIII ion. The RMD calculations, using the NMR experimental 
data as conformational restraints, indicated two helical peptide chains, oriented 
about perpendicularly.  
In summary, Mimochrome IV is a simple, structurally defined heme protein 
model, which  provide an excellent opportunity for exploring the subtle 
mechanisms that control the heme functions. The peptide structure of 
Mimochrome IV is such that a partially open hydrophobic cage around the 
imidazole ring is present. Except for the position 20 of the deuteroporphyrin ring, 
all the other meso positions are covered by the polypeptide chains, which, similarly 
to the natural systems, may protect the deuteroporphyrin ring from degradation 
during catalytic cycles. 
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The amino acid composition of Mimochrome IV was then modified by the 
substitution of serines, glutamines and asparagines, which point outward from the 
molecular core, with differently charged residues for modulating the redox potential 
of the heme. Based on the Mimochrome IV design, two new models were 
obtained: Mimochrome IV 8Glu and Mimochrome IV 8Lys (G. Del Gatto PhD 
thesis, 2007; Figure 2.12), that contained respectively eight Glu residues and eight 
Lys residues.  
The spectroscopic characterization of the two models, Mimochrome IV 8Lys 
and Mimochrome IV 8 Glu were performed. The UV-vis spectra of both Fe(III)-
Mimochrome IV 8Glu and Fe(III)-Mimochrome IV 8Lys, at pH 7, are typical of 
octahedral bis-His low spin complexes, in good agreement with the spectral 
features previously observed for Fe(III)-Mimochrome IV. CD measurements in the 
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UV region indicates the peptides to be in helical conformation, in both complexes 
at pH 7 (G. Del Gatto PhD thesis, 2007). 
The effect of the charge distribution on the redox properties of the metal center 
has been determined by square wave voltammetry in solution. 
The deuteroheme redox potential of  Fe-Mimochromes, at pH 7, are the 
following: 
 
Fe-Mimochrome IV 8Glu:   -170 mV vs SHE 
Fe-Mimochrome IV:              -58 mV vs SHE 
Fe-Mimochrome IV 8Lys:     -48 mV vs SHE 
 
E°‟Fe-Mimohrome IV 8Glu < E°‟Fe-Mimochrome IV < E°‟ Fe-Mimochrome IV 8Lys 
 
The measured redox potential of -170 mV for Fe-Mimochrome IV 8Glu and -48 
mV for Fe-Mimochrome IV 8Lys demonstrate that negatively charged residues, as 
for Fe-Mimochrome IV 8Glu, around the molecular core, stabilize the ferric 
deuteroheme, while the positively charged residue of Fe-mimochrome IV 8Lys 
stabilize the ferrous deuteroheme. This hypothesis was further confirmed from the 
redox potential of the parent Mimochrome IV (-58 mV), that is intermediate 
between that Fe-Mimochrome IV 8Glu and Fe-Mimochrome IV 8Lys (G. Del Gatto 
PhD thesis, 2007). The potential values measured are that expected from the 
electrostatic properties of the heme environment. 
Moreover, these redox potential values of Mimochromes are significantly more 
positive than the reduction potential  of  bis-imidazole-ligated heme, as 
Fe(protoporphyrin IX)(Im)2, -235 mV vs SHE, or Fe(mesoporphyrin IX)(Im)2, -285 
mV vs SHE. This result would suggest that the sandwich structure of 
Mimochromes decreases solvent exposure, thus leading to a positive shifts of the 
reduction potential. 
In summary, Fe-Mimochrome IV and the analogs Fe-Mimochrome IV 8Glu and 
Fe-Mimochrome IV 8Lys are simple, structurally defined deuteroheme protein 
models, which may provide an excellent opportunity for exploring the subtle 
mechanisms that control the redox properties of the heme in natural proteins. 
Additionally, they are able to exchange electrons with solid electrodes, making 
them suitable for application in biosensor technology. 
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2.3.2 Fe(III)-Mimochrome VI 
Mimochrome VI (Fig. 2.13) is the result of a refinement procedure, which 
involved several cycles of molecular design, characterization end redesign. In 
particular, the NMR solution structure of Co(III)-Mimochrome IV (Lombardi et al., 
2003) and the model structure of 
Co(III)-Mimochrome II (Lombardi et al., 
1998) were used as starting point. They 
both are examples of bis-His cobalt 
porphyrin-peptide conjugate. The first is 
a bis-tetradecapeptide-porphyrin 
conjugate, and the latter is a bis-
nonapeptide-porphyrin conjugate. Both 
are pseudo-C2 symmetrical systems. 
the sequences of Mimochrome II and IV 
were combined to construct an 
unsymmetrical five-coordinate mono-
histidine model. The primary structure 
contains a histidine (His6) on the tetradecapeptide chain (derived from the 
sequence of Mimochrome II), as potential axial ligand to the metal (proximal face), 
and a serine (Ser6) on the decapeptide chain (derived from the sequence of 
Mimochrome IV) in order to create a cavity near the metal site (distal face). Some 
substitutions from the sequences of Mimochrome II and IV were introduced to 
further stabilize the secondary and tertiary structure. Similarly to other 
Mimochromes, both peptide chains are covalently linked to the porphyrin 
propionate through the Lys9 side chains. In terms of secondary structure, the 
tetradecapeptide was designed to adopt: a short helical conformation (residues 1-
9), a loop γαD (residues 10-11), and a short β-strand (residues 12-14) that folds 
back (through the loop) to interact with the helical part; the decapeptide adopts a 
helical conformation (residues 1-8). The tertiary structure can be described with 
the characteristic sandwich of the Mimochrome molecules. The two peptide chains 
embrace the metalloporphyrin;  the helical segments are antiparallel to each other 
and the helix axes are about parallel to the porphyrin plane. Stabilization of the 
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Figure 2.13: Schematic structure of 
Mimochrome VI. 
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tertiary structure was contributed by inter-chain ion-pairs between the carboxylate 
side chains of glutammate residue (Glu2) on the helix and the guanidine groups of 
arginines (Arg10) on the other helix. The positive Arg10 and the negative Glu2 at the 
C-terminal and N-terminal ends, respectively, with opposite sign relative to the 
helix dipole, may also provide stabilization of the secondary structure. Finally, 
several glutamines (Gln3,4,8) and a serine (Ser7) were introduced in the solvent 
exposed positions to convey water solubility (Nastri el al., submitted). 
Spectroscopic studies indicate that Fe(III)-Mimochrome VI is able to coordinate 
small exogenous ligands, such as carbon monoxide and nitric oxide, thus 
confirming the existence of an easily accessible face of the heme (Nastri el al., 
submitted). Further, Fe(III)-Mimochrome VI catalyzes the oxidation of several 
substrates by the activation of hydrogen peroxide (Nastri el al., submitted). All 
these results demonstrates that Fe(III)-Mimochrome VI embodies some of the key 
elements for reproducing the functional properties of heme oxidases, such as 
peroxidases and cytochrome P450, which catalyze a variety of oxidation reactions 
by using clean oxidants (H2O2 and O2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4 Aims of the thesis 
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This work aims at the development of nano-structured devices made up of 
heme-protein mimetics immobilized on solid electrodes, to be exploited as active 
constituents of third-generation biosensors, to detect and quantify analytes of 
clinical and environmental interest. 
The first objective is to take advantage of the remarkable properties of the 
Mimochrome models, in terms of direct electron transfer, molecular recognition 
and redox catalysis, to obtain layers of synthetic proteins immobilized  on 
electrode surfaces, able to yield quantitative amperometric responses upon 
interaction with given molecular targets. 
In particular, two type of devices for the development of  third-generation 
biosensors will be discussed: 
 Affinity biosensors, obtained by coating a gold electrode with one of the 
Fe(III)-Mimochrome IV analogs,  functionalized with a RE, through an 
appropriate spacer. The heme-protein mimetic acts as redox wire to 
detect the biological event, such as the recognition between the epitope 
HA_ep and its specific antibody.  
 Biocatalytic biosensor, developed using gold electrodes coated with 
Fe(III)-Mimochrome VI, able to electrocatalitically reduce molecules of 
clinical interest, such as dioxygen. 
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Chapter 3: Development of affinity electrochemical biosensors 
 
3.1 Introduction 
During the past few years, affinity biosensors have attracted growing attention. 
In fact, they show numerous advantages over alternative methods, such as high 
sensitivity, selectivity and robustness (Hock et al., 1997).
 
The extremely high 
selectivity and affinity of antibody/antigens, receptors and DNA molecules for their 
corresponding targets have been widely exploited for analytical purposes in 
various fields (environmental analysis (Suri et al., 2002; Mallat et al., 2001), clinical 
diagnostics (Luppa et al., 2001) and the food and drink industries (Mello and 
Kubota, 2002)).  
The development of an affinity biosensor involves first the selection of a 
naturally occurring macromolecule, which provide the desired analyte specificity 
(typically DNA or antibodies). Subsequently, a suitable signal transduction and 
detection methodology needs to be adapted to the selected macromolecule  
(Rogers, 2000). This step in affinity biosensor construction generally requires long 
development time, since the recognition elements are so different that is 
impossible to realize a simple, unique detection method (Rogers, 2000).  
To overcome this limitation, new approaches are being developed. Protein 
engineering is used to adapt the signal-transduction properties of  the biological 
molecules to the detector instrumentation and to the transduction chemistry, rather 
than adapting instruments and chemistry to the unique requirements of each 
natural molecule. In the present work, we have followed this approach by 
integrating a small synthetic heme protein, which provides a simple signal-
transduction mechanism, between the detector and the bio-recognition element. 
 
3.2 Affinity biosensor based on synthetic peptides 
The system developed in the present study is a third generation 
electrochemical affinity biosensor, based on the artificial heme-protein models 
named Mimochromes IV. These molecules have been selected as redox tags for 
the detection of the binding event between electrochemically inactive species. 
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3.2.1 General structure of the biosensor and working hypothesis 
The basic element of the biosensor system proposed (Figure 3.1) is an 
electrode linked to a signal transducer, which is made up by a miniaturized 
electron transfer proteins derivatized with a recognition element (RE). The working 
hypothesis is that upon binding of the RE (antigen, enzyme inhibitor, receptor 
agonist or antagonist, DNA binding peptides, etc.) to the analyte (antibody, 
enzyme, receptor, DNA, etc.) the redox potential of the metal ion encapsulated 
into the electron transfer protein changes. This change is very likely to occur 
because the charge distribution is affected by the binding. Thus, detection of a 
target analyte can be performed through measurements of electron transfer 
protein redox potentials. The innovation offered by such a system relies on the 
direct integration of the signal-transducer  into the recognition element. 
The main feature of this system is its versatility: in principles, it could work with 
every recognition element/analyte pair able to produce a conformational change 
that can influence the charge distribution around the metal center of the electron 
transfer molecule. 
  
3.2.2 The electron transfer protein 
In an electrochemical biosensing system like the one we have developed, it is 
of fundamental importance the choice of the electron transfer protein, which must 
be able to exchange electrons rapidly and directly with the electrode. This can be 
obtained using small synthetic heme proteins models, the Mimochromes IV 
analogs. They consist of a heme group linked to two α-helical peptide chains via 
an amide bond between the porphyrin propionyl groups and the side chains of two 
Figure 3.1: Schematic representation of the proposed affinity electrochemical 
biosensor. 
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Lys residues. Two His residues axially coordinate the heme-iron (See section 2). 
Owing to their small size, the heme group is not buried inside the protein scaffold, 
and they can successfully achieve direct electron transfer with the supporting 
electrode. 
In a previous PhD thesis (G. Del Gatto PhD thesis, 2007), three Mimochrome 
IV analogs (Mimochrome IV, Mimochrome IV 8 Glu and Mimochrome IV 8 Lys) 
were synthesized and characterized. All the results demonstrate that these 
molecules could be useful for electrochemical application. As a consequence, the 
first step of the present work was to investigate the most suitable procedures to 
immobilize Mimochrome molecules on the electrode surface, and to functionalize 
them with a biorecognition 
element.  
The most popular methods 
to bind a protein on a solid 
surface or to another protein is 
the introduction of functional 
groups on the ε-amino group of 
the Lys residues side chain. 
Mimochrome IV and the 8 Glu 
analogue lack free lysines in 
their sequence. On the 
opposite, the 8 Lys analogue 
possesses too much free lysine 
to obtain a mono-oriented layer.. Therefore, a new analog was synthesized, 
starting from the sequence of the parent Mimochrome IV. The Gln3 in the peptide 
sequence was substituted with a Lys, in order to have one free lysine residue on 
each peptide chain. This molecule was named Mimochrome IV Lys
3
 and its 
schematic structure in shown in Figure 3.2.  
 
3.2.3 Choice of the analyte-recognition element couple 
Biosensors, which monitor antigen–antibody interactions, are referred to as 
immunosensors, and are among the most popular affinity biosensors. This kind of 
sensors employ either an antigen or antibody immobilized on a solid surface and 
participates in a biospecific interaction with the other component, allowing 
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Figure 3.2: Schematic structure of 
Mimochrome IV Lys3. 
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detection and quantification of an analyte of interest. The specific interaction is 
followed by a measuring device (transducer) capable of sensing a change in a 
physical property resulting from the antigen–antibody interaction. 
Coupling of immunological reactions to amperometric electrodes has been 
demonstrated as a versatile technique for the measurement of numerous analytes 
of clinical interest (D'Orazio, 2003; Liu et al., 2008; Liu and Gooding, 2009).  
To assay the effectiveness of the hypothesized biosensor system, we decided 
to test the ability of Fe(III) Mimochrome IV Lys3 to transduce an antigen-antibody 
binding event into an electrochemical signal. 
To this purpose, we decided to functionalize the heme-protein model with a 
synthetic peptide corresponding to the 98-106 amino acid sequence 
(YPYDVPDYA) of the human influenza virus hemagglutinin (HA), known as HA 
epitope (Kolodziej and Young, 1991). This epitope constitutes the recognition 
element in the affinity electrochemical biosensor developed, to detect the 
presence of the specific antibody. This epitope was chosen because of the 
simplicity of the synthesis and the availability of commercial monoclonal 
antibodies, with high affinity that can ensure the specificity of binding.  
 
3.2.3.1 A brief description of antibodies (the analyte) and antigens (the 
RE) 
Antibodies are immune system-related proteins, called immunoglobulins. 
Antibodies can be classified into five classes, IgG, IgM, IgA, IgE and IgD (Figure 
3.3). The IgD, IgE and IgG antibody classes are each made up of a single 
structural unit, whereas IgA antibodies may contain either one or two units. IgM 
antibodies are pentameric made up of five disulfide-linked structural units (Figure 
3.3). 
IgG antibodies are further divided into four subclasses (isotypes). 
Immunoglobulin G (IgG) is the most abundant immunoglobulin derivative in serum. 
This class of antibodies is also the most commonly used in immunochemical 
assays and sensor applications. The IgG molecule consists of four polypeptide 
chains, two identical heavy (H) chains and to two identical light (L) chains, joined 
together to form a Y shaped molecule (Figure 3.4). The identical H-chains are 
connected via disulfide bridges. Disulfide bonds are also responsible for the 
connection between the L- and H-chains, referred to as inter-chain disulfide 
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bridges. Each chain is further divided into regions or domains, consisting of ≈ 110 
aminoacid residues. The light chain consists of two domains while the heavy chain 
is made up of four domains. The N-terminal domain at the tip of the arms of the “Y” 
on both the light and the heavy chain are known to be variable in their amino acid 
sequence, and are thus referred to as variable (VL and VH) regions. The 
subdomains of the H-chain are made up of three C regions (CH1, CH2, CH3) and 
one V region (VH). The L-chain, on the other hand, consists of one C region (CL) 
and one V region (VL). The base of the Y shaped antibodies is called Fc fragment 
(fragment that crystallizes) and is formed by the association of the two CH2 and 
two CH3 domains. Each arm of the Y shape is referred to as Fab fragment 
(fragment containing the antibody binding site) and is formed by the association of 
CH1 with CL and VH with VL (Figure 3.4). The binding site (paratope) of the 
antibodies is located within the VH and VL domains, each arm containing one 
binding site. In the variable regions, amino acid sequences can vary from one 
antibody to another. Certain regions within the V regions have very high amino 
acid residue variability. These regions are called hypervariable regions, also 
known as complementary determining regions (CDRs). Three CDRs are integrated 
into the L-chain and three into the H-chain resulting in six CDSs for each arm 
(Roitt et al., 1985; Kaplan et al., 2003). 
 
Figure 3.3: Structures of the different classes of immunoglobulins. 
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An antigen is a molecule that can bind to an antibody. The region of the 
antigen that binds to an antibody is called epitope or antigenic determinant, where 
the corresponding part of the antibody is named paratope. Antibody- antigen 
binding is usually reversible and it is mainly based on non-covalent interactions, 
such as hydrogen bonds, Van der Waals and electrostatic forces. The nature of 
the interactions depends on the structure of the antibody, which varies with 
isotype, and on the structure of the antigen. The antibody can have either one 
(monovalent) binding interaction with an antigen, or multiple simultaneous 
(multivalent) interactions (Absolom and Van Oss, 1986). 
The affinity is the measure of the strength of the binding of an antigen to an 
antibody. The reaction between an antibody and an antigen can be described by 
the following equation (3.1):  
Figure 3.4: Schematic structure of an antibody. 
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Where [Ab] represents the antibody concentration, [Ag] the antigen 
concentrations and [Ab-Ag] the concentration of the antigen-antibody complex. ka 
is the association rate constant and kd is the dissociation rate constant. Generally, 
antibodies with association constants Kass of 10
8 M-1 are used in immunochemical 
assays (Davies, 1994). 
 
 
In this chapter, all the steps that have been followed to construct the affinity 
electrochemical biosensor are reported. 
In particular, the following aspects will be discussed: 
 
 Synthesis of the transducer, Fe(III)-Mimochrome IV Lys3. 
 Synthesis of the recognition element. 
 Synthesis of the transducer-recognition element complex. 
 Characterization of the transducer by voltammetric techniques: 
a. freely diffusing; 
b. immobilized on a gold electrode surface. 
 Characterization of the transducer-recognition element complex 
covalently bound on a gold electrode by voltammetric techniques. 
 Working test of the complete biosensor in the recognition of the 
analyte. 
3.1 
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3.3 Synthesis of the transducer: Fe(III)-Mimochrome IV Lys3 
 
3.3.1 Peptide synthesis 
The nonapeptide (Ac-Glu1(OtBu)-Ser2(tBu)-Lys3(Boc)-Leu4-His5(Trt)-Ser6(tBu)-
Asn7(Trt)-Lys8(Mmt)-Arg9(Pbf)-NH2) was synthesized by the solid-phase method 
using the Fmoc strategy, using the following protocol: 
 
1)  Automatic peptide synthesis, consisting of the following steps: 
• Deprotection of the α- Fmoc group 
• α-carboxyl group Activation 
• Coupling 
2)  Deprotection of the Lys ε-amino group. 
3)  Cleavage from the resin. 
 
The most difficult step in the Mimochrome synthesis was the preparation of the 
nonapeptide fragment, protected at all functional groups, except at the ε-amino 
function of the Lys8 residue. 
The Sieber amide resin (Figure 3.5) was 
chosen because it allows the cleavage of the 
peptide from the resin, while leaving all the 
protecting groups on the side-chains, as well 
as on the N-terminal residue, intact. 
Another fundamental point was the 
choice of the protecting group on N-ε 
function of the Lys8, since its cleavage conditions should be different than those 
used for the other side chain protecting groups. The Mmt protecting group was 
chosen, since it can be easily removed by repeated treatments with a solution 
containing 10% acetic acid and 20% trifluoroethanol (TFE) (v/v) in CH2Cl2, without 
affecting the other protecting groups. 
The peptide was synthesized on a 0.2 mmol scale, using a 0.16 mmol/g resin 
substitution. At the end of the synthesis, when the peptide is still linked to the 
resin, the N-ε Mmt protecting group of the Lys8 residue was removed with 
repeated treatments of a solution containing 10% acetic acid and 20% 
trifluoroethanol (TFE) in CH2Cl2. After this step, cleavage of the peptide from the 
Figure 3.5: Sieber amide resin. 
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resin was achieved with a solution 1%TFA  in DCM, and the fractions eluted from 
the resin were checked by TLC and pooled if they contained the desired product. 
The pooled fractions obtained from the cleavage reaction were evaporated under 
reduced pressure up to 5% of the volume.  Ice-cold water was added to the 
residue and the mixture was cooled on ice to aid precipitation of the protected 
peptide. The product was filtered, washed several times with fresh water, and 
dried under vacuum to give the crude C-terminal peptide amide. The product was 
analyzed by RP-HPLC (Figure 3.6). 
This analysis showed that the desired product was obtained in high purity. It 
was used in the next reaction without further purification. 
 
 
 
 
 
 
 
 
 
Figure 3.6:  HPLC chromatogram of  the Mimochrome IV Lys3 peptide. 
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3.3.2 Peptide-deuteroporphyrin coupling 
The fully protected nonapeptide, except for the Lys8 side chain, was coupled in 
solution to the deuteroporphyrin moiety. A small molar excess of the peptide (20%) 
was used. The porphyrin carboxyl groups were activated with HATU, which is one 
of the most efficient coupling reagent in peptide synthesis. In order to favour the 
formation of the bis-substituted deuteroporphyrin IX, the mixture of the activated 
porphyrin was slowly added to the nonapeptide solution. This procedure allows the 
activated porphyrin to be in the presence of excess of peptide. The completeness 
of the reaction was verified by RP-HPLC, following the disappearance of the peak 
with adsorption at 400 nm, corresponding to the free porphyrin. 
The side chain protecting groups were removed by acid cleavage at 0 °C for 
2.5 h. This treatment was performed twice. The reaction mixture was concentrated 
to approximately 1-2 mL. Extraction of the scavengers and precipitation of the 
crude product was achieved by addition of cold diethylether. The crude material 
was then dried in vacuo and purified by preparative RP-HPLC; the pooled fractions 
containing the desired product were  
lyophilized. 
The HPLC chromatogram of the pure product is reported in Figure 3.7a, 
showing the presence of a main peak at tr 19,20 min. 
The identity of the product was ascertained by mass spectrometry (Figure 3.7b 
(mass expected: 2753 u.m.a.; mass observed: 2751,91 ± 0.31 u.m.a.).  
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3.3.3 Iron insertion  
Basically, the reaction between the metal ion and a porphyrinic compound 
consists of a) the formation of the equatorial MN4 plane; and b) the completion of 
the axial coordination sphere. However, certain considerations have to be made 
concerning the metalation procedure:  
1. The solvent for the reaction should be able to dissolve the porphyrin as well 
as the metal compound, but without coordinating the metal ion with high 
affinity in order to avoid competition with the porphyrin. 
2. The porphyrin has to be deprotonated in order to produce the negative P2- 
ion that is present in the metal-porphyrin complex. The presence of strong 
acids in the reaction media will impede or even reverse metalation by 
shifting the protonation/ deprotonation equilibrium to the left.  
 
(b) 
Figure 3.7 (a) HPLC chromatogram and (b) mass spectrum of  pure Mimochrome 
IV Lys3 free base. 
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3. To be able to react with the porphyrin macrocycle, the metal compound 
which carries the metal ion should dissociate, yielding an active 
(coordinatively unsaturated) species. Therefore, the metal complex should 
not be too stable otherwise it will not react with the porphyrin present in the 
reaction mixture. Other considerations are the availability, ease of handling, 
and solubility of the metal complexes in organic solvents. 
4. After the incorporation of a metal ion with a positive charge greater than +2, 
it will bind one or more anions from the reaction medium to form a neutral 
species. Some metal ions prefer certain defined geometries, which require 
the addition of a neutral ligand (solvent, H2O, O2) to complete their 
coordination sphere. 
The methods commonly used for the insertion of metal ions in the porphyrin 
macrocycle are listed below. The systems are characterized either by the solvent 
or the metal carrier used, depending on the more essential component. Since 
metalloporphyrins have characteristic UV-VIS properties, the reaction is usually 
monitored by spectrophotometry. 
 
 
The acetate method 
 
           Zn(OAc)2.xH2O + H2P                 Zn(P) + 2 HOAc + 2 H2O  
 
The acetate method includes all metalation reactions in which the protons of 
the porphyrin are transferred to acetate or propionate ions of the metal 
acetates/propionates. The solvents can be glacial acetic acid, or mixtures of 
CHCl3/MeOH. This method can be applied to all divalent metals, except those 
which are unstable in acetic acid, and to some tri- and tetravalent metal ions. 
Often sodium acetate is added to further buffer the solution and to enhance 
deprotonation of the porphyrins. This method is considered the method of choice 
for the synthesis of manganese-porphyrin complexes. 
 
 
 
HOAc 
 
50 ºC 
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The pyridine method 
 
          Mg(ClO4)2 + H2P  + 4 Py               Mg(P)Py2 + 2 [PyH][ClO4] 
 
In those cases where the metalloporphyrin is very labile towards acids, the 
basic solvent pyridine is used for divalent metal ions. Pyridine is capable of 
dissolving the porphyrins as well as the metal salts, and the good complexing 
properties of pyridine allow the direct isolation of metalloporphyrin pyridinates. The 
same properties, however, impede the incorporation of metal ions with higher 
charges by forming pyridine complexes with the metal carrier, thus retarding the 
dissociation of the metal ion. 
 
The dimethylformamide method 
 
                 4 CrCl4 + 4 H2P  + O2              4 Cr(P)Cl + 2 H2O + 4 HCl 
 
Weakly coordinating, high boiling oxygen-donor solvents such as 
dimethylformamide, tetramethylurea and sulfolan are excellent solvents for the 
metal carriers and porphyrins. The best results have been obtained with 
anhydrous metal chlorides (although they can be difficult to obtain and to handle), 
as the high boiling temperature forces the formed HCl to escape.  
 
The metal carbonyl method 
 
                Re2(CO)10 + H2P              [Re(CO)3]2(P) + H2 + 4 CO  
 
In metal carbonyls some of the CO groups may be eliminated, resulting in a 
coordinatively unsaturated species. This species acts as a Lewis acid, attacking 
the lone pairs of the porphyrin nitrogen atoms. This method is especially useful for 
the preparation of porphyrins containing the metals of groups VI to VIII.  
 
 
 
Py 
DMF 
 
153 ºC 
decalin 
 
195 ºC 
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Iron ion was inserted into Mimochrome IV Lys3 according to the acetate 
method (Buchler, 1978). 
Iron (II) acetate (10 molar excess) was added to a solution of pure 
Mimochrome IV Lys3 free base in TFE/Acetic acid (6/4 v/v), and the reaction 
mixture was kept at 50°C for 2 h, refluxing under nitrogen. After 20 minutes, the 
reaction mixture started to turn slowly brown, and the HPLC chromatogram (Figure 
3.8 a) showed the presence of a new peak at 18.32 min with the characteristic UV-
visible spectrum of the iron (III) deuterophorphyrins at acidic pH, λmax = 387 nm 
(Figure 3.8 b). The mass spectrum confirmed (Figure 3.8 c) the identity of the 
desired product (mass expected: 2807 u.m.a.; mass observed 2805.62 ± 0.18 
u.m.a.). 
The product was then purified by RP-HPLC and pooled fractions containing 
the pure product were lyophilized. 
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Figure 3.8: (a) HPLC chromatogram, (b) UV-vis and (c) mass spectra of pure 
Fe(III)-Mimochrome IV Lys3. 
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3.4 Synthesis of the recognition element: Ha_epitope 
HA_epitope was synthesized by the solid-phase method using the Fmoc 
strategy. A cisteine residue was added at the N-terminus of the peptide sequence 
to simplify the functionalization protocol of Fe(III)-Mimochrome IV Lys3 with the 
epitope. 
The peptide (Ac-Cys1(Trt)-Tyr2(tBu)-Pro3-Tyr4(tBu)-Asp5(OtBu)-Val6-Pro7-
Asp8(OtBu)-Tyr9(tBu)-Ala10-NH2) was synthesized following the protocol described 
in Chapter 3 (section 3.2.1) for Mimochrome IV Lys3 peptide.  
In this case, the peptide was cleaved from the resin fully deprotected and 
purified via preparative RP-HPLC. The purity of the product was ascertained by 
analytical HPLC and MALDI-TOF spectrometry.  Figure 3.9 reports the RP-HPLC 
chromatogram and the mass spectrum of the pure HA_epitope. The experimental 
molecular weight, 1268 uma, corresponds to the NA+ adduct (1245 + 23), and fully 
(a) 
(b) 
Figure 3.9: (a)  HPLC chromatogram and (b) mass spectrum of  pure 
HA_epitope. 
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agree with the calculated mass (1245 uma), thus confirming the identity of the 
product. 
 
3.5 Synthesis of the complex Fe(III)-Mimochrome IV Lys3-Ha_ep 
 
Fe-Mimochrome IV Lys3 was modified with the HA_epitope utilizing the Sulfo-
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate reagent (sulfo-
SMCC,  Figure 3.10), (Mattson et al., 1993).  
Sulfo-SMCC is a water-soluble heterobifunctional crosslinker containing an N-
hydroxysuccinimide (NHS) ester and a maleimide group. It allows covalent 
conjugation of amine- 
and sulfhydryl-
containing molecules. It 
is often used to prepare 
antibody-enzyme and 
hapten-carrier protein 
conjugates in a two-step 
reaction scheme. NHS 
esters react with primary 
amines at pH 7-9 to form amide bonds, whereas maleimides react with sulfhydryl 
groups at pH 6.5-7.5 to form stable thioether bonds (Mattson et al., 1993). In 
aqueous solutions, NHS ester hydrolytic degradation is a competing reaction, 
whose rate increases with pH. The maleimide group is more stable than the NHS-
ester group (Mattson et al., 1993). For these reasons, conjugations between Fe-
Mimochrome IV Lys3 and HA epitope was performed in two steps: first, the NHS-
ester was coupled with the ε-amino group of one Lys of the heme-protein; in the 
second step, maleimide reaction with the N-terminal Cys of HA epitope was 
carried out. 
 
 
 
 
 
 
Figure 3.10 Structure of sulfo-SMCC. 
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3.5.1 Fe-Mimochrome IV Lys3 functionalization with sulfo-SMCC 
In order to obtain the mono-functionalized derivative, with only one Lys residue 
bound to the crosslinker, the reaction was carried out using a 1:1 molar ratio 
between Fe-Mimochrome IV Lys3 and sulfo-SMCC, in 100 mM phosphate buffer, 
pH 7.2. 
After 1 hour, the proceeding of the reaction was controlled via LC-MS (Figure 
3.12 a). The chromatogram shows the presence of two new peaks, at higher 
retention times respect to the starting molecule Fe(III)-Mimochrome IV Lys3. 
The analysis of the mass spectrum allowed the identification of the two peaks. 
The peak at tr = 44.9 min corresponds to the unmodified Fe(III)-Mimochrome IV 
Lys3, while the peaks at tr = 48.6 min and tr = 51.5 min correspond to the mono- 
and the bis-functionalized products, respectively.  
Due to the high reactivity of the NHS moiety of the sulfo-SMCC towards 
primary amines, it is difficult to obtain only the desired, mono-substituted product. 
For this reason, the reaction was stopped, even though it was not completed. This 
is because further additions of sulfo-SMCC bring to the modification not only of the 
free Mimochrome, but also of the mono-functionalized species present in the 
reaction mixture. Figure 3.12c reports the mass spectrum of the mono-substituted 
product (mass expected: 3026 u.m.a., mass observed: 3024.12 ± 0.32 u.m.a.).  
 
Figure 3.11 First step of crosslinking reaction: activation of Fe(III)-Mimochrome IV 
Lys3 with maleimido-group. 
Sulfo-SMCC N-idrossisuccinimmide
100mM  phosphate buffer, pH 7.2
Reagents molar ratio 1:1
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Figure 3.12 (a) HPLC chromatogram, (b) mass chromatogram of the reaction 
mixture, and (c) mass spectrum of peak at tr = 48.6 min.  
(b) 
Z=+3; m=3024.45 u.m.a 
 
 
700 750 800 850 900 950 1000 1050 1100 1150 m/z
0.0
0.5
1.0
Inten.(x100,000)
1009.15
756.95 1022.00
1076.65 1172.351121.65
702.00
946.75836.90 980.10812.90 867.85 916.35
Z=+4; m=3023.80 u.m.a 
 
(c) 
(a) 
35.0 40.0 45.0 50.0 55.0 min
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
mAU(x100)
Ch2-387nm,4nm (1.00)
Ch1-210nm,4nm (1.00)
44
.9
21
48
.6
32
51
.4
95
41
.7
73
43
.5
08 4
4.
92
2
48
.6
33
51
.4
98
Fe-Mimo IV 
Lys
3
 + SMCC  Fe-Mimo IV Lys
3
  
Fe-Mimo IV 
Lys
3
 + 2 SMCC  
64 
 
3.5.2 Fe-Mimochrome IV Lys3 functionalization with HA_ep 
The Fe(III)-Mimochrome IV Lys3 mono-sulfo-SMCC was used without further 
purification. HA_ep was added to the reaction mixture in a molar ratio 3.5 to the 
total Fe(III)-Mimochrome IV Lys3.  
The mixture was allowed to react for 2 hours at room temperature, under 
continuous stirring. The proceeding of the reaction was followed by LC-MS (Figure 
3.14). After two hours, the analysis of the chromatogram and the mass spectra 
showed the complete functionalization of the Fe(III)-Mimochrome IV Lys3-SMCC 
with HA_epitope.  
In the electrospray process a population of variably charged  ions are 
generated (Figure 3.14 b), depending on the number of protonation sites in the 
peptide sequence.  
The mass spectrum of the peak at tr = 44.789 min (Figure 3.13 c) corresponds 
to the unmodified Fe (III)-Mimochrome IV Lys3 (mass expected: 2808 u.m.a., mass 
observed: 2806.62 ± 0.42 u.m.a.). 
The mass spectrum of the peak at tr = 43.762 min (Figure 3.14 d) corresponds 
to HA_epitope functionalized with a molecule of sulfo-SMCC (mass expected: 
1482 u.m.a., mass observed: 1482.80 u.m.a.). 
The mass spectrum of the peak at tr = 48.815 min (Figure 3.14 e) corresponds 
to the final desired product (mass expected: 4272 u.m.a., mass observed: 4271 
u.m.a.). 
 
 
Figure 3.13: Second step of crosslinking reaction: modification of Fe(III)-
Mimochrome IV Lys3-SMCC with HA_epitope. 
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Figure 3.14: (a) HPLC chromatogram, (b) mass chromatogram of the reaction 
mixture, and mass spectra of: (c)  peak at tr = 44.789 min, (d) peak at tr = 43.762 
min, (e) peak at tr = 48.815 min.  
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The reaction mixture was then purified by preparative HPLC, and the fractions 
corresponding to the desired product were collected and lyophilized. Figure 3.15 
shows the chromatogram and the mass spectrum of the pure product (mass 
expected: 4272 u.m.a., mass observed: 4270.50 ± 0.12 u.m.a.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: (a) HPLC chromatogram, and (b) mass relative to the pure Fe(III)-
Mimochrome IV Lys3-HA_ep conjugate. 
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3.6 Voltammetric analysis of Fe(III)-Mimochrome IV Lys3  
 
3.6.1 Voltammetric methods 
The common characteristic of all the voltammetric techniques is that they 
involve the application of a potential (E) to an electrode and the monitoring of the 
resulting current (i) flowing through the electrochemical cell (Kounaves, 1997). In 
many cases the applied potential is varied or the current is monitored over a 
period of time (t). Thus, all voltammetric techniques can be described as some 
function of E, i, and t. They are considered active techniques (as opposed to 
passive techniques such as potentiometry) because the applied potential forces a 
change in the concentration of an electroactive species at the electrode surface by 
electrochemically reducing or oxidizing it. 
The analytical advantages of the various voltammetric methods include:  
1. excellent sensitivity with a very large useful concentration ranges (10–12 
to 10–1 M), for both inorganic and organic species;  
2. large number of useful solvents and electrolytes; 
3.  wide range of useful temperatures; 
4. rapid analysis times (seconds);  
5. simultaneous determination of several analytes. 
In addition, these techniques are supported by a well-developed theory, 
leading to the possibility to determine kinetic and mechanistic parameters, the 
ability to reasonably estimate the values of unknown parameters, and the ease 
with which different potential waveforms can be generated and small currents 
measured. 
 
A sensitive, electroanalytical method for detection of analytes in solution or on 
the surface of an electrode is Cyclic Voltammetry (CV) (Kounaves, 1997). It is 
perhaps the most effective and versatile electroanalytical technique available for 
the study of redox systems. It enables the electrode potential to be rapidly 
scanned in search of redox couples. Once located, a couple can then be 
characterized from the potentials of peaks on the cyclic voltammogram and from 
changes caused by varying the scan rate. CV is often the first experiment 
performed in an electrochemical study. It is rarely used for quantitative 
determinations, but it is widely used for the study of redox processes, to determine 
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redox potentials, reaction mechanisms, chemical concentrations and kinetic rate 
constants. Cyclic voltammetry uses a triangular waveform to linearly ramp the 
potential through time and measuring the current as a function of the applied 
potential. Figure 3.16 is an example of the triangular waveform used for cyclic 
voltammetry. The potential is varied linearly with time, and the rate at which the 
potential is varied is called the sweep rate. A cyclic voltammetry experiment starts 
by scanning from t1 to t2 in a linear fashion. The scan then reverses direction back 
to the original potential at t3. The detection limit of this technique is about 1*10
-5 M. 
Square-Wave Voltammetry (SWV) (Wang, 1994) is a large-amplitude 
differential technique in which a waveform composed of a symmetrical square 
wave, superimposed on a base staircase potential, is applied to the working 
electrode (Figure 3.17).  
The net current, inet, is obtained by taking the difference between the forward 
and reverse currents (ifor – irev) and is centered on the redox potential. The peak 
height is directly proportional to the concentration of the electroactive species and 
detection limits as low as 10–8 M are possible.  
 
Square-wave voltammetry has several advantages: excellent sensitivity and 
the rejection of background currents, and speed. This speed, coupled with 
computer control and signal averaging, allows for experiments to be performed 
repetitively and increases the signal-to-noise ratio. Applications of square-wave 
voltammetry include the study of electrode kinetics, catalytic homogeneous 
Figure 3.16: Triangular waveform used in cyclic voltammetry. 
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chemical reactions, determination of some species at trace levels, and its use with 
electrochemical detection in HPLC. 
 
 
3.6.2 The electrochemical cell  
The basic components of a modern electroanalytical system for voltammetry 
are a potentiostat, a computer, and the electrochemical cell. A typical 
electrochemical cell consists of the sample dissolved in a solvent, an ionic 
electrolyte, and three (or sometimes two) electrodes: a working (indicator) 
electrode, a reference electrode, and usually a counter (auxiliary) electrode. While 
the working electrode is the electrode at which the reaction of interest occurs, the 
reference electrode provides a stable potential (indipendent of the sample 
composition), against which the potential of the working electrode is compared. An 
inert conducting material, such as a platinum wire, is used as the current carrying 
auxiliary electrode.  
Figure 3.17: Potential time waveform for square‐wave voltammetry and 
definition of the different parameters: Esw is the square‐wave amplitude, 
ΔEs the staircase step height, tp = τ/2 the pulse width. 
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The sample holders come in a variety of sizes, shapes, and materials. The 
type used depends on the amount and type of sample, the technique, and the 
analytical data to be obtained. The material of the cell (glass, Teflon, polyethylene) 
is selected to minimize reaction with the sample. An accurate temperature control 
is generally achieved by immersing or jacketing the cell in a constant temperature 
bath.  
In Figure 3.18 is shown the electrochemical cell used for all the 
electrochemical measurements. The electrodes employed are listed below: 
 
Working electrode: Glassy carbon (GC, 3mm dia.) or Gold (Au, 1.6 mm dia.) 
Reference electrode: Ag | AgCl | NaCl 3 M 
Auxiliary electrode: Platinum wire (Pt) 
 
Prior to each measurement, the electrolytic solution was bubbled with argon 
for about 15-20 minutes to get rid off of any dissolved oxygen. During the 
measurement, the electrochemical cell was blanketed with argon. All the 
Figure 3.18 : The three electrodes electrochemical cell used for 
the measurements. 
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measured potentials are measured against the Ag/AgCl 3 M NaCl reference 
electrode, the E°' are also reported against SHE. 
 
3.6.3 Square wave and cyclic voltammetry of freely diffusing Fe(III)-
Mimochrome IV Lys3 
The FeIII/FeII reduction potential (E˚‟) of the diffusing Fe(III)-Mimochrome IV 
Lys3 was determined by square-wave and cyclic voltammetry. All the 
measurements were performed using a glassy carbon electrode, at 25 C˚. A 0,1 M 
Fe(III)-Mimochrome IV Lys3 solution in a 10 mM phosphate buffer at pH 7, 100 mM 
NaClO4 was used. The sample volume in the electrochemical cell was 1 ml.  
Figures 3.19, 3.20 and 3.21 report the square-wave voltammograms, for both 
the cathodic and the anodic scans, recorded at different scan rates.  
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Figure 3.19: Square-wave voltammograms of Fe(III)-Mimochrome IV Lys3 at 
3.7 mV/s on a glassy carbon electrode. (a) cathodic scan, (b). anodic scan. 
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Voltammograms recorded at low scan rate (3.7 mV/s) showed broad peaks in 
both scans, suggesting the presence of two signals at different potential. 
Increasing the scan rate (4.8 mV/s) the peaks in both the anodic and cathodic 
scans became sharper (Figure 3.20). At high scan rate (37.5 mV/s) both scans 
showed a single peak, with a well-defined voltammetric wave (Figure 3.21). 
This finding is indicative of the electron transfer of a single species. The 
cathodic and anodic peaks are located at -350 and -333 mV, respectively. 
Interestingly, the peak current intensity ratio (Ip,c/Ip,a) is ≈1, indicating that Fe(III)-
Mimochrome IV Lys3 molecule undergoes a reversible electrochemical reaction 
(Jiang et al., 1997). The formal potential is obtained as below: 
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Figure 3.20 : Square-wave voltammograms of Fe(III)-Mimochrome IV Lys3 at 4.8 
mV/s on a GC electrode. (a) cathodic scan, (b) anodic scan. 
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E°'= (Ep cat + Ep an)/2 = -340 mV vs Ag/AgCl 
E°' of the Ag/AgCl 3 M NaCl reference electrode = +209 mV vs SHE 
E°'= -340 mV + 209 mV = -131 mV vs SHE 
 
This value is in good agreement with previous reported for other Mimochrome 
molecules (Lombardi et al., 2003; Ranieri et al., 2010). 
In the voltammograms obtained at lower scan rates, the broad peak observed 
in both cathodic and anodic scans can be related to the presence of a second 
species, absorbed on the electrode surface, that contributes to the total signal 
registered. In the voltammograms recorded at 3.7 mV/s is clearly visible a second 
peak, both in cathodic and in the anodic scans, with the maximum intensity values 
located at -424 mV (Fig. 3.19 a) and -434 mV (Fig. 3.19 b), respectively. This peak 
can be assigned to the molecule adsorbed on the electrode surface, a common 
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Figure 3.21 : Square-wave voltammograms of Fe(III)-Mimochrome IV Lys3 at 37.5 
mV/s on a GC electrode. (a) cathodic scan, (b) anodic scan. 
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phenomenon observed in the direct electrochemical measurements of heme-
proteins and models (Chattopadhyay and Mazumda, 2000; Hu, 2001). In this 
specific case, it is likely that the adsorption of Fe(III)-Mimochrome IV Lys3 on the 
surface of the glassy carbon electrode causes a major exposition of the heme 
group to the solvent. As a consequence, the redox potential of the adsorbed 
species is more negative than the E°' value for the freely diffusing protein in 
solution. 
 
E°'= (Ep cat + Ep an)/2 = -444 mV vs Ag/AgCl 
E°'= -444 mV + 209 mV = -234 mV vs SHE 
 
This hypothesis is supported by the finding that the E°' value measured for the 
adsorbed species is in a good agreement with the values obtained for some iron-
porphyrins (e.g. Fe-porphyrin IX- bis imidazole  -235 mV vs SHE, Fe-
mesoporphyrin bis imidazole -285 mV vs SHE)(Kassner, 1972).  
 
Results of cyclic voltammetry measurements are consistent with the SWV 
observations. Figure 3.22 reports the cyclic voltammograms obtained at three 
different scan rates: 0.025 V/s (Figure 3.22 a), 0.5 V/s (Figure 3.22 b) and 5 V/s 
(Figure 3.22 c). 
The cyclic voltammogram registered at the highest scan rate (Figure 3.22 c) 
consists of a single, well-defined signal arising from the quasi-reversible one-
electron reduction-oxidation process of the heme-iron of the freely diffusing 
molecule. 
 
75 
 
The cathodic and anodic peaks are located at -372 and -306 mV, respectively. 
The peak potential separation is ≈ -66 mV, in good agreement with the expected 
theoretical value of -59 mV, for a reversible mono-electronic process. This indicate 
that the Fe(III)-Mimochrome IV Lys3 molecules possess reversible electrochemical 
behavior. The formal potential is -339 mV vs Ag/AgCl and -130 mV vs SHE. This 
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Figure 3.22 : Cyclic voltammograms of diffusive Fe(III)-Mimochrome IV Lys3 at 
different scan rates on a glassy carbon electrode. (a) 0.025 V/s, (b) 0.5 V/s, (c) 
5 V/s. 
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value is in good agreement with the one obtained by SWV experiments, and it 
represents the redox potential of the freely diffusing molecule. 
 
Similarly to the finding observed in SWV measurements, at lower scan rate it is 
possible to observe the adsorption phenomenon. In fact, in the voltammogram 
registered at 0.025 V/s (Figure 3.22 a), a species with a more negative redox 
potential is particularly evident. The E°' value of - 234 mV is the same measured 
for the adsorbed molecule in SWV experiments. In the scan performed at 0.50 
mV/s it is possible to note the presence of both the diffusing and the adsorbed 
species. 
Analysis of freely diffusing Fe(III)-Mimochrome IV Lys3 confirmed that this 
heme-protein model is able to exchange electrons with the electrode surface in a 
reversible process. Therefore the immobilization of the molecule on a gold 
electrode via covalent binding was carried out, in order to study its electrochemical 
behavior once anchored on a surface. 
 
3.7 Immobilization of Fe(III)-Mimochrome IV Lys3 on the electrode surface 
 
3.7.1 Immobilization method 
One of the crucial steps in the development of third generation electrochemical 
biosensors is the proper immobilisation of the electron transfer element on the 
electrode surface, since its electron transfer activity must be preserved (Collings  
and Caruso, 1997). In fact, for heme-proteins, which exhibit direct electron transfer 
to the electrode surface, the orientation, distribution, organization and proximity of 
the heme-group respect to the electrode surface are parameters of outmost 
relevance. 
Several strategies have been employed to immobilize molecules on 
electrodes, such as physical adsorption (Yaropolov et al., 1996), covalent or 
electrostatic attachment to electrochemically modified surfaces (Quan and Shin, 
2004) and to self-assembled monolayers (SAMs) (Gooding et al., 2001; Chaki and 
Vijayamohanan, 2002). 
The self-assembly method for the anchoring of enzymes or other bio-
molecules displays a number of advantages relatively to other approaches, such 
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as high reproducibility, molecular level control (e.g. distribution on the surface), 
vicinity to the surface, which allows direct electron transfer (Gooding et al., 2001).  
The most studied systems make use of the strong affinity between thiols or 
disulphides and gold substrates (Ulman, 1996; Schreiber, 2004; Love et al., 2005). 
Some biomolecules, containing thiol or disulphide groups in their structure, may 
spontaneously bind to gold surfaces without any functionalization. However, the 
main reported routes (Hyung et al., 1997) relate to the chemical modification of 
bio-molecules through the introduction of terminal thiol groups (Hegner et al., 
1993), or the formation of SAMs containing specific groups with subsequent non-
covalent (Hyung et al., 1997) or covalent (Gooding et al., 2001) attachment of 
biomolecules.  
When the alkanethiol has proper functionalities, such as carboxylic acid or 
amine, chemical anchoring of the biomolecule to the SAM can be realized through 
the formation of peptide bonds. Nevertheless, the success of the chemical reaction 
involves the activation of either the amine or carboxylic acid moieties in the SAMs, 
through the use of appropriate coupling reagents (Quan and Shin, 2004; Disley et 
al., 1998; Mirsky et al., 1997), such as 1-ethyl-3-
(dimethylaminopropyl)carbodiimide hydrochloride / N-hydroxysuccinimide 
(EDC/NHS). 
 
In the present work, the immobilisation strategy employed involves the 
modification of a gold electrode surfaces with a SAM of 11-mercaptoundecanoic 
acid (11-MUA). The carboxylic group at the end of the alkanethiol is activated as 
hydroxysuccinimide ester, which reacts with primary amines, such as the ε-amino 
group of the free Lys residue on one of the peptide chains of Fe(III)-Mimochrome 
IV Lys3. 
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3.7.2 Electrode surface modification with a SAM of 11-MUA 
The monolayer of 11-mercaptoundecanoic acid was formed by exposing clean 
gold electrodes to a solution of freshly prepared 1.0 mM 11-MUA in ethanol 
(Figure 3.23, step a). The electrodes have an exposed working surface of 1.6 mm. 
The gold electrodes were allowed to sit for 18 hours at room temperature in the 
thiol solution, to obtain maximum monolayer packing. Then, they were removed 
from the SAM solution and thoroughly rinsed with ethanol. 
SAM formation was ascertained by studying the electron-transfer reaction of a 
redox probe, the K3Fe(CN)6, on the SAM-modified surfaces, by taking advantage 
Figure 3.23: Representation of the steps of the electrode surface modification: 
(a) gold coating with 11-MUA, (b) activation of the carboxylic groups with 
EDC/NHS and (c) Fe-Mimochrome IV Lys3 coupling, with final capping with 
Tris solution. 
(a)                                     (b)                                       (c) 
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Figure 3.24: Cyclic voltammograms of freely diffusive K3Fe(CN)6 on bare (red 
line) and SAM coated (blue line) gold electrode. 
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of the ability of alkanethiol SAMs to block the electron transfer between the metal 
surface and a redox species in solution (Garcìa-Raya et al., 2008). 
 Figure 3.24 shows cyclic voltammograms for the bare gold and a SAM-
modified electrode in 10 mM K3Fe(CN)6 in ethanol/10 mM NaClO4 (50/50 v/v), at a 
potential scan rate of 0.05 V/s. The cyclic voltammogram of the bare gold 
electrode shows a CV with a shape typical of a diffusion-controlled reversible 
redox couple (Figure 3.24, red line). On the opposite, in the presence of the SAMs 
the electron transfer for the Fe3+/Fe2+ couple is totally absent (Figure 3.24, blue 
line), thus suggesting the formation of a monolayer which blocks the redox 
reaction. The 11-MUA SAM is completely formed after 18 h of modification time, 
according to literature data (Garcìa-Raya et al., 2008). 
 
3.7.3 SAM activation and Fe(III)-Mimochrome IV Lys3 anchoring 
In order to couple proteins via their amino groups, typically the 1-ethyl-3-(3-
dimethylamino-propyl)carbodiimide and N-hydroxysuccinimide procedure is used 
to activate a carboxylic group on the surface (Cass and Ligler, 1998).  
The SAM coated electrode was immersed in a solution of EDC 75 mM / NHS 
15 mM for 1.5 hours at room temperature (Figure 3.23, step b), then removed from 
the activating solution and thoroughly rinsed with 
deionized water (Patel et al., 1997). The activated 
electrode surface was immediately immersed in a 0.1 
M Fe(III)-Mimochrome IV Lys3 solution in 0.1 M 
phosphate buffer, pH 7, for 1 hour at room 
temperature. 
After covalent coupling, the surface was rinsed 
with deionized water to remove unreacted protein 
molecules. A 1 M solution of Tris (2-Amino-2-
hydroxymethyl-propane-1,3-diol) buffer, pH 8, was 
used to quench the activated carboxyl groups of 11-MUA, in order to eliminate 
further chemical reaction with free amines (Balasubramanian et al., 2006). 
Electrodes were immersed in Tris solution for 15 minutes, then rinsed with 
deionized water  and stored into phosphate buffer solution till the electrochemical 
measurements have been performed. 
 
Figure 3.25: Structure of 
tris(hydroxymethyl)amino
methane. 
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3.7.4 Square wave and cyclic voltammetry of Fe(III)-Mimochrome IV Lys3 
immobilized on the gold electrode 
The FeIII/FeII reduction potential (E˚‟) of the immobilized Fe(III)-Mimochrome IV 
Lys3 was determined by square-wave and cyclic voltammetry. All measurements 
were performed by deeping the Fe(III)-Mimochrome IV Lys3 coated electrode in 1 
ml of 10 mM phosphate buffer at pH 7, at 25 °C.  
Figure 3.26 shows the square wave voltammograms, for the cathodic and 
anodic curves, of the immobilized molecule. The scans were performed at a scan 
rate of 37.5 mV/s.  
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Figure 3.26 : Square-wave voltammograms of Fe(III)-Mimochrome IV Lys3 
immobilized on a SAM coated gold electrode, at 37.5 mV/s, (a) cathodic 
scan, (b) anodic scan. 
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The covalently immobilized Fe(III)-Mimochrome IV Lys3 exhibits a pair of well-
defined redox peaks located at - 390 and - 341 mV/s, respectively, with a E°' =  - 
365 mV vs Ag/AgCl and - 156 mV vs SHE. The average ratio of cathodic and 
anodic peak current intensities is 0.85, this value remains constant even when 
scans at different scan are registered. This finding clearly demonstrates a 
reversible electrode reaction and also excludes involvement of dioxygen in the 
reduction process.  
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Figure 3.27: Cyclic voltammograms of Fe(III)-Mimochrome IV Lys3 immobilized 
on a SAM coated gold electrode, at different potential scan rates: 0,5 V/s line 
red; 1 V/s line blue; 5 V/s line green; 10 V/s line cyano. 
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Cyclic voltammetry scans were also performed at different scan rates, in the 
potential range 40-500 mV (Figure 3.27). The peak current intensity varies linearly 
as a function of the scan rate (Figure 3.28), indicating that the peptide is bound to 
the electrode surface (Ranieri et al., 2009). The measured peak potential 
separation measured slightly increases with scan rate, ranging from -77 to -110 
mV, indicating that once bound to the 11-MUA coated electrode, Fe(III)-
Mimochrome IV Lys3 undergoes a surface controlled quasi-reversible process. 
Similar results were reported for the direct electron transfer of Microperoxidase-11 
(MP-11) bound to a chitosan-graphene electrode with a 11-mercaptoundecanoic 
SAM (Zhou et al., 2010). 
The measured redox potential (E°') of the immobilized Fe(III)-Mimochrome IV 
Lys3 shows a 25 mV anodic shift, when compared to the potential observed for the 
freely diffusing protein in the same medium. This observation is consistent with 
Figure 3.28: Linear dependence of the peak current intensity from the scan rate; 
line red cathodic peaks; line blue anodic peaks. 
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literature data reported for Microperoxidase-11 (Jiang et al., 1997; Zhou et al., 
2010). The shift is probably due to the changes in the environment of the protein-
iron assembly, which occur when the peptide is covalently bound to the SAM. 
 
3.8 Square wave and cyclic voltammetry of Fe(III)-Mimochrome IV Lys3-
HA_epitope immobilized on the gold electrode 
The conjugate Fe(III)-Mimochrome IV Lys3-HA_epitope was immobilized on 
the gold electrode coated with a SAM of 11-mercaptoundecanoic acid following 
the procedure previously described for Fe(III)-Mimochrome IV Lys3.  
The FeIII/FeII reduction potential (E˚‟) of the immobilized Fe(III)-Mimochrome IV 
Lys3-HA_epitope complex was determined by square-wave and cyclic 
voltammetry. All measurements were performed immersing the Fe(III)-
Mimochrome IV Lys3 coated electrode in 1 ml of 10 mM phosphate buffer, pH 7, 
100 mM NaClO4, at 25 °C.  
Figure 3.29 reports the square wave voltammograms of the immobilized 
conjugate, both for the cathodic and the anodic scans, performed at a scan rate of 
37.5 mV/s.  
Each scan shows a single peak, with a well-defined voltammetric wave, 
indicative of the electron transfer of a single species. The cathodic and anodic 
peaks are located at -407 and -369 mV, respectively, and the peak current 
intensity ratio (Ip,c/Ip,a) is ≈ 1.1; the peak potential separation measured is ≈ 0.52 
mV. This finding indicates that the Fe(III)-Mimochrome IV Lys3 molecules undergo 
a reversible electrochemical reaction, even when functionalized with the epitope. 
The formal potential measured is E°' = -384 mV vs Ag/AgCl and -175 mV vs SHE.  
 
84 
 
 
The dependence of peak current intensity from the scan rate was determined 
from cyclic voltammetry scans, performed at different scan rates in the potential 
range 1 - 10 V (Figure 3.30). Figure 3.31 reports the linear increase of the peaks 
current intensity with increasing scan rate. This indicates that the Fe(III)-
Mimochrome IV Lys3-HA_epitope conjugate is immobilized onto the electrode 
surface. 
The measured peak potential separation slightly increases with scan rate up to 
2 V/s, as observed for other molecules of the Mimochrome series (Ranieri et al., 
2010). 
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Figure 3.29: Square-wave voltammograms of Fe(III)-Mimochrome IV Lys3-
HA_epitope complex immobilized on a SAM coated gold electrode, at 37.5 mV/s, 
(a) cathodic scan, (b) anodic scan. 
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Figure 3.31: Linear dependence of the peak current intensity from the scan rate 
for the immobilized Fe(III)-Mimochrome IV Lys3-HA_ep; line red cathodic peaks; 
line blue anodic peaks. 
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Figure 3.30: Cyclic voltammograms of Fe(III)-Mimochrome IV Lys3-Ha_ep 
immobilized on a SAM coated gold electrode, at different potential scan rates: 
(1 - 10 V/s). 
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Table 3.1 reports the E° values of Fe(III)-Mimochrome IV Lys3 in different 
environment. As discussed before, the covalent binding of the molecule on the 
gold substrate causes the formal potential to shift towards more negative values 
(25 mV) relatively to the freely diffusing molecule.  
The observed potential shift toward negative values may be caused by the 
interaction of the molecule with the anionic SAM. Probably, the SAM carboxyl 
groups were not completely quenched by the reaction with TRIS. Therefore, the 
presence of free negatively charged groups on the SAM surface could shift the E° 
to more negative values. A further shift of E° toward negative values (-19 mV) was 
observed upon functionalization of Fe(III)-Mimochrome IV Lys3 with the epitope 
HA. This finding is in agreement with the negatively charged residues present in 
the epitope sequence.  
All the results so far obtained show that Fe(III)-Mimochrome IV Lys3 
electrochemical properties  are very sensitive to small changes in the environment. 
 
 
 
 
 
 
 
 
 
 
Table 3.1: Comparison of the E°' values measured for Fe(III)-
Mimochrome IV Lys3  in different environments. 
 
Mimochrome IV Lys3 E°’ measured (mV vs SHE) 
Freely diffusing - 131 
Immobilized on gold -156 
Functionalized with HA_ep 
and immobilized on gold - 175 
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3.9 Antibody detection 
The immunosensor was tested for the detection of specific Anti-HA_epitope 
monoclonal antibodies.  
The assay procedure consisted of placing the sensor in an electrochemical cell 
containing 1.0 ml of measurement buffer (10 mM phosphate, pH 7). After 
registering the control voltammograms (t = 0), 2 μg of mAb anti-HA_epitope ([mAb] 
= 2*10-3 M) were added directly in the electrochemical cell. The modified electrode 
surface was allowed to incubate for 10 minutes, under stirring, prior to performing 
the electrochemical detection of the binding event. Then, SW voltammograms 
were recorded every 10 minutes to monitor the time-response of the sensor.  
As shown in Figure 3.32, in  the presence of the target antibody, there is a 
significant decrease of the Faradic current. After 30 minutes the signal is 
completely suppressed.  
The decrease in current intensity upon binding of anti-HA_epitope IgG may 
reflect the changes in the interfacial microenvironment arising from the formation 
of the immunocomplex on the electrode surface. Probably, after Ab binding, the 
transducer is immersed in a protein environment that hinders electron transfer, 
causing the lowering of the electrochemical signal. This interpretation is consistent 
with literature data (Liu et al., 2008; Liu and Gooding, 2009; Yan et al., 2001). 
Gooding and co-workers reported similar observations on two immunoaffinity 
biosensors for the detection of anti-biotin IgG, in which the transducer is 
represented by small redox probes, such as ferrocene (Liu et al., 2008; Liu and 
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Figure 3.32: The response of the electrode coated with Fe(III)-Mimochrome IV 
Lys3-HA_epitope complex before (green line) and after exposure to 2 mM target 
antibody. 
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Gooding, 2009). The same behavior was already observed for viologen modified 
electrodes, in the detection of anti-biotin IgG (Yan et al., 2001). 
To proof that this response was related to the specific interaction of anti-
HA_epitope antibody with HA_epitope, a control measurement was performed 
employing an electrode coated with Fe(III)-Mimochrome IV Lys3, devoid of the 
recognition element. In this case, only slight lowering in current, upon exposure to 
the target antibody, was observed (Figure 3.33). 
These results indicate that anti-HA_epitope IgG selectively associate with the 
HA_epitope sites on the electrode surface, and only this selective interaction leads 
to a change in the electrochemistry of Fe(III)-Mimochrome IV Lys3.  
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Figure 3.33: The response of the electrode coated with Fe(III)-Mimochrome IV 
Lys3 complex before (green line) and after exposure to 2 mM target antibody. 
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3.10 Conclusions 
The application of a newly synthesized heme-protein model, Fe(III)-
Mimochrome IV Lys3, as signal transducer in a label-free immunoaffinity 
electrochemical biosensor was investigated, as reported in this chapter.  
The artificial heme-protein was characterized by the electrochemical point of 
view, to understand its ability to exchange electrons with an electrode surface. 
Fe(III)-Mimochrome IV Lys3 showed a well- defined electrochemical behavior, both 
freely diffusing than covalently bound to a gold electrode surface. For this reason, 
the next step in the development of the biosensor provided the functionalization of 
the heme-protein with the recognition element: the specific epitope recognized by 
the antibody to be detected. In fact, the model immunosensor developed is based 
on revealing the antigen-antibody recognition event.  
The complex Fe(III)-Mimochrome IV Lys3-HA_epitope was covalently 
immobilized on the gold electrode surface through the activated terminal carboxyl 
groups contained in the 11-MUA monolayer. The direct electron transfer of Fe(III)-
Mimochrome IV Lys3, once conjugated to the epitope, was evaluated by SW and 
cyclic voltammetry. The molecule showed a reversible behavior, with well-defined 
signals, demonstrating that the coupling with epitope has not remarkable influence 
on the redox properties of Fe(III)-Mimochrome IV Lys3. 
Preliminary experiments on the target antibody detection were performed in 
the presence of an excess of anti-HA_epitope IgG. The developed biosensor 
demonstrated to respond to the presence of the specific antibody. The detection of 
the antibody in solution occurs via the attenuation of  Fe(III)-Mimochrome IV Lys3 
current intensity, as the antibodies bind to the HA_epitope. In the absence of the 
epitope the signal remains quite unchanged, thus demonstrating that signal 
changes are due to specific antigen-antibody interactions. 
In summary, we have developed a new model of a label free immunoaffinity 
electrochemical sensor, based on the modulation of amperometric signals of 
surface-bound redox species. Further experiments to determine the limits of 
detection of the antibodies are required. Nevertheless, but the results so far 
obtained demonstrate the ability of the developed system to function as an 
immunobiosensor. 
An important advantage of the biosensor model here described resides in the 
simplicity of construction, which allows the functionalization with different 
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recognition element in reasonable time at low costs. Therefore, it could be applied 
in the near future to a wide range of antigen-antibody pairs, as well as to receptor-
ligand recognition. This finding may open numerous interesting perspectives in 
diagnostic field. 
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Chapter 4: Bio-catalytic electrochemical biosensors 
 
4.1 Introduction 
As previously described, engineered protein-based biosensors represent a 
further advancement in the detection of chemical substrates, compared to those 
made up of natural enzymes (Lambrianou et al., 2008). In fact, the use of native 
proteins, especially in the case of enzymes, cannot adequately embrace the limit 
of detection and the level of stability required for an usable sensor, since natural 
proteins are often subjected to degradation or denaturation by heat, organic 
solvents, extreme values of pH, and ionic strength. Therefore, a simpler enzyme 
model would have greater stability towards these destructive conditions, and it 
would be more useful for the afore-mentioned biotechnological applications 
(Moore et al., 1996). Another limitation in the use of natural enzymes is that, once 
immobilized on the electrode, they generally require an electron transfer mediator, 
which allows the electrochemical communication between the electrode and the 
enzyme active site. On the opposite, the direct and efficient communication 
between the electrode and the active site should be possible using a suitable 
immobilized small catalyst (Figure 4.1). In addition, a smaller catalyst would allow 
a higher density of active sites on the electrode surface, and hence, an enhanced 
amperometric sensitivity.  
For these reasons, an electrode on which the immobilized enzyme is replaced 
by a simple and low-molecular-weight engineered enzyme could be desirable for 
Figure 4.1: Schematic representation of a bio-catalytic electrochemical biosensor. 
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studying advanced models of electrochemical catalytic biosensors (Moore et al., 
1996). 
 
In this chapter, the application of the artificial enzyme Fe(III)-Mimochrome VI 
(figure 4.2) in the development of a totally sinthetic electrode surfaces is 
discussed. In the following paragraphs are reported: a brief description of the 
synthetic protocol, the analysis of Fe(III)-Mimochrome VI direct electron transfer in 
solution and adsorbed on a modified electrode surface, and its ability of 
electrochemically reduce dioxygen. 
 
 
Figure 4.2: Figure 4.2 shows a model structure of Mimochrome VI, generated using 
the Visual Molecular Dynamics software (VMD: 
http://www.ks.uiuc.edu/Research/vmd/) (Humphrey et al., 1996). The aminoacid 
sequence of the two chains are shown, in which the heme iron-binding histidine is 
in blue and the two lysine residues bound to the two heme propionate groups are in 
red. 
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4.2 Synthesis of Fe(III)-Mimochrome VI 
 
4.2.1 Peptides synthesis 
Peptides were synthesized by the solid-phase method using the Fmoc 
strategy, and they were coupled to deuteroporphyrin in solution to afford 
Mimochrome VI. The decapeptide (Ac-Asp1(OtBu)-Glu2(OtBu)-Gln3(Trt)-Gln4(Trt)-
Leu5-Ser6(tBu)-Ser7(tBu)-Gln8(Trt)-Lys9(Mmt)-Arg10(Pbf)-NH2) and the 
tetradecapeptide (Ac-Asp1(OtBu)-Glu2(OtBu)-Gln3(Trt)-Gln4(Trt)-Leu5-His6(Boc)-
Ser7(tBu)-Gln8(Trt)-Lys9(Mmt)-Arg10(Pbf)-Lys11(Boc)-Ile12-Thr13(tBu)-Leu14-NH2) 
were synthesized following the protocol described in Chapter 3 (sections 3.2.1 and 
3.2.2) for Mimochrome IV Lys3. 
Fully protected peptides amide, except for the Lys9, were generated from the 
resin separately, following the same protocol. They were cleaved from the resin by 
applying a solution of TFA/TIS/DCM (1/1/98 v/v/v) (triisopropylsilane: TIS; 
dichloromethane: DCM). Fractions eluted from the resin were checked by TLC and 
pooled if they contained the desired product. Analytical RP-HPLC (Vydac C18 
column, using a gradient of acetonitrile in 0.1% aqueous TFA, 50% to 90% over 20 
min, flow rate 1 mL min-1) showed a main peak for both the protected peptides. 
Purification was accomplished by precipitation in ice-cold water, as previously 
described for Mimochrome IV Lys3 peptide. Both peptides were homogeneous as 
determined by analytical HPLC and by MALDI mass spectrometry (MALDI/MS).  
Since Mimochrome VI is an asymmetrical complex, after the synthesis of the 
two peptides, their coupling with porphyrin was performed in two steps: first, we 
obtained the mono substituted intermediate decapeptide-deuteroporphyrin IX, then 
this intermediate was coupled with the tetradecapeptide. 
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4.2.2 Decapeptide-deuteroporphyrin coupling 
The fully protected decapeptide, except for the Lys9,  was coupled in solution 
to the deuteroporphyrin ring. In order to favour the formation of the mono 
substituted deuteroporphyrin IX, the peptide solution was slowly added to the 
activated porphyrin.  
The crude product was purified on a silica gel column to eliminate unreacted  
deuteroporphyrin IX, and its purity was estimated by analytical RP-HPLC.  
From the chromatogram shown in Figure 4.3 a is possible to note the presence 
of two peaks: the first, with a tr of 25.429 min corresponds to the mono-substituted 
decapeptide-DPIX, while the second, with tr = 32.63 min corresponds to the bis-
substituted species, decapeptide-DPIX-decapeptide. 
The first peak was collected from the analytical RP-HPLC and its identity was 
confirmed by MALDI/MS spectrometry (Figure 4.3 b) (2980 u.m.a.). 
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Figure 4.3: (a) HPLC chromatogram and (b) mass spectrum of the decapeptide-
porphyrin complex. 
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4.2.3 Coupling of the tetradecapeptide to the mono substituted 
intermediate 
Mimochrome VI free base, was synthesized by coupling the tetradecapeptide 
to the mono-substituted intermediate. The reaction was carried out adding 20% 
TFE (v/v) to the reaction mixture to avoid aggregation of peptide and porphyrin in 
solution.  
The reaction was allowed to proceed at room temperature for 2 hours. The 
reaction progress was followed by analytical HPLC and by tlc. When reaction was 
complete, the mixture was evaporated under reduced pressure up to 20% of the 
volume, and precipitated with cold diethylether, and finally centrifuged. The crude 
product was dried in vacuo. Side chain deprotection was achieved by addition of 
the cleavage mixture (0.75 g phenol in thioanisole/H2O/EDT/TFA 
0.25/0.5/0.5/8.75, v/v/v/v) (1,2-ethanedithiol: EDT) at 0 °C for 2.5 h. This treatment 
was performed twice. The reaction mixture was concentrated on a rotary 
evaporator to a volume of approximately 1-2 mL. Extraction of the scavengers and 
precipitation of the crude product was achieved by addition of cold diethylether. 
The crude material was then dried in vacuo and purified by preparative RP-HPLC; 
the pooled fractions containing the desired product were lyophilized. Analytical 
RP-HPLC (Figure 4.4 a) indicated that the purified product was > 99% pure, and 
ESI/MS (Figure 4.4 b) confirmed the expected molecular weight (expected mass: 
3498 u.m.a; observed mass: 3498.62 ± 0.43 u.m.a). 
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4.2.4 Iron insertion  
Iron ion was inserted into Mimochrome VI according to the acetate method 
(Buchler, 1978), as previously described for Fe(III)-Mimochrome IV Lys3.  
Iron (II) acetate (10 molar excess) was added to a solution of pure 
Mimochrome VI free base in TFE/Acetic acid, and the reaction mixture was kept at 
50 °C for 2 h, refluxing under nitrogen. After 20 minutes the reaction mixture 
started to turn slowly brown, and the HPLC chromatogram showed the presence 
of a new peak at 23.77 min with the characteristic UV-visible spectrum of an iron 
(III) porphyrin at acidic pH.(Figure 4.5 b). When the reaction was complete, the 
product was purified by RP-HPLC and the pooled fractions containing the pure 
product were analized by analytical HPLC (Figure 4.5 a) and ESI-MS. 
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Figure 4.4: (a) HPLC chromatogram and (b) mass spectrum of the pure 
Mimochrome VI free base. 
 
Z=+3; m= 3499.05 u.m.a. 
 
Z=+3; m= 3498.20 u.m.a. 
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The mass spectrum confirmed (Figure 4.5 c) the identity of the desired product 
Fe(III)-Mimochrome VI (expected mass: 3552 u.m.a; observed mass: 3551.67 ± 
0.12 u.m.a.). 
Figure 4.5: (a) HPLC chromatogram, (b) UV-vis and (c) mass spectra of pure 
Fe(III)-Mimochrome VI. 
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4.3 Voltammetric analysis of Fe(III)-Mimochrome VI 
Cyclic voltammetry experiments reported in this chapter were performed in 
collaboration with the Bioinorganic chemistry group directed by professor Marco 
Sola at the University of Modena and Reggio Emilia. 
4.3.1 Cyclic voltammetry of freely diffusing Fe(III)-Mimochrome IV Lys3 
The FeIII/FeII reduction potential (E˚‟) of the diffusing Fe(III)-Mimochrome VI 
was determined by cyclic voltammetry. All measurements were performed using a 
gold electrode (1 mm dia.), at 20 C˚. The electrode was coated with a SAM of 4-
mercapto-pyridine. A saturated calomel electrode (SCE) was used as reference 
electrode. Fe(III)-Mimochrome VI concentration was 1 µM in a 5 mM phosphate 
buffer pH 7, 20 mM NaClO4. The sample volume in the electrochemical cell was 
0,5 ml, and before starting the measurements the sample was bubbled with argon, 
in order to avoid the presence of any dissolved oxygen. All the measured 
potentials are referred to SHE.  
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Figure 4.6: Cyclic voltammogram for diffusing Mimochrome VI at a 
polycrystalline gold electrode coated with a SAM of 4-mercapto-pyridine. 
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Figure 4.7: Electrostatic potential of two 
sides of Mimochrome VI computed using 
the NOC software. 
The cyclic voltammogram registered at 2 V/s (Figure 4.6) is clearly due to a 
specific electrochemical species, a pair of well-defined redox peaks clearly 
appears in the potential region between 0.0 and -0.7 V, corresponding to the 
electron transfer process between the heme-protein in solution and the electrode 
surface. 
The cathodic and anodic peaks are located at - 370 and - 310 mV vs SCE, 
respectively, and the peak potential separation measured is about - 60 mV, 
indicating that the Fe(III)-Mimochrome VI  molecules possess a reversible 
electrochemical behavior. The formal potential E°' is - 99 mV vs SHE. 
 
4.3.2 SAM deposition and Fe(III)-Mimochrome VI adsorption 
The immobilization strategy employed involves the modification of a gold 
electrode surfaces with a SAM of 
decane-1-thiol (DT). Electrode 
coating with the decane-1-thiol (DT) 
SAM was done by dipping the 
cleaned electrode into a 1 mM 
ethanolic DT solution for 12 h at 4 
°C and then rinsing the electrode 
with deionized water.  
Adsorption of the artificial heme-
protein was achieved by dipping the 
functionalized electrode into a 
freshly prepared 1 µM Fe(III)-
Mimochrome VI solution made up in 
5 mM phosphate buffer at pH 7, for 
4 h at 4 °C. Fe(III)-Mimochrome VI 
was adsorbed on this modified 
electrode taking advantage of the 
hydrophobic interaction between the SAM and the non-polar patch of the heme-
peptide, including residues of both R and R‟ chains. In Figure 4.7 is shown the 
electrostatic potential of two sides of Fe(III)-Mimochrome VI computed using the 
NOC software (Chen et al., 2007). Positive and negative charge are shown in blue 
and red color, respectively. The structure on the right showing the hydrophobic 
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patch is that which likely faces the decane-1-thiol-coated Au electrode. The helix-
heme-helix sandwich motif of Mimochrome VI is also shown.  
 
4.3.3 Cyclic voltammetry on the electrode surface 
The FeIII/FeII reduction potential (E˚‟) of the immobilized Fe(III)-Mimochrome VI 
was determined by cyclic voltammetry. All measurements were performed 
immersing the Fe(III)-Mimochrome VI coated electrode in 0,5 ml of 5 mM 
phosphate buffer at pH 7 at 20 °C. All the measured potentials are reported 
against SHE. 
Figure 4.8 reports the cyclic voltammogram obtained at a scan rate of 2 V/s. It 
consists of a single well-defined signal arising from the quasi-reversible one-
electron reduction/oxidation process of the heme iron. 
 
The current intensity is linearly dependent on the scan rate, as expected for a 
diffusionless electroactive species (Figure 4.9). Repeated cycling does not affect 
the voltammograms from 5 to 35 °C, indicating that the peptide monolayer is 
stable. Above 35 °C, currents decrease due to peptide desorption and/or 
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Figure 4.8: Cyclic voltammograms for Mimochrome VI immobilized on a 
polycrystalline gold electrode coated with a SAM of decane-1-thiol. Solid line: 
cathodic scan starting from a poise at positive (oxidizing) potential; dotted line: 
anodic scan starting from a poise at negative (reducing) potential. 
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unfolding. Peptide coverage of the functionalized electrode surface resulted to be 
23.5±0.9 pmol cm-2, which is similar to the value of 19 pmol cm-2 obtained for 
microperoxidase-11 in analogous conditions (Liu et al., 2010; Ruzgas et al., 1999) 
and for cytochrome c on carboxyalkanethiol SAMs (Tarlov et al., 1991; Battistuzzi 
et al., 2007). Fe-Mimochrome VI yielded no electrochemical response on anionic 
(1:1 mixed 11-mercapto-1-undecanoic acid – 11-mercapto-1-undecanol) and 
cathionic (cysteamine) SAMs, consistent with the low net charge of both redox 
states (see below).  
It is worthy of note that the apparent E°‟ value (determined as the average of 
the cathodic and anodic peak potentials) is dependent on the potential scan rate, 
v, and on whether the potential scan is started from a reducing (negative 
potentials, dotted line) or oxidizing (positive potentials, solid line) poise (Figure 
4.8). 
 
For v higher than 2 V/s (Figure 4.10) the scan rate dependence of E° is lost 
and two distinct and constant E°‟ values are obtained (Figure 4.8). This behaviour 
indicates that two redox state-dependent electrochemically active conformers of 
Fe-Mimochrome VI exist, which interconvert depending on the applied potential. At 
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Figure 4.9: Current intensity as a function of the scan rate for Mimochrome VI 
immobilized on a polycrystalline gold electrode coated with a SAM of decane-1-thiol. 
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low scan rates, the experimental E°‟ would be the result of an average of the 
individual potentials weighted over the conformer populations, whereas at high 
scan rates the individual voltammetric features can be recognized, and thereby the 
individual E°‟ values determined (Table 4.1).  
 
These conformers have been termed “high-potential” (HP) and “low-potential” 
(LP), corresponding to the voltammetric response obtained starting from an 
oxidizing and reducing poise, respectively. The measured E°‟ values for the two 
conformers are: -106 mV (for the HP) and -131 mV (for the LP) vs SHE. The HP 
and LP conformers likely differ in the heme surrounding environment. This 
hypothesis is supported by analysis of the CD spectra in the Soret region (Figure 
4.11) for the oxidized and reduced Fe-Mimochrome VI in solution.  
 
 
 
 
Figure 4.10: E°’ values for Mimochrome VI immobilized on a gold electrode 
coated with a SAM of decane-1-thiol measured at varying scan rates (0.02-10 
V/s). 
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In particular, the CD spectrum of oxidized Fe-Mimochrome VI, in aqueous 
phosphate buffer (5.0 mM, pH 7), displays a positive Cotton effect with a maximum 
at 390 nm. Reduced Fe-Mimochrome VI, obtained by sodium dithionite addition to 
the ferric form, display a negative Cotton effect with a minimum at 420 nm. The 
induced Cotton effect in the Soret region of heme-proteins has proven to be a 
useful probe for investigating protein conformational change. It is well known that 
the shape and the intensity of the induced Cotton effect in the Soret region is 
strictly related to the composition and structural organization of the polypeptide 
surrounding the heme (Mayer, 1978; Myer and Pande, 1978). CD analysis on 
previously developed Mimochromes demonstrated that the induced Soret Cotton 
effect in this class of molecules is related to the coupling between porphyrin (π-π*) 
and peptide backbone (n-π* and π-π*) transitions, and that the sign of the Cotton 
effect depends on the relative orientation of the peptide chains respect to the 
porphyrin plane (Lombardi et al., 2001; Nastri et al., 1997; D‟Auria et al., 1997; 
Figure 4.11. CD spectra of Fe-MimochromeVI in the Soret region, in 5.0 mM 
phosphate buffer at pH 7. Dotted line: CD spectrum of ferric MimochromeVI, solid line 
CD spectrum of ferrous Fe-Mimochrome VI (a). Corresponding absorption spectra (b). 
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Nastri et al., 1998; Lombardi et al., 1998; Lombardi et al., 2003; Di Costanzo et al., 
2004). In particular, a detailed analysis on the structurally characterized 
derivatives revealed that the flexibility of the linker between the peptide and the 
deuteroporphyrin ring allows each peptide chain to be positioned either above or 
below the porphyrin plane (D‟Auria et al., 1997; Lombardi et al., 2003; Di Costanzo 
et al., 2004). These arrangements produce enantiomeric configurations around the 
metal ion, i.e. Δ or Λ: the Λ configuration gives rise to a positive Cotton effect, 
whereas the Δ configuration gives rise to a negative effect. Therefore, it is possible 
to hypothesize that the two redox forms of Fe-Mimochrome VI in solution 
correspond to two conformers differing in the configurations around the metal ion. 
This conclusion can be extended to electrode-immobilized LP and HP forms of Fe-
Mimochrome VI. It is likely that protein-electrode interactions decrease the rate of 
conformer interconversion, so that at reasonably high potential scan rates the 
nuclear coordinates of each conformer can be “frozen”, irrespective of the initial 
redox state of the metal. 
 
4.3.4 Thermodynamic and kinetic aspects of the electron transfer 
reaction of Mimochrome VI adsorbed on the electrode surface 
The E°‟ values for both immobilized conformers are more negative compared 
to the single freely diffusing species observed in the same conditions (Figure 4.13) 
(Table 4.1).  
This can be explained considering that the oxidized and reduced  states of Fe-
Mimochrome VI features a net charge of 0 and -1, respectively. Therefore the 
adsorption process (involving hydrophobic interactions) stabilizes selectively the 
oxidized form of the heme-peptide which, bearing a zero charge, binds more 
strongly to the SAM. Such a cathodic shift is different for the two conformers, 
probably because of peculiar conformational features which affect the strength of 
the adsorption process, possibly also including a different rearrangement of 
solvent molecules at the SAM-peptide interphase. We note that similar E°‟ values 
were determined for microperoxidase-11 in solution (-0.134 V, vs. SHE) and 
adsorbed on alkanethiolate SAMs (-0.118 V) (Liu et al., 2010). The lower E°‟ 
values of both peptide systems in solution with respect to class I cytochromes c 
(E°‟ values from approximately +0.200 to +0.350 V vs. SHE) (Casalini et al., 2008) 
is the result of the enhanced accessibility of the heme group to solvent, which 
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favors the ferric state, and of the presence of a water or hydroxide ion axially 
bound to the heme iron in place of the Met ligand (Battistuzzi et al., 2005; 
Battistuzzi et al., 2004). 
The enthalpy (H°'rc) and entropy (S°'rc) changes for the Fe(III) to Fe(II) 
reduction (where the subscript rc stands for the iron „redox couple‟) for both 
conformers of immobilized Fe-Mimochrome VI, determined from the E° 
measurements at variable temperature (Figure 4.12), are negative (Table 4.1). 
Therefore, the reduction potentials turn out to be the result of opposite and thereby 
partially compensatory thermodynamic contributions, a behavior common to heme 
proteins (Battistuzzi et al., 2005; Battistuzzi et al., 2004). 
Mimochrome VI 
E°’ 
b 
(V) 
G°’rc
 
c 
(kJ 
mol-1) 
S°’rc 
(JK-1 
mol-1) 
H°’rc 
(kJ 
mol-1) 
ks 
(s-
1) 
 
(eV) 
H# 
(kJ 
mol-
1) 
r 
(Å) 
Adsorbed HP 
conformerd 
-0.106 +10.2 -66 -9.1 92 0.51 -12.3 5.0 
Adsorbed LP 
conformere 
-0.131 +12.6 -50 -2.1 33 0.48 -11.7 6.2 
freely diffusing -0.099 +9.5 +35 +20 - - - - 
 
Table 4.1: Thermodynamic and kinetic parameters for the electron transfer 
process of Mimochrome VIa 
a Average errors on E°’, G°’rc , S°’rc, H°’rc, ks, , H
#, rMC- VI  are ±0.002 V, 
±0.2 kJ mol-1 , ±2 J K-1 mol-1, ±0.3 kJ mol-1, ±2 s-1, ±0.03 eV, ±0.6 kJ mol-1, ±0.4 
Å respectively. 
b at 20 °C. 
c Corresponding to peptide-based H°’rc (see text). 
d 
Stable Fe-Mimochrome VI conformation with the Fe(III) heme, corresponding to 
the voltammetric response obtained starting from an oxidizing poise (see text).  
e Stable Fe-Mimochrome VI conformation with the Fe(II) heme, corresponding to 
the voltammetric response obtained starting from a reducing poise (see text). 
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The same scheme holds for freely diffusing Fe-Mimochrome VI as well, which 
however features positive enthalpy and entropy changes (Table 4.1).  
It is now well documented that this thermodynamic scenario is the signature of 
the dominant role played by solvent reorganization effects as effectors of the 
reduction thermodynamics (Battistuzzi et al., 2005; Battistuzzi et al., 2004). In 
particular, the reduction-induced changes in the hydrogen bonding network 
between the water molecules and surface residues within the hydration sphere of 
the molecule can be considered to a first approximation as the only determinants 
of the measured reduction entropy. However, these solvent reorganization effects 
are known not to contribute to the overall free energy change of the reaction due 
to exactly compensatory enthalpy and entropy changes. Therefore, the 
determinants of free energy change of the reaction (i.e the E°‟ value) would be 
peptide-based and, considering that the corresponding entropy changes are 
conceivably small compared to solvation effects, the ∆G°‟rc values can be 
assumed to first approximation to correspond to the peptide-based ∆H°‟rc term 
(Battistuzzi et al., 2005; Battistuzzi et al., 2004). As a result, adsorption of the 
Figure 4.12: E°' vs. T plots for immobilized and for diffusing Mimochrome VI Ferric 
conformer (×); Ferrous conformer (□); diffusion (Δ). Solid lines are least-squares 
fits to the data points. 
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heme peptide on the SAM through van der Waals interactions induces a large 
change in the reduction thermodynamics of Fe-Mimochrome VI. Several factors 
may account for this: alteration of reduction-induced changes in the network of 
hydrogen bonds at the peptide-solvent interface, the interaction with ions in 
solution and, to much lesser extent, the peptide conformational degrees of 
freedom. Yet, the much lower change in reduction free energy is determined by 
the enthalpy-based stabilization of the oxidized peptide on the non-polar SAM due 
to its zero charge.  
The rate constant of peptide-electrode heterogeneous ET (ks) has been 
determined from the scan rate dependence of the anodic and cathodic peak 
potentials, according to Laviron (Laviron, 1979). The activation enthalpy (H#) and 
the reorganization energy (λ) values have been determined from the temperature 
dependence of ks (Figure 4.13) and from the Marcus theory. The Marcus equation 
for the heterogeneous electron transfer process is (Marcus and Sutin, 1985 ): 
 
Figure 4.13:  Arrhenius plot for the ferric (×) and ferrous (□) conformer of 
Mimochrome VI immobilized on a polycrystalline gold electrode coated with a SAM 
of decane-1-thiol in 5 mM phosphate buffer at pH 7. Solid lines are least-squares 
fits to the data points. 
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where ΔG# = λ/4, 0 is the frequency factor,  and r are the electronic tunneling 
factor for the peptide matrix and the distance between the metal center of 
adsorbed peptide and the electrode surface (tunneling distance), respectively. 
As in these systems the entropic term of the free activation energy is 
negligible(Yee and Weaver, 1977; Nahir et al., 1994), ΔH# would correspond to 
ΔG# and can obtained by the Arrhenius equation. In this way, λ can be easily 
calculated. The calculated values for the adsorbed ferric and ferrous conformer 
are 0.51 and 0.48 eV, respectively (Table 4.1). The above equation can be 
arranged in the form: 
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Using a 0 value of 6·10
12 s-1 and a mean  values of 1 Å-1 and r0 = 3 Å (Nahir 
et al., 1994; Tarlov and Bowden, 1991; 
Hildebrandt and Murgida, 2002; Ulmann, 
and Kostic, 1995) r values of 23.0 and 24.2 
Å have been determined for the “ferric” 
and “ferrous” conformers, respectively 
(Table 4.1) (Figure 4.14). Assigning the DT 
SAM an upper value of tunnelling distance 
of 18 Å, corresponding to the length of a 
fully extended DT chain (Reipa et al., 
1999), the distance of closest approach 
between the solvent exposed heme edge 
and the SAM surface would be of 5.0±0.4 
Å and 6.2±0.4 Å. The difference in ET 
distance for the two conformers may be 
ascribed to the abovementioned redox 
state-dependent conformational features which may result in differences in the 
molecular volume and/or orientation toward the electrode. Manual docking of the 
Figure 4.14: Cartoon showing the 
orientation of Mimochrome VI 
onto an ideally flat DT-coated gold 
electrode surface obtained from 
manual docking of the heme-
peptide. 
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Fe-Mimochrome VI molecule on an ideally flat DT-coated electrode surface carried 
out in such a way as to maximize the contact of the heme-peptide with the 
hydrophobic patch, yields an orientation of the construct with the heme plane 
nearly perpendicular to the SAM surface. The calculated SAM-heme iron distance 
of 5.7 Å is in good agreement with those determined above from the kinetic data 
(Figure 4.14). 
 
4.3.5 Electrocatalytic reduction of dioxygen 
Figure 4.15 shows the electrochemical response of adsorbed Fe-Mimochrome 
VI in the presence of increasing oxygen concentration (obtained by increasing the 
time of exposure of the electrochemical cell, initially under argon) to air. The 
corresponding increase in intensity of the cathodic peak, with a concomitant 
decrease of the anodic current indicates that immobilized Fe-Mimochrome VI in 
these conditions is able to electrocatalytically reduce dioxygen at the heme iron, 
as observed previously for five-coordinate heme iron-containing cytochrome c 
variants (Battistuzzi et al., 2004; Casalini et al., 2010). The mechanism for O2 
reduction likely implies an oxidative addition of O2 to Fe(II), yielding a Fe(III)-O2
- 
derivative, which then dissociates. After a few catalytic cycles, the CV response 
taken after dioxygen removal contains the initial Fe-Mimochrome VI signal, 
indicating that the overall process is reversible. Re-use of the Fe-Mimochrome VI-
functionalyzed electrode is limited by the natural loss of immobilized peptide from 
the adsorbed layer. The ability of immobilized Fe-Mimochrome VI to carry out 
reductive dioxygen turnover at the electrode is an essential finding for further 
applications. In fact, it constitutes a prerequisite for exploring the mono-
oxygenase/hydroxylase activity toward a substrate, in conditions where electrons 
are pumped into the molecular systems by the electrode. 
 
 
 
111 
 
 
It is interesting to notice that Fe-Mimochrome VI, such a small heme-protein 
model, behaves like a natural protein. In particular, it showed an electrochemical 
behavior comparable to five-coordinate heme iron-containing cytochrome c 
variants (Bortolotti et al., 2006; Casalini et al., 2008; Casalini et al., 2010). In fact, 
it reproduces the properties of the Met80Ala cytochrome c mutant to 
electrocatalitically reduce dioxygen (Casalini et al., 2008), with the same 
mechanism  proposed for Mimochrome VI. 
 
 
 
 
 
 
-400
0
400
800
1200
1600
2000
-800-600-400-2000
i 
(n
A
)
E (mV vs. SCE)
B
Increasing O2
concentration
Figure 4.15: Cyclic voltammograms for Mimochrome VI immobilized on a 
polycrystalline gold electrode coated with a SAM of decane-1-thiol in 5 mM 
phosphate buffer at pH 7, recorded at different exposure times of the 
electrochemical cell (initially under argon) to air at normal atmospheric pressure. 
Sweep rate, 0.1 Vs-1. T = 20°C. 
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4.4 Conclusions 
Mimochrome VI was developed to engineer into the Mimochrome scaffold a 
catalytic site, by creating a cavity able to accommodate small molecules and/or 
substrates. Therefore, it is an attractive system to be used as novel catalyst or as 
a constituent of hybrid synthetic interfaces in electrochemical biosensors.  
To understand the possibility of the application of Mimochrome VI in the field of 
biosensing, the iron complex of this molecule was characterized by the 
electrochemical point of view.  In particular, first the electrochemical properties of 
the freely diffusing species were determined. 
Subsequently, the thermodynamics and kinetics of the electron transfer 
process for the FeIII/FeII couple of Fe-Mimochrome VI immobilized on a SAM-
coated electrode were determined. 
This is a very important result, since this work constitute the first exemple of a 
complete analysis of the thermodynamic parameters that contribute to the 
reduction potential of a totally synthetic five-coordinated heme-protein (Ranieri et 
al., 2010) 
Finally, the ability of the molecule to catalytically turn over molecular oxygen 
has been established. 
All the results here reported show that Fe-Mimochrome VI, suitably 
immobilized on an electrode surface, maintains its redox properties and the 
chemistry of the five-coordinate heme iron. The most intriguing feature is that it is 
able to catalytically reduce dioxygen, similarly to five-coordinated cytochrome c 
variants. This study opens the way to the development of electrocatalytic hybrid 
Mimochrome-modified electrode surfaces for biosensing in the clinical and 
pharmaceutical areas. 
 
113 
 
Chapter 5: Concluding remarks and future perspectives 
 
The main goal of this thesis was to develop sensitive third-generation 
electrochemical biosensors, based on artificial heme-protein mimetics. These new 
devices would be able to detect analyte of clinical interest in complex matrices. In 
order to accomplish this goal, the first step of this work was to select a suitable 
transduction method, to obtain label-free generic biosensors, that could be applied 
to the detection of a wide range of analytes, simply by varying the recognition 
element.  
The field of third generation biosensors grew a few years ago when it was found 
that direct electrochemistry with redox proteins is possible without using a co-
substrate (Armstrong and Cox, 1987), but efficient direct electron transfer 
reactions have been reported for a restricted number of redox enzymes. In fact, 
direct ET can be difficult to achieve and the electron transfer rates between the 
majority of redox proteins and electrode surfaces are prohibitively slow. There are 
several possible reasons for this (Zhang and Li, 2004).  
Direct electron transfer can be difficult to achieve, and the electron transfer 
rates between the majority of redox proteins and electrode surfaces are often 
prohibitively slow (Zhang and Li, 2004). There are several possible reasons, as 
reported in the following: 
 Unfavourable orientation of protein molecules on electrode surface may 
hinder electron exchange between the electrode and the electroactive 
centre of the proteins, which is usually deeply buried inside the 
polypeptide chains, especially in larger proteins.  
 The "bad" orientation may increase the distance between the redox 
centre and the electrode surface, thus limiting the direct 
electrochemistry of the molecules (Zhang and Li, 2004).  
 The monolayer concentration/coverage of the redox protein on the 
electrode surface decreases as the protein size increased, thus 
resulting in low electrochemical signals.  
 Natural proteins can also denaturate on the electrode surface, blocking 
the electron exchange (Heller, 1990; Armstrong, 1990). 
Our strategy to overcome the above limitations was the exploitation of artificial 
proteins, designed on rational bases to possess the required activity, structural 
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robustness (to prevent denaturation on the electrode surface), and small size (to 
simplify the electron transfer path to the electrode and increase surface coverage). 
For application in biosensor technology, we have employed a particular class of 
heme-protein models, named Mimochromes. 
This work was divided into two parts:  
(i) the construction of an affinity electrochemical biosensor based on the redox 
transducer Fe(III)-Mimochrome IV Lys3; and  
(ii) the development of a bio-catalytic electrochemical biosensors based the 
artificial enzyme Fe(III)-Mimochrome VI. 
 
The first part of this thesis was focused on the translation of a biological 
interaction, the antigen-antibody binding, into an electrical signal using the esa-
coordinated heme-protein model Fe(III)-Mimochrome IV Lys3 as signal transducer. 
This model was developed starting from a class of analogs (Fe(III)-Mimochrome 
IV, Fe(III)-Mimochrome IV 8Lys and Fe(III)-Mimochrome IV 8Glu), synthesized 
and characterized in a previous PhD thesis. They showed a good ability in 
exchanging electrons with solid electrodes, making them suitable for application in 
biosensor technology. 
Starting from this point, the new model was developed to simplify its binding to 
a solid electrode surface and its functionalization with a recognition element. The 
most popular methods to bind a protein on a solid surface or to another protein, is 
by introducing functional groups on the ε-amino group of the Lys residues side 
chain. For this reason, two Gln residues in the sequence of the parental Fe(III)-
Mimochrome IV were substituted with Lys. 
The newly synthesized molecule was electrochemically characterized, using 
square wave and cyclic voltammetry, to understand its ability to exchange 
electrons with an electrode surface. Fe(III)-Mimochrome IV Lys
3
 showed a well-
defined electrochemical behavior, when freely diffusing to a glassy carbon 
electrode surface. 
A method to covalently immobilise the peptide to a gold electrode surface was 
developed. The immobilization of biomolecules onto surfaces of electrically-
conducting materials is an active area of research, useful for a range of 
applications, involving the construction of electrochemical biosensors. A general 
methodology that is currently being used for this purpose, is the self-assembly of 
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various functional groups onto specific surfaces. In this work, the best 
immobilization of Fe(III)-Mimochrome IV Lys3 was obtained employing a SAM of 
11-mercaptoundecanoic acid, activated at the terminal carboxyl group with an 
hydroxysuccinimide ester, which reacts with primary amines, such as the ε-amino 
group of the free Lys residue on one of the peptide chains of the molecule. 
Electrochemical studies allowed us to understand that, once covalently bound 
to the gold surface, Fe(III)-Mimochrome IV Lys3 maintains its redox properties. Its 
electrochemical behaviours were consistent with literature data. 
The next step in the development of the biosensor was focused on the 
functionalization of the heme-protein with the chosen recognition element, a 
specific epitope recognized by the antibody to be detected. In fact, the 
immunosensor developed uses an epitope as biorecognition element, in order to 
detect the specific antibody, which constitutes the analyte to be determined. The 
chosen biorecognition element was a synthetic epitope (HA_ep) of the 
hemagglutinin A of the human influenza virus, Haemophilus Influenzae. A rapid 
and simple functionalization protocol was developed to bind the epitope to the 
heme-protein mimetic, employing the heterobifunctional crosslinker sulfo-SMCC. 
This makes our model immunosensor really versatile. In fact, it can be easily used 
for the application to a wide range of analytes, by simply changing the recognition 
element. 
The complex Fe(III)-Mimochrome IV Lys3-HA_epitope was covalently 
immobilized on the gold electrode surface through the activated terminal carboxyl 
groups contained in the 11-MUA monolayer. The direct electron transfer of Fe(III)-
Mimochrome IV Lys3, once conjugated to the epitope, was evaluated by SW and 
cyclic voltammetry. The molecule showed a reversible behavior, with well-defined 
signals, demonstrating that the coupling with epitope has not remarkable influence 
on the redox properties of Fe(III)-Mimochrome IV Lys
3
. 
Preliminary experiments on the target antibody detection were performed in 
the presence of an excess of anti-HA_epitope IgG. The developed biosensor 
demonstrated to respond to the presence of the specific antibody. The detection of 
the antibody in solution occurs via the attenuation of the Fe(III)-Mimochrome IV 
Lys3 current signal as antibodies bind to the HA_epitope. In the absence of the 
epitope, presence of the antibody does not cause any changes in the signal. 
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The development of this model biosensor system and the first experiments in 
analyte detection were done to proof the working hypothesis. We have developed 
a new model of a label free immunoaffinity electrochemical sensor based on the 
modulation of amperometric signals of surface-bound redox species. Further 
experiments are required, in order to determine the limits of detection of the 
antibodies. Therefore, the system will be optimized and eventually applied to the 
recognition of other analytes, of clinical and pharmaceutical interest.  
 
The second part of this project was focused on the application of the artificial 
enzyme Fe(III)-Mimochrome VI in the development of a totally sinthetic catalytic 
electrode surfaces. Mimochrome VI was developed to engineer into the 
Mimochrome scaffold a catalytic site, by creating a cavity able to accommodate 
small molecules and/or substrates. It is an attractive system to be exploited as 
novel catalyst or as a constituent of hybrid synthetic interfaces in electrochemical 
sensing devices.  
To understand the possibility of the application of Fe(III)-Mimochrome VI in the 
field of biosensing, the iron complex of this molecule was characterized by the 
electrochemical point of view. In particular, the ability of exchange electrons with 
an electrode surface was investigated performing cyclic voltammetry experiments 
on the freely diffusing molecule at a gold electrode coated with a SAM of 4-
mercapto-pyridine. Fe(III)-Mimochrome VI showed a quasi reversible, well-defined 
electrochemical behavior. 
The next step was related to the biosensor assembly. Fe(III)-Mimochrome VI 
was adsorbed on a gold electrode coated with a SAM of decane-1-thiol, taking 
advantage of the hydrophobic interaction between the SAM and the non-polar 
patch of the heme-peptide. Cyclic voltammetry analysis of the adsorbed molecule 
allowed to study the electrochemical behaviour of Mimochrome VI. Notably, once 
adsorbed on the SAM coated electrode, two redox state-dependent 
electrochemically active conformers of Fe-Mimochrome VI were detected, which 
interconvert depending on the applied potential. This hypothesis was supported by 
analysis of the CD spectra in the Soret region of the oxidized and reduced Fe-
Mimochrome VI, in solution.  
The thermodynamics and kinetics of the electron transfer process for the 
Fe(III)/Fe(II) couple of Fe-Mimochrome VI, adsorbed on the SAM-coated gold 
117 
 
electrode, were also determined, in order to verify that the immobilization produces 
a stable hybrid interface allowing for fast heterogeneous electron transfer (ET). In 
these conditions, Fe-Mimochrome VI was found to maintain its redox properties 
and the chemistry of a five-coordinate heme iron; and it was also able to exchange 
electrons with the electrode at a reasonable rate. 
The developed biosensor was tested for the ability of catalytically reduce 
dioxygen. The reaction was followed by cyclic voltammetry: the adsorbed Fe-
Mimochrome VI was able to electrocatalytically reduce dioxygen at the heme iron, 
as previously observed for five-coordinate heme iron-containing cytochrome c 
variants. This study opens the way to the development of electrocatalytic hybrid 
Mimochrome-modified electrode surfaces for biosensing in the clinical and 
pharmaceutical areas. 
In summary, the developed biosensor models, based on the use of totally 
synthetic heme-protein mimetics and peptides interfaces, demonstrated the 
possibility of creating a new class of third generation electrochemical biosensors, 
potentially applicable to the detection of a wide range of analytes. Their possible 
applications range from environmental, food and clinical analysis. 
Future work of this project will include a deep investigation of the response of 
the immunosensor, at different concentration of the specific antibody, in order to 
determine the detection limit.  
It would be also interesting to proof the biosensor working with a different 
recognition element/analyte pair, such as biotin and streptavidin, or a larger 
antigen and the corresponding antibody. 
Future studies would also include further investigation of the immobilization 
methods of Fe-Mimochrome VI with different SAMs, adsorbed or covalently linked, 
to improve the electron transfer rate and the stability of the system. 
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Chapter 6: Experimental section 
 
6.1 Solid phase peptide synthesis 
Since R. B. Merrifield‟s report (Merrifield, 1963) on the solid phase chemical 
synthesis of peptides and small proteins, solid-phase peptide synthesis (SPPS) 
has become a widely utilized technique for the production of peptides and small 
proteins.  
The basic idea of the solid-phase approach involves the covalent attachment 
(anchoring) of the growing peptide chain to an insoluble polymeric support (resin); 
in this way unreacted soluble reagents can be removed simply by filtration and 
washing, without losses of the growing peptide chain. Subsequently, the insoluble 
peptide-resin is elongated by addition of α-amino- and side-chain-protected amino 
acid residues in a series of addition reactions, which must be performed with high 
yields. Excess soluble reagents are used to drive sequential coupling and 
deprotection reactions to completion. The repetitive nature of the coupling and 
deprotection steps has led the major portion of the SPPS method to automation. 
The acid-labile Boc group or base-labile Fmoc-group are used for the N-α-
protection of amino acids. The general scheme of SPPS using Fmoc chemistry is 
illustrated in Figure 3.2. Fmoc- protected amino acids are most popular in SPPS 
since a mild basic treatment, using piperidine, can be used for the Fmoc-group 
removal at every stage. The final cleavage and deprotection of the peptidyl resin is 
accomplished using TFA. An N-α-derivatized amino acid is attached to an 
insoluble (solid) support, via a flexible linker. The N-α-blocking group is then 
removed (deprotected) and the amino acid-linker-support is thoroughly washed 
with solvent. The next amino acid (which is also N-α-protected) is then coupled to 
the amino acid-linker-support directly in the presence of coupling reagents. The 
coupling may also be carried out using peptides instead of single amino acids: this 
method is referred to as fragment condensation (Simmerman et al., 1982). After 
the completeness of the coupling reactions, the N-α-dipeptide (or oligopeptide)-
linker-support is washed with the solvent. The deprotection/coupling cycle is 
repeated until the desired sequence of amino acids is generated. The peptide-
linker-support is cleaved to obtain the peptide as a free acid or amide, depending 
on the chemical nature of the linker. The cleavage reagent also removes the 
amino acid side chain protecting groups, which are stable to the deprotection 
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reagent. These steps may be carried out as either a batch process, where the 
support is filtered between each step, or as a continuous flow process, where the 
support is always solvated during reagent exchange and the release of the 
protecting groups is monitored spectrometrically. 
Figure 6.1: General approach to solid phase peptide synthesis using Fmoc chemistry. 
Peptides are synthesized from the C-terminus to the N-terminus by stepwise addition of 
N-α-amino- and side chain-protected amino acid residues to an insoluble polymeric 
support (resins). Final cleavage of the peptidyl resin and side chain deprotection is 
achieved using TFA. 
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     Materials and Methods 
 
6.1.1 Materials 
All 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids, Sieber amide 
resin and coupling reagents: Nhydroxybenzotriazole (HOBt), 2-(1H-benzotriazole-
1-yl)-1,1,3,3 tetramethyluronium hexafluorophosphate (HBTU), and benzotriazole-
1-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP) were 
purchased from NovaBiochem (EMD Biosciences, La Jolla, CA). PAL-PEG-PS 
resin was purchased from  Applied Biosystems. 
Silica gel 60 (230-400 mesh) was from Merck. Precoated silica G-60 plates, 
F254, were used for thin-layer chromatography (tlc).  
All solvents used in the peptide synthesis and purification were anhydrous and 
HPLC grade respectively, and were supplied by Romil. Piperidine and scavengers 
(ethanedithiol, thioanisol, triisopropylsilane) were from Fluka. N,N-
Diisopropylethylamine (DIPEA), trifluoroacetic acid (TFA)  were supplied from 
Applied Biosystems. N,N-dimethylformamide (DMF), dichloromethane (DCM), 
pyridine, ethanol, methanol and ninhydrin reagent and 1-methyl-2-pyrrolidone 
(NMP) were supplied by Romil.  Deuteroporphyrin IX was from Porphyrin 
Products. Iron(II) acetate, tetramethylsilane, sulfo-SMCC and EDTA were from 
Sigma Aldrich. Solvent mixtures are indicated in the respective sections. 
 
6.1.2 Solid phase synthesis of peptides 
Mimochrome IV Lys3 peptide, HA_epitope, Mimochrome VI decapeptide, 
Mimochrome VI tetradecapeptide were synthesized using  Fmoc solid phase 
peptide synthesis (SPPS) on an ABI 433 automatic peptide synthesizer on a 0.25 
mmol scale for Mimochrome VI tetradecapeptide, and 0.2 mmol scale for 
HA_epitope, Mimochrome VI decapeptide and Mimochrome IV Lys
3
 peptide. The 
resin used for the Mimochrome peptides was the super acid labile Sieber Amide 
(substitution level 0.52 mmol/g). For the HA_epitope, the resin used was the PAL-
PEG-PS (substitution level 0.16 mmol/g). For the synthesis of the four peptides the 
following amino acids were used: 
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Mimochrome IV Lys3: Fmoc-Glu(OtBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-
Lys(Boc)-OH,    Fmoc-Leu-OH, Fmoc-His(Trt)-OH, Fmoc-Asn(Trt)-OH , Fmoc-
Lys(Mmt)- OH, Fmoc-Arg(Pbf)-OH. 
 
Mimochrome VI decapeptide: Fmoc-Asp(OtBu)-OH; Fmoc-Glu(OtBu)-OH; 
Fmoc-Gln(Trt)-OH; Fmoc-Leu-OH; Fmoc-Ser(tBu)-OH; Fmoc-Lys(Mmt)-OH; 
Fmoc-Arg (Pbf)-OH. 
 
Mimocrome VI tetradecapeptide: Fmoc-Asp(OtBu)-OH; Fmoc-Glu(OtBu)-
OH; Fmoc-Gln(Trt)-OH; Fmoc-Leu-OH; Fmoc-His(Boc)-OH; Fmoc-Ser(tBu)-OH; 
Fmoc-Lys(Mmt)-OH; Fmoc-Arg(Pbf)-OH; Fmoc-Lys(Boc)-OH; Fmoc-Ile-OH; 
Thr(tBu)-OH. 
 
 HA_epitope: Fmoc-Cys(Trt)-OH; Fmoc-Tyr(tBu)-OH; Fmoc-Pro-OH; Fmoc-
Asp(OtBu)-OH; Fmoc-Val-OH; Fmoc-Ala-OH. 
 
For all the peptides  the same synthetic procedures were used. The first step 
was the synthesis of  the fully protected peptides. The synthetic procedure can be 
summarized as follow.  
The α- Fmoc group, was removed at the beginning of every cycle with a 20% 
piperidine solution. After deprotection, the resin was washed with NMP to remove 
the piperidine. The peptide resin was then ready for coupling. All amino acids were 
coupled using a 0.45 M HBTU/HOBT solution in DMF. In the coupling step, the 
activated Fmoc aminoacid reacts with the amino-terminal group of the growing 
peptide chain to form a peptide bond. Deprotection and coupling steps were 
repeated with each subsequent amino acid, until the chain assembly was 
completed. When the coupling was complete, the resin was washed with NMP. 
Peptides N-terminal amino groups were acetylated with acid acetic (1mmol, 57 μl). 
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6.1.3 Cleavage of the peptides from the resin 
 
6.1.3.1 Cleavage and deprotection of HA_epitope 
The final peptide product was released from the resin in its fully deprotected 
form by treatment with TFA. Some scavengers (i.e., molecules that react 
preferentially with free radical and other reactive species released during the 
cleavage reaction) like thioanisole, ethanedithiol and anisole were added to avoid 
undesirable modification of the peptide during the cleavage process. At the end of 
the synthesis, the resin was washed three times each with DMF, DCM and 
methanol and allowed to dry. To cleave the peptide from the resin and deprotect 
the side chains, the resin was transferred to a flask and a freshly prepared 
cleavage mixture (2% anisole, 5% thioanisole, 3% ethanedithiol, 90% TFA; 10 ml) 
was added, and the reaction mixture was incubated for 2 hours (1 hour in an ice 
bath, 1 hour at room temperature) with stirring. The resin was filtered and the 
solution was collected by draining it into a 50-ml glass flask, then the resin were 
washed again with undiluted TFA. The crude peptide was precipitated immediately 
by adding 5 volumes of cold diethyl ether to the collected reaction mixture. The 
mixture was centrifuged, the supernatant was removed and the precipitate was 
washed twice with three volumes of cold diethyl ether. The peptide was dried to 
remove diethyl ether, redissolved in water and lyophilized.  
 
6.1.3.2 Mmt deprotection and cleavage of Mimochromes peptides 
The protocol of Mmt deprotection and cleavage from the resin was the same 
for all the Mimochromes peptides.  
After the final assembly on the resin, the N-ε Mmt protecting group of the Lys 
residue was removed by repeated treatments with a solution containing 10% 
acetic acid and 20% trifluoroethanol (TFE) in CH2Cl2 (10 ml) for 15min. Each step 
was repeated until no yellow or red trityl cations were detected in the eluent .  
The product thus obtained, was transferred  into a reaction vessel. To release 
the peptide from the resin, 3-4 resin volumes of a freshly prepared cleavage 
mixture (1%TFA  in DCM, 20 ml) were added. The acidic mixture was incubated 
for 2 minutes, under mixing. The solution was filtered with a vacuum pump, into an 
ice-cold flask containing 2 ml of 10% pyridine/methanol (v/v). Finally, the resin was 
washed with DCM and methanol. The reaction was followed by TLC 
124 
 
(chloroform/methanol/acetic acid 80:18:2); each step was repeated until no 
product was detected in the collected fractions. The fractions containing the 
product were combined.  
 
6.1.4 Purification of the peptides 
 
6.1.4.1 Purification of HA-epitope 
Purification of the fully deprotected peptide was accomplished by preparative 
RP-HPLC (Shimadzu LC-8A, equipped with a SPD-M10 AV detector), on a 2.2 cm 
Vydac C18 column, at a flow rate of 22 mL min-1, with a gradient of acetonitrile in 
0.1% aqueous TFA, 5% to 95% over 35 min. The pooled fractions containing the 
desired products were lyophilized. The peptide was homogeneous as determined 
by analytical HPLC and by MALDI mass spectrometry (MALDI/MS). MALDI/MS 
measurements were made on a Voyager DE instrument Perkin-Elmer operating at 
the Centro di Metodologie Chimico-Fisiche, University of Naples Federico II. 
240 mg of pure product (83% yield were obtained on the basis of the resin 
initial substitution level). 
 
6.1.4.2 Purification of Mimochrome peptides 
The pooled fractions obtained from the cleavage reaction were evaporated 
under reduced pressure up to 5% of the volume.  Ice-cold water was added to the 
residue and the mixture was cooled on ice to aid precipitation of the protected 
peptide. The product was filtered, washed several times with fresh water, and 
dried under vacuum to give the crude C-terminal peptide amide. 
Analytical RP-HPLC (Vydac C18 column, using a gradient of acetonitrile in 
0.1% aqueous TFA, 50% to 90% over 20 min, flow rate 1 mL min-1) showed a 
main peak for all the protected peptides: therefore the coupling reaction was 
performed without further purification of the peptides. 
The side chain protecting groups were found to be stable in both deprotection 
and cleavage reactions.  
The yield of reaction are the followings: 
 Mimochrome IV Lys3 peptide:                240 mg of  product (62% yield) 
 Mimochrome VI tetradecapeptide:         570 mg  of product (70% yield) 
 Mimochrome VI decapeptide:                320  mg of product (80% yield) 
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6.1.5 Coupling of Mimochrome peptides to deuteroporphyrin 
 
6.1.5.1 Synthesis of Mimochrome IV Lys3 free base 
The coupling reaction between the carboxyl groups of the porphyrin scaffolds 
and the free ε amino groups of Lys8 was achieved by using HATU as activant. 
The coupling reaction was performed in DMF at room temperature. 
The first step was the deuteroporphyrin activation. The deuteroporphyrin IX 
dihydrochloride (24 mg, 0.042 mmol, M.W. 583.5 g/mol) was dissolved in a small 
volume of DMF and DIEA (0.2 mmol, M.W., 129,24 g/mol; density, 0.742 g/mL). 
Then, 2 equivalents of HATU (M.W., 380.23 g/mol), other 2 equivalents of DIEA 
were added to this solution, and the reaction mixture was allowed to react for 15 
min. In the following step, the activated deuteroporphyrin was added to a solution 
containing the peptide (214 mg, 0.1 mmol, M.W. 2146 g/mol) in DMF and DIEA (3 
equivalents). Additional DIEA was added to bring pH at ~ 7/8.  In order to favour 
the formation of the bis-substituted deuteroporphyrin IX, the mixture of the 
activated porphyrin was slowly added to the solution of the nonapeptide. This 
approach gave good average yields. 
 
The proceeding of the reaction was followed by analytical RP-HPLC on a 
Vydac C8 colum. After completion of the reaction (usually in 24 hours) the mixture 
was evaporated to dryness and extracted with chloroform and acid water (10% 
2 
Figure 6.2: Schematic representation of Mimochrome IV Lys3 coupling. 
+ +2 H2O 
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citric acid  p/v) to eliminate the reagents (DIEA, HATU and the peptide). The 
organic phase was anydrificated and evaporated under vacuum.  
The next step was the deprotection of the aminoacid side chains. It was 
achieved at room temperature by addition of the cleavage mixture 
(TIS/H2O/EDT/TFA 0.1/2.5/2.5/9.5, v/v/v/v). The thiol-based scavengers were 
added to avoid any side reaction that might occur when the protecting groups were 
removed from the peptide side chains. The deprotection was complete in 2 h; 
then, the solvent that contained the crude product was evaporated under reduced 
pressure to 5% of the volume. Ice-cold diethyl ether was added to the residue and 
the mixture was cooled on ice to aid product precipitation. The mixture was 
centrifuged, the supernatant was removed and the precipitate was washed twice 
with three volumes of diethyl ether. The peptide was dried, redissolved in water 
and then it was further purified by HPLC on a Vydac C18 column (2.2 x 25 cm; 10 
µm), eluted with a linear gradient of acetonitrile 0.1 % TFA (v/v) from 5 % to 90% 
over 66 min, at a flow rate of 22 ml/min. The fractions containing the desired 
products were pooled, verified by LC-ESI-MS (Figure 3.6 a,b) and lyophilized. 52 
mg of pure product (53% yield) were obtained. 
 
6.1.5.2 Synthesis of Mimochrome VI free base 
Synthesis of the decapeptide-deuteroporphyrin mono-substituted derivative: 
the Mimochrome VI decapeptide (100 mg, 0.040 mmol), deuteroporphyrin IX2HCl 
(28 mg, 0.048 mmol, and DIEA (0.032 mL, 0.184 mmol) were dissolved in 30 mL 
of DMF. A solution of PyBop (25 mg, 0.048 mmol), HOBt (7.5 mg, 0.048 mmol), 
and DIEA (0.017 mL, 0.096 mmol) in DMF (10 mL) was then added dropwise. The 
reaction mixture was stirred for 3 h at room temperature, and the pH was verified 
every 20 min, and adjusted with DIEA, if necessary. The reaction was monitored 
by analytical HPLC (Vydac C8 column, using a gradient of acetonitrile in 0.1% 
aqueous TFA, 50% to 90% over 20 min), and by tlc (solvent system 
chloroform/methanol 90:10, Rf = 0.52). The reaction mixture was evaporated 
under reduced pressure up to 20% of the volume, and precipitated with cold 
diethylether. The crude product was purified on a silica gel column (5  60 cm), 
with stepwise elution using a chloroform/methanol gradient from 0 to 10% 
methanol. The product was eluted at 10% methanol, and obtained in a 48% yield. 
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Analytical RP-HPLC (Figure 4.3 a) and MALDI/MS spectrometry (Figure 4.3 b) 
confirmed the purity and the identity of the product (2980 amu). 
 
Synthesis of Mimochrome VI free base: monopeptide adduct (50 mg, 0.017 
mmol), tetradecapeptide (52 mg, 0.017 mmol), and DIEA (0.009 mL, 0.051 mmol) 
were dissolved in 16 mL of 20% TFE in DMF. A solution of HATU (6.5 mg, 0.017 
mmol) in 1 mL of DMF was then added dropwise, and the reaction was allowed to 
proceed at room temperature for a total of 2 h. The pH was checked during the 
reaction time. The reaction progress was followed by analytical HPLC (Vydac C8 
column, using a gradient of acetonitrile in 0.1% aqueous TFA, 50% to 90% over 20 
min, flow rate 1 mL min-1), and by tlc (solvent system chloroform/methanol 90:10, 
Rf = 0.80). The reaction mixture was evaporated under reduced pressure up to 
20% of the volume, and precipitated with cold diethylether, and finally centrifuged. 
The crude product was dried in vacuo. Side chain deprotection was achieved 
by addition of the cleavage mixture (thioanisole/H2O/EDT/TFA 0.25/0.5/0.5/8.75, 
v/v/v/v) (1,2-ethanedithiol: EDT) at 0 °C for 2.5 h. This treatment was performed 
twice. The reaction mixture was concentrated on a rotary evaporator to a volume 
of approximately 1-2 mL. Extraction of the scavengers and precipitation of the 
crude product was achieved by addition of cold diethylether. The crude material 
was then dried in vacuo and purified by preparative RP-HPLC (Vydac C18 column, 
using a gradient of acetonitrile in 0.1% aqueous TFA, 10% to 80% over 35 min); 
Decapeptide 
Deuteroporphyrin 
IX Mono-adduct                          
decapeptide-deuteroporphyrin 
IX 
Figure 6.3: Schematic representation of the decapeptide-deuteroporphyrin 
coupling.  
 
+ H2O 
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the pooled fractions containing the desired product were lyophilized, affording 25 
mg (7.2  10-3 mmol, yield 42%) of Mimochrome VI. Analytical RP-HPLC (Figure 
4.4 a) indicated that the purified product was > 99% pure, and ESI-MS (Figure 4.4 
b) confirmed the expected molecular weight (3502 amu). 
 
6.1.6 Iron insertion 
Iron ion was inserted into Mimochrome IV Lys3 and Mimochrome VI according 
to literature procedures (Buchler, 1978). Iron (II) acetate (10 molar excess) was 
added to a solution of pure Mimochromes free bases in TFE (≈ 2  10-6 mol, final 
concentration, 1.0  10-4 M), and the reaction mixture was kept at 50 °C for 2 h, 
refluxing under nitrogen. The reaction was monitored by analytical HPLC. The 
solvent was then removed under vacuum, and the product was purified to 
homogeneity by preparative RP-HPLC (Vydac 2.2 cm C18 column at 22 mL min-1, 
using a gradient of acetonitrile in 0.1% aqueous TFA, 10% to 80% over 58.4 min 
for Fe(III)-Mimochrome VI, 5 % to 90% over 66 min for Fe(III)-Mimochrome IV 
Lys3). Pure products were obtained as the TFA salt (yeld was 44% for Fe(III)-
Mimochrome IV Lys3 and 54% for Fe(III)-Mimochrome VI). ESI-MS confirmed the 
expected molecular weight (Figure 3.7 c, 4.5 c) (Fe(III)-Mimochrome IV Lys3 2806 
amu, Fe(III)-Mimochrome VI: 3552 amu). 
 
 
 
Mono-adduct                          
decapeptide-deuteroporphyrin IX 
 
Tetradecapeptide- 
 
Mimochrome VI free base 
 
Figure 6.4: Synthesis of Mimochrome VI free base.  
 
+ H2O 
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6.2 Synthesis of the conjugated Fe(III)-Mimochrome IV Lys3-Ha_ep 
 
6.2.1 Fe-Mimochrome IV Lys3 activation with sulfo-SMCC 
Because of the high hydrophilicity of the sample, Fe (III)-Mimochrome IV Lys3 
solution was assayed for its concentration by UV-vis spectroscopy. A sample of 
the molecule (≈ 1 mg) was dissolved in 500 µl of H2O 0.1% TFA. This stock 
solution was diluted 1:1000. The diluted sample was transferred in a quartz 
cuvette with a path length of 1 cm, and its UV-Visible spectrum recorded (Figure 
6.5) (on a Cary Varian 5000 UV Spectrophotometer, see below). The 
concentration of the solution was determined as follow: 
Abs = 0.348;  ε = 103.000 M-1cm-1;   l = 1 cm 
[Mimo IV Lys3] = 3.4 mM; nmimo = 1.7*10
-6 mol  5.5 mg 
 
250 µl of the stock solution were added to 1 ml of 100 mM phosphate buffer, 
pH 7.2 (reaction buffer), to reach a final concentration 0.68  mM of the molecule. A 
solution of sulfo-SMCC (1 eq, 0.42 mg, dissolved in the reaction buffer) was added 
to the Fe(III)-Mimochrome IV Lys3 solution. The reaction was carried out for 1 hour 
at room temperature, under stirring. After 1 hour, the proceeding of the reaction 
was controlled via LC-MS (Figure 3.11). The chromatogram (Figure 3.11 a) 
showed the presence of two new peaks corresponding to the mono- and the bis-
functionalized products (see section 3.5.1).  
Figure 6.5: UV-vis spectrum of Fe(III)-Mimochrome IV Lys3 in H2O 0.1 % 
TFA (pH 2). 
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6.2.2 Fe-Mimochrome IV Lys3 functionalization with HA_ep 
The Fe(III)-Mimochrome IV Lys3 mono-sulfo-SMCC was used without further 
purification. HA_ep was added to the reaction mixture in a molar ratio 3.5 to the 
activated Fe(III)-Mimochrome IV Lys3 (3*10-6 mmol, 3.7 mg HA_ep). 
The mixture was allowed to react for 2 hours at room temperature, under 
continuous stirring. The proceeding of the reaction was followed by LC-MS (Figure 
3.13). After two hours, the analysis of the chromatogram and the mass spectra 
showed the complete functionalization of the Fe(III)-Mimochrome IV Lys3-SMCC 
with HA_epitope. The product was purified to homogeneity by preparative RP-
HPLC (Vydac 1 cm C18 column, using a gradient of acetonitrile in 0.1% aqueous 
TFA, 5 % to 90% over 66 min, at 5 mL min-1). The fraction containing the desired 
product were pooled, lyophilized and then dissolved in 0.1 M phosphate buffer, pH 
7. The concentration was checked by UV-vis (Figure 6.6) and it was 0.16 mM, tne 
reaction yield was 57.4%. 
 
 
 
 
 
 
 
 
Figure 6.6: UV-Vis spectrum of the complex Fe(III)-Mimochrome IV 
Lys3-HA_epitope in 0.1 M phosphate buffer, pH 7. 
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6.3 Voltammetric analysis 
 
All cyclic and square wave voltammetry experiments were performed with a 
Potentiostat/Galvanostat µAUTOLAB Type III (Ecochemie) using a three-electrode 
cell for small volume samples (0.5-1 ml) purchased from BASi, under argon. 
Temperature controlled measurements were conducted using a thermo-cryostat 
R2 (Grant).  
For all the measurement on Fe(III)-Mimochrome IV Lys3, a 3 mm-diameter 
glassy carbon and a 1.6 mm-diameter polycrystalline gold electrode were used as 
working electrode, for the freely diffusing and the immobilized species, 
respectively. A Pt wire and a Ag | AgCl | NaCl 3 M as counter and reference 
electrode, respectively. A Vycor (PAR) set ensured the electric contact between 
the Ag/AgCl electrode and the working solution. 
For all the measurement on Fe(III)-Mimochrome VI, a 1 mm-diameter 
polycrystalline gold electrode was used as working electrode, and a Pt sheet and a 
saturated calomel electrode (SCE) as counter and reference electrode, 
respectively. A Vycor (PAR) set ensured the electric contact between the SCE and 
the working solution. 
 
Materials and Methods 
 
6.3.1 Materials 
Alumina was from BASi. 11-mercaptoundecanoic acid, 1-decanthiol, di-sodium 
hydrogen phosphate dihydrate, sodium dihydrogen phosphate monohydrate and 
sodium chloride were purchased from Sigma-Aldrich. Sodium perchloride, 
potassium hexacyanoferrate, N-hydroxysuccinimide (NHS) and N-(3-
dimethylaminopropyl)-N‟-ethylcarbodiimide (EDAC) were from Fluka. All solvents 
(H2O, ethanol, methanol, nitric acid) were obtained from Romil. All solutions and 
buffers were prepared with ultra pure water. 
For all voltammetric analysis, argon gas was purged through the solution for at 
least 20 minutes to remove any dissolved oxygen before every experiment. An 
argon atmosphere was maintained over the solution during the measurements. 
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6.3.2 Cleaning of the electrodes 
Glassy carbon electrodes were polished mechanically with an abrasive 
alumina powder. An alumina water-suspension (0.3 µm particle size) was dropped 
on a texmet pad. The electrodes were moved in a figure-of-eight motion for three 
minutes during polishing, to ensure uniform polishing. The electrode surface was 
then rinsed with deionized water, and the polishing procedure was repeated using 
a smaller particle size alumina (0.05 µm). Once polishing was completed, the 
electrode surface was rinsed thoroughly with deionized water, then sonicated first 
in distilled water and then in methanol for 5 minutes to ensure complete removal of 
all traces of the polishing material. 
Gold electrodes were treated with HNO3 3 M, by dropping 5 µl of the acid on 
the surface of the electrode. After 15 minutes, electrodes were rinsed thoroughly 
with deionized water, then the same polishing procedure described above for GCE 
was applied. 
The degree of polishing of gold electrodes was evaluated by looking at the 
difference in the peak potential for the redox couple of Ferri/Ferrocyanide, which is 
expected to be close to 60 mV (Ranganathan et al., 1999). A 10 mM ferricianide 
solution in ethanol/0.1 M NaClO4 50/50 (v/v) was used to register a cyclic 
voltammogram at a scan rate of 0.05 V/s. 
 
6.3.3 Voltammetric analysis of the freely diffusing species 
 
6.3.3.1 Freely diffusing Fe(III)-Mimochrome IV Lys3 
Square-wave and cyclic voltammetry experiments on freely diffusing Fe(III)-
Mimochrome Lys3 were performed using a glassy carbon electrode as working 
electrode, at 25 C˚. A 0,1 M Fe(III)-Mimochrome IV Lys3 solution in 10 mM 
phosphate buffer and 100 mM NaClO4 at pH 7 was used. The sample volume in 
the electrochemical cell was 1.0 ml. SW voltammograms were recorded at the 
scan rates 3.7, 4.8 and 37.5 mV/s, while for CV the measurements were 
performed at 0.025, 0.5 and 5 V/s. 
 
6.3.3.2 Freely diffusing Fe(III)-Mimochrome VI 
Cyclic voltammetry experiments on freely diffusing Fe(III)-Mimochrome VI were 
carried out using a polycrystalline gold disk coated with 4-mercapto-pyridine as 
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working electrode, at 20 C˚. Modification of the electrode surface was performed 
by dipping the polished electrode into a 1.0 mM solution of 4-mercaptopyridine in 
water for 30 s, then rinsing it with ultrapure water. A 1.0 µM solutions of Fe(III)-
Mimochrome VI, in 5.0 mM phosphate buffer and 20 mM NaClO4 at pH 7 was 
used. The sample volume in the electrochemical cell was 0.5 ml. 
 
6.3.4 Immobilization of Mimochromes on gold 
 
6.3.4.1 Covalent binding of Fe(III)-Mimochrome IV Lys3 and Fe(III)-
Mimochrome IV Lys3-HA_ep 
Electrode coating with the 11-MUA SAM was done by dipping the cleaned 
electrode into a 1.0 mM 11-MUA solution in ethanol, for 18 h at room temperature. 
Then the electrode was thoroughly rinsed with ethanol and ultrapure water, and 
then SAM formation was checked by studying the electron-transfer reaction of a 
the K3Fe(CN)6 solution (10 mM ferricianide solution in ethanol/0.1 M NaClO4 50/50 
v/v), previously used for the control of the cleaning procedure of the electrode 
surface. When the SAM formation was complete, the SAM carboxyl groups were 
activated by immersing the electrode in a solution of EDC 75 mM / NHS 15 mM in 
water, for 1.5 hours at room temperature. After this, the electrode was removed 
from the activating solution and thoroughly rinsed with deionized water. The 
activated electrode surface was immediately immersed in a 0.1 mM Fe(III)-
Mimochrome IV Lys3 solution (or Fe(III)-Mimochrome IV Lys3-HA_epitope) in 0.1 
M phosphate buffer, pH 7, for 1 hour at room temperature. After this step, the 
surface was rinsed with deionized water to remove unreacted protein molecules. 
Finally, a 1.0 M solution of Tris  buffer, pH 8, was used to quench the activated 
carboxyl groups of 11-MUA that didn‟t reacted with the molecule, by immersing the 
electrode for 15 minutes; the electrode was then rinsed with deionized water. 
Functionalized electrodes were stored into phosphate buffer solution before 
starting measurements. 
 
6.3.4.2 Adsorption of Fe(III)-Mimochrome VI 
Electrode coating with the decane-1-thiol (DT) SAM was done by dipping the 
cleaned electrode into a 1.0 mM ethanolic DT solution for 12 h at 4 °C and then 
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rinsing the electrode with ethanol and MILLIQ water. The formation of the SAM 
was followed with the same method described above for Mimochrome IV Lys3. 
Adsorption of Fe-Mimochrome VI was achieved by dipping the functionalized 
electrode into a freshly prepared 1.0 µM Fe-Mimochrome VI solution (checked 
spectrophotometrically) made up in 5.0 mM phosphate buffer at pH 7, for 4 h at 4 
°C. 
 
6.3.5 Voltammetric analysis of the immobilized species 
 
6.3.5.1 Fe(III)-Mimochrome IV Lys3 and Fe(III)-Mimochrome IV Lys3-
HA_ep 
SWV and CV experiments on the peptide (or conjugate)-coated electrodes 
were performed in 1.0 ml 10 mM phosphate buffer at pH 7, at 25 °C. All 
voltammograms were collected between -700 and +100 mV, at potential scan rate 
of 37.5 mV/s for SWV and between 0.5-10 V/s for CV. CV measurement at 
different scan rate were used to verify the effective bonding of the molecules to the 
surface.  
The formal redox potential (E°‟) was calculated from the average of the 
cathodic and anodic peak potentials. Experiments were repeated at least two 
times, and the E°‟ values were found to be reproducible within ± 5 mV. 
Antibody detection was performed by adding 2.0 μg of monoclonal antibody 
anti-HA_ep to the measurement buffer in the electrochemical cell, using an 
antibody stock solution (1.0 μg/μl). The solution was stirred for 10 minutes, then 
stirring was stopped and the cell was allowed to equilibrate for 60 seconds before 
recording SW voltammograms. 
 
6.3.5.2 Fe(III)-Mimochrome VI 
CV experiments on the peptide-coated electrodes were performed in 5 mM 
phosphate buffer at pH 7, at different scan rates (0.02-10 V/s). The reduction 
potentials (E°') of Fe-Mimochrome VI, taken as the average of the anodic and 
cathodic peak potentials, were invariably found to be reproducible within 2 mV. 
To estimate the % surface coverage of the peptide-coated electrode, the area of 
the immersed portion of the gold wire was calculated after each cyclic voltammetry 
(CV) session by applying the Randles-Sevcik relationship to the CV signal 
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obtained for a solution of ferricinium tetrafluoborate (an electrochemical standard) 
using the bare electrode dipped into the standard solution at exactly the same 
depth of the peptide-coated electrode. The electron-transfer rate constants, ks, for 
the adsorbed peptide, were determined with the method of Laviron, that is 
measuring the cathodic and anodic peak potentials at varying scan rate. The ks 
values were averaged over five measurements and found to be reproducible within 
10%, which was taken as the associate error. 
The reaction thermodynamics of Fe(III) to Fe(II) reduction for Mimochrome VI 
can be determined from variable-temperature E°‟ measurements carried out using 
a “non-isothermal” electrochemical cell, in which the reference electrode is kept at 
constant temperature (21 ± 0.1 °C) whereas the half-cell containing the working 
electrode and the Vycor junction is under thermostatic control. For this 
experimental configuration S°'rc was determined from the slope of the E°' versus 
T profile which is linear when assuming that S°'rc is constant over the limited 
temperature range investigated (from 5 to 35 °C). Using the same assumption, the 
enthalpy change (H°'rc) can be obtained from the Gibbs-Helmholtz equation, 
namely as the negative slope of the plot of E°'/T versus 1/T. The non-isothermal 
behavior of the cell was carefully checked by determining the H°'rc and S°'rc 
values of the ferricyanide/ferrocyanide couple.  
The electrocatalytic reduction of dioxygen by the immobilized Fe-Mimochrome 
VI was investigated by gradually adding air to the initially O2-free cell solution at 
normal atmospheric pressure, at 20 °C. 
 
6.4 Circular dichroism and UV-Vis analysis 
 
6.4.1 CD analysis of Mimochrome VI 
CD spectra were obtained at 25°C on a Jasco J-715 dichrograph. Data were 
collected from 470 to 360 nm at 0.2 nm intervals with a 20 nm min-1 scan speed, a 
1 nm bandwidth and a 16 s response. In order to improve signal to noise ratio, 
spectra were averaged on 5 accumulations. Cuvette path length of 1 cm was 
used. Sample concentration was 2.0*10-5 M, in 5 mM sodium phosphate buffer, pH 
7. The ferrous form of Mimochrome VI was obtained by adding a 2000 molar 
excess of dithionite to the solution of the ferric sample. CD intensities are reported 
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as total molar ellipticities (deg cm2 dmol-1). Absorption spectra have been collected 
as HT voltage and converted into absorbance by JASCO Spectra Manager 
standard software. All data are blank subtracted. 
 
6.4.2 UV-Vis spectroscopy  
UV-Vis spectra were recorded on a Cary Varian 5000 UV Spectrophotometer. 
All measurements were performed at room temperature. Quartz cuvettes with a 
path length of 1.0 cm were used for most measurements. Wavelength scans were 
performed at 25 °C (unless otherwise specified) from 200 nm to 800 nm, with a 
300 nm min-1 scan speed. Wavelength scans were performed at 25 °C from 200 
nm to 800 nm, with a 300 nm min-1 scan speed. 
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